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“The saddest aspect of life right now is that science  
gathers knowledge faster than society gathers wisdom.” 
Isaac Asimov (1902-1992)  
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Ac  acetyl 
acac  acetylacetonate 
aq.  aqueous 
ATR  attenuated total reflection 
Bu  butyl 
Bn  benzyl 
calc.  calculated 
dba  trans,trans-dibenzylideneacetone 
DMF  N,N-dimethylformamide 
DMSO  Dimethyl sulfoxide 
e.g.  exempli gratia, for example 
EI  electron ionization (MS) 
equiv  equivalent(s) 
Et  ethyl 
EX  electrophile 
FG  functional group 
GC  gas chromatography 
Hal  halogen 
Het  undefined heteroaryl substituent 
HRMS  high resolution mass spectrometry 
i  iso 
i.e.  id est, that is 
IR  infrared spectroscopy 
J  coupling constant (NMR) 
M  mol L-1 
Me  methyl 
Met  metal 
mol%  equiv.•10-2 
m.p.  melting point 
MS  mass spectrometry 
NMR  nuclear magnetic resonance 
PG  protecting group 
Ph  phenyl 
Piv  pivaloyl 
ppm  parts per million 
Pr  propyl 
 R  undefined organic substituent 
sat.  saturated 
t  tert 
THF  tetrahydrofuran 
TLC  thin layer chromatography 
TMP  2,2,6,6-tetramethylpiperidine 
TP  typical procedure 
vol  volume 
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1 Overview 
In 2018, according to the International Agency of Research on Cancer (IARC), an estimated 18.1 
million new cases of cancer occurred worldwide causing 9.6 million deaths.1 In the following 5 years 
there will be an estimated 43.8 million people diagnosed with this deadly disease. By 2030, the global 
burden is expected to rise up to 21.7 million new cancer cases simply due to the aging and increase of 
the world’s population. This tremendous expansion of cancer accompanied by other epidemics or 
terminal illnesses require a constant development of new drugs that can fight against these diseases or 
at least relieve occurring pain in the most bearable way.  
 
To tackle these challenges, the FDA’s Center for Drug Evaluation and Research (CDER) approved 48 
new drugs in 2019, which is the third highest approval number in history. In 2018 with 59 approvals, 
the development of new compounds reached its temporary high.2 The majority of the new therapeutic 
drugs (35) are still categorized in the broad class of small organic molecules with a low molecular 
weight (< 900 g mol-1). Alpelisib (Piqray®, Novartis, anti-breast cancer, 1), Darolutamide (Nubeqa®, 
Roche, anti-prostate cancer, 2), Istradefylline (Nourianz®, Kyowa Kirin, Parkinson, 3) and 
Lumateperone (Caplyta®, intra-cellular-therapies, 4) are four typical examples for such approved small 
molecule drugs. Nowadays, these agents are identified in high throughput screenings using large 
chemical libraries of synthetic small molecules or natural products. This process is known as classical 
pharmacology in which the tools and knowledge of a synthetic organic chemist are irreplaceable.3 
 
Figure 1: Selected small molecules approved as therapeutic drugs in the U.S. by the FDA in 2019. 
 
1  International Agency for Research on Cancer (2018, September 12th): Latest global cancer data: Cancer burden 
rises to 18.1 million new cases and 9.6 million cancer deaths in 2018; Retrieved from: 
https://www.iarc.fr/www.iarc.fr › wp-content › uploads › 2018/07 › pr223_E  
2 A. Mullard (2020, January 8th): 2019 FDA drug approvals; Retrieved from: doi: 10.1038/d41573-020-00001-7 
3 J. A. Lee, M. T. Uhlik, C. M. Moxham, D. Tomandl, D. J. Sall, J. Med. Chem. 2012, 55, 4527.   
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In fact, the field of organometallics have turned out to be capable of developing such difficult scaffolds, 
where the conventional synthetic methods reached their limits.4 Nobel Prize laureate E.-I. Negishi once 
said: “Nowadays, it is not only unwise but rather difficult to accomplish an efficient and selective 
multiple synthesis without using organometallics.”5 Since 1760, when Louis-Claude Cadet de 
Gassicourt prepared the first organometallic species,6 these compounds have shown a variable 
applicability in the formation of new carbon-carbon and carbon-heteroatom bonds and with that in hand, 
they provide access to complex molecules and many applications in total synthesis.7  
However, the reactivity of organometallic reagents is determined by the polarity of the carbon-metal 
bond. Compounds with a high ionic character (Figure 2), such as organolithium, are highly reactive, 
but often require low temperatures reaction temperatures (below –78 °C)8 and need to be stored in 
hydrocarbon solvents to avoid degradation by ethereal solvents.9 Due to their high reactivity, functional 
group tolerance is comparatively low, which can lead to side reactions. Because of their less polarized 
metal-carbon bond, magnesium and aluminum organometallics are significantly less reactive with an 
improved tolerance of functional groups. 
 
Figure 2: Electronegativity difference of selected metals relative to carbon (Pauling electronegativity scale).10 
On the other end of the scale, there are elements like gallium and bor. Further, these elements are likely 
to tolerate a broad scope of reaction partners with a minor reactivity. Whereas, zinc organometallics 
show a perfect balance between reactivity and functional group tolerance and additionally being prone 
to be quite stable in solution.  
 
4 R. H. Crabtree, Organometallics 2011, 30, 17. 
5 E.-I. Negishi, Organometallics in Organic Synthesis, Wiley-VCH, Weinheim, 1980. 
6 D. Seyferth, Organometallics 2011, 20, 1488. 
7 K. C. Nicolaou, J. S. Chen, in Classics in Total Synthesis III, Wiley-VCH Verlag GmbH, 2011.   
8 For a general review, see: a) P. Knochel, H. Leuser, L.-Z. Gong, S. Perrone, F. Kneisel in Handbook of 
Functionalized Organometallics, (Eds.: P. Knochel), Wiley-VCH, Weinheim 2005; b) P. Knochel, P. Millot, A. 
L. Rodriguez, C. E. Tucker in Organic reactions, (Eds.: L. E. Overman), Wiley & Sons Inc., New York, 2001, 
p. 1. 
9 H. Gilman, B. J. Gaj, J. Org. Chem. 1957, 22, 1165. 
10 A. Boudier, L. O. Bromm, M. Lotz, P. Knochel, Angew. Chem. Int. Ed. 2009, 39, 4414.   
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2 Organozinc Compounds 
2.1 Overview 
The research field of organozinc compounds can look back on a history, which last already for over 
170 years. In 1849, Frankland and co-workers already discovered diethyl- and dimethyl zinc as the first 
organozinc compounds.11 Since then, organozinc compounds played in important role in numerous 
applications in modern organic synthesis. The Simmons-Smith cyclopropanation12 and the Reformatsky 
reaction13 are two well-known examples. Furthermore, due to the presence of empty p-orbitals of 
appropriate energy, which facilitates 4-membered transition states leading to mixed zinc-copper 
species, organozinc compounds easily undergo transmetalation reactions with various copper salts. 
These zinc-copper reagents are more reactive due to the presence of nonbonding, nucleophilic d-
electrons that interact in an oxidative process with the electrophile and mediate the formation of the 
new carbon-carbon bond, despite containing the thermodynamically more stable carbon-copper bond.14 
The ability to transmetalate to palladium in the Negishi cross-coupling reactions granted the organozinc 
compounds being a powerful and essential tool in organic synthesis. In 2010, Ei-ichi Negishi, Richard 
F. Heck and Akira Suzuki were rewarded with the Nobel Prize in Chemistry for their pre-eminent work 
in the field of carbon-carbon bond formation.15 Organozinc compounds are one of the most versatile 
and advantageous reagents in cross-coupling chemistry. They have a high functional group tolerance 
and good reactivity without producing any toxic byproducts.16 However, organozinc compounds show 
an instability when exposed to air, which can be related to hydrolysis by air.  
2.2 Preparation of Organozinc Compounds 
2.2.1 Oxidative Insertion 
Based on the preparation of organomagnesium compounds, the most common method for the direct 
preparation of organozinc reagents is the insertion into organic halides using zinc powder. To avoid the 
typical drawbacks of using expensive organic iodides and high reaction temperatures, Rieke et al. 
developed highly active zinc (Zn*), which is prepared by reduction of ZnCl2 with lithium naphtatilde. 
These reagents allow the preparation of functionalized organozinc compounds from the less reactive 
 
11 E. Frankland, Liebigs Ann. Chem. 1849, 71  ¸171.  
12 a) H. E. Simmons, R. D. Smith, J. Am. Chem. Soc. 1958, 80, 5323; b) H. E. Simmons, R. D. Smith, J. Am. 
Chem. Soc. 1959, 81, 5323; c) H. Lebel, J.-F. Marcoux, C. Molinaro., A. B. Charette, Chem. Rev 2003, 203, 977. 
13 a) S. Reformatsky, Chem. Ber. 1887, 20, 1210; 1895, 28, 2842; b) R. Ocampo, Tetrahedron 2004, 60, 9325. 
14 P. Knochel, H. Leuser, L.-Z. Cong, S. Perrone, F. F. Kneisel, in Handbook of FunctionalIized Organometallics, 
Wiley-VCH Verlag GmbH 2008, pp.251. 
15 X.-F. Wu, P. Anbarasan, H. Neumann, M. Beller, Angew. Chem. Int. Ed. 1020, 49, 9047. 
16 a) P. Knochel, J. Almena, P. Jones, Tetrahedron 1998, 54, 8275; b) A. Boudier, L. O. Bromm, M. Lotz, P. 
Knochel, Angew. Chem. Int. Ed. 2000, 39, 4414; c) P. Knochel, N. Millot, A. L. Rodriguez, C. E. Tucker, Org. 
React. 2001, 58, 417; d) A. Lemire, A. Côté, M. K. Janes, A. B. Charette, Aldrichimica Acta 2009, 42, 71.   
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alkyl bromides (Scheme 1).17 Hence, starting from ethyl 4-bromobutyrate (5) the organozinc bromide 
(6) was formed using the Rieke zinc. In a subsequent addition to benzoyl chloride in the presence of 
CuCN·2LiBr the desired ethyl 5-oxo-5-phenylpentatnoeate (7) was formed in 95% yield over two steps 
(Scheme 1).17b  
 
Scheme 1: Zinc insertion using Rieke zinc and subsequent acylation.17b 
Since the Rieke reagent always has to be freshly prepared, Knochel and co-workers developed a 
procedure using commercially available zinc powder in the presence of LiCl for the insertion to highly 
functionalized halides under mild conditions (Scheme 2).18 With this method in hand, the preparation 
of benzylic, aromatic and heteroaromatic zinc reagents has been developed, tolerating a variety of 
functional groups like nitriles, aldehydes and esters. The role of LiCl has been investigated by means 
of experimental, computational and analytical studies.19 Furthermore, LiCl increases the solubility of 
the formed organozinc reagents in THF. Thus, in the insertion reaction a “clean” metal surface is 
regenerated, which allows a further reaction with the starting halide.18a,20 Therefore, the aromatic 
bromide 8 was converted into the zinc species 9 at 25 °C and subsequently underwent a copper catalyzed 
allylation forming the allylated product 10 in 91% yield. Furthermore, the preparation and palladium-
catalyzed cross-coupling of zinc reagent 12 led to the arylated heteroatomic compound 13 in 85% yield 
(Scheme 2).18a.b 
 
 
17 a) R. D. Rieke, P. T.-J. Li, T. P. Burns, S. T. Uhm, J. Org. Chem. 1981, 46, 4322; b) L. Zhu, R. M. Wehmeyer, 
R. D. Rieke, J. Org. Chem. 1991, 56, 1445.   
18 a) A. Krasovskiy, V. Malakhov, A. Gavryushin, P. Knochel, Angew. Chem. 2006, 118, 6186; b) N. Boudet, S. 
Sase, P. Sinha, C.-Y. Liu, A. Krasovskiy, P. Knochel, J. Am. Chem. Soc. 2007, 129, 12358; c) A. Metzger, M. A. 
Schade, P. Knochel, Org. Lett. 2008, 10, 1107.   
19 a) C.-Y. Liu, X. Wang, T. Furuyama, S. Yasuike, A. Muranaka, K. Morokuma, M. Uchiyama, Chem. Eur. J. 
2010, 16, 1780; b) K. Koszinowski, P. Böhrer, Organometallics 2009, 28, 771; c) J. E. Fleckenstein, K. 
Koszinowski, Organometallics 2011, 30, 5018.   
20 a) A. Krasovskiy, B. F. Straub, P. Knochel, Angew. Chem. Int. Ed. 2006, 45, 159; b) C. Feng, D. W. 
Cunningham, Q. T. Easter, S. A. Blum, J. Am. Chem. Soc. 2016, 138, 11156.   
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Scheme 2: Preparation of functionalized organozinc reagents using zinc dust in the presence of LiCl.18a,b 
2.2.2 Iodine-Zinc Exchange 
Alternatively, organozinc compounds can be formed from organic iodides. They are prepared through 
an exchange reaction using a more reactive organozinc reagent. The driving force in this reaction is the 
formation of the more stable organometallic reagent.21 For instance, iPr2Zn in the presence of Li(acac) 
(acac = acetylacetonate) can perform iodine-zinc exchange on various iodinated aromatics and 
heteraromatics.22 Using this method, the aryl iodide 14 could be transformed into the diorganozinc 
species 15 at room temperature and furnishes 2-(cyclohexanecarbonyl)-4-formyl-6-methoxyphenyl 
acetate (16) after a smooth acylation in 75% yield (Scheme 3).22 
 
Scheme 3: Preparation of diorganozinc reagents through a Li(acac)-mediated iodide-zinc reaction.22  
2.2.3 Metalation 
The directed metalation using metal bases is another approach to obtain functionalized organometallics. 
Strong alkyllithium bases and lithium amides, such as n-BuLi or LDA, are extensively used for this 
matter. Due to their very high reactivity, undesired side reactions often occure. In addition, their strong 
nucleophilicity and low functional group tolerance have been a serious problem for the use of these 
bases. Another disadvantage of lithium bases is their low stability in THF at room temperature. Thus, 
reaction temperatures below –78 °C are necessary to perform these metalations. Knochel and co-
workers solved this problem, by developing the highly active mixed Mg/Li-bases of type 
 
21 D. Hauk, S. Lang, A. Murso,Org. Process Res. Dev. 2006, 10, 733.   
22 F. F. Kneisel, M. Dochnahl, P. Knochel, Angew. Chem. Int. Ed. 2004, 43, 1017.   
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R2NMgCl·LiCl.23 TMP (2,2,6,6-tetrametyhlpiperydin) has shown to be the best amine for this kind of 
metalations. Since then TMPMgCl·LiCl (17) has been used in a variety of metalations.24 As, this base 
still has a limited functional group tolerance and high reactivity, Knochel and co-workers developed 
the high chemoselective TMP-zinc bases (TMP)2Zn·MgCl2·2LiCl (18) and TMPZnCl·LiCl (19). Both 
bases have the ability to metalate sensitive heterocycles and aromatics under mild conditions (Scheme 
4).25 
 
Scheme 4: TMP-bases 18 and 19 developed by Knochel and co-worker for the regioselective metalation and 
functionalization of aromatic and heteroaromatic scaffolds.25a,c 
 
 
23 a) A. Krasovskiy, V. Krasovskaya, P. Knochel, Angew. Chem. Int. Ed. 2006, 45, 2958; b) T. Kunz, P. Knochel, 
Angew. Chem. 2012, 124, 1994; Angew. Chem. Int. Ed. 2012, 51, 1958.   
24 a) B. Haag, M. Mosrin, H. Ila, V. Malakhov, P. Knochel, Angew. Chem. Int. Ed. 2011, 50, 9794; b) S. M. 
Manolikakes, N. M. Barl, C. Sämann, P. Knochel, Z. Naturforsch., B: Chem. Sci. 2014, 68, 411.   
25 a) S. H. Wunderlich, P. Knochel, Angew. Chem. Int. Ed. 2007, 46, 7685; b) S. H. Wunderlich, P. Knochel, Org. 
Lett. 2008, 10, 4705; c) M. Mosrin, P. Knochel, Org. Lett. 2009, 11, 1837; d) T. Bresser, G. Monzon, M. Mosrin, 
P. Knochel, Org. Process Res. Dev. 2010, 14, 1299; e) S. H. Wunderlich, C. J. Rohbogner, A. Unsinn, P. Knochel, 
Org. Process Res. Dev. 2010, 14, 339. 
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2.2.4 Transmetalation 
A different approach towards functionalized organozinc reagents is the treatment of organomagnesium 
or organolithium compounds with a ZnCl2 solution in THF leading to the transmetalation to the 
corresponding organozinc compounds. The driving force in this reaction is the more covalent and 
thereby more stable C–Zn bond. For example, the magnesium insertion into 5-chloro-3-methyl-1-
phenyl-1H-pyrazole (20) in the presence of ZnCl2 leads to the intermediate formation of the organo-
magnesium compound 22 (Scheme 5). Avoiding undesired side reactions the zinc salt traps this reagent 
and results in the stable zinc compound 22. A subsequent acylation in the presence of CuCN·2LiCl 
provides the desired ketone 23 in 91% yield.26 
 
Scheme 5: Transmetalation of organomagnesium compound of type 21 in the presence of ZnCl2.26 
An important tool for the functionalization of complex aromatic scaffolds is the lithiation of arenes and 
heteroarenes. This method has major drawbacks like an exceptionally high reactivity, instability at 
ambient temperature and limitations in terms of functional group tolerance. To solve this issue, Knochel 
and co-worker developed a procedure, which allows the use of TMPLi in the presence ZnCl2, MgCl2 or 
CuCN. For instance, the use of TMPZnCl·LiCl (19) in a reaction with 2,4-dichlorobenzonitrile leads to 
the metalation and subsequent trapping with I2 of the most acidic 3-position providing the functionalized 
aromatic 25, whereas the metalation with TMPLi in the presence of ZnCl2·LiCl furnishes the kinetic 
iodinated product 26. Furthermore, it was shown that the reaction of TMPLi with 24 is more than six 
times faster than the reaction of TMPLi with ZnCl2·LiCl which leads to this high regioselectivity 
(Scheme 6).27 
 
Scheme 6: Regioselectivity switch in the metalation of 24 using TMPLi in the presence of ZnCl2·LiCl or 
TMPZnCl·LiCl (19). aCalculated pka for H3, H5 and H6.27 
 
26 F. M. Piller, A. Metzger, M. A. Schade, B. A. Haag, A. Gavryushin, P. Knochel, Chem. Eur. J. 2009, 15, 7192.   
27 A. Frischmuth, M. Fernández, N. M. Barl, F. Achrainer, H. Zipse, G. Berionni, H. Mayr, K. Karaghiosoff, P. 
Knochel, Angew. Chem. Int. Ed. 2014, 53, 7928.   
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3 Solid Salt Stabilized Organozinc Reagents 
3.1 Overview 
As mentioned in Chapter 2, organozinc compounds play an important role in organometallic chemistry. 
With their high compatibility with a broad variety of functional groups, they are valuable reagents for 
transition metal mediated C–C bond formations, namely allylations,28 acylation29 or the Negishi cross-
coupling30 reactions. To overcome the problem of instability towards air and moisture, Knochel and co-
workers developed a new class of solid zinc organometallic compounds, which show enhanced air and 
moisture stability. After evaporation of the solvent, the obtained powders can readily be used on the 
benchtop and stored under argon for several weeks.31 These so called zinc pivalates can be prepared  by 
magnesium insertion or halogen–magnesium exchange followed by transmetalation with 
Zn(OPiv)2·2LiCl (OPiv = pivalate) to give the corresponding aryl, heteroaryl, and benzylic zinc 
reagents described with the proposed formula RZnOPiv·Mg(OPiv)X·2LiCl (X = Cl, Br, I) (Scheme 7, 
A and B).31a A halogen–lithium exchange followed by transmetalation with Zn(OPiv)2 proved to be a 
feasible way to prepare 2-pyridylzinc reagents.27d Another possible route is directed metalation using 
the sterically hindered base TMPMgCl·LiCl (17)23,24 and subsequent addition of Zn(OPiv)2, giving 
organozinc reagents described as RZnOPiv·Mg(OPiv)Cl·LiCl (Scheme 7, C). The air-stability of such 
zinc organometallics was substantially superior to organozinc pivalates prepared by magnesium 
insertion or exchange.31b In the presence of sensitive functionalities such as an aldehyde or a nitro group, 
the milder zinc amide base TMPZnOPiv·Mg(OPiv)Cl·LiCl (27) 31c may be used for highly selective 
metalation reactions to give the desired organozinc reagents, which undergoes a range of reactions with 
various electrophiles (Scheme 7, D). 
 
28 a) F. Dübner, P. Knochel, Angew. Chem. Int. Ed. 1999, 38, 379; b) F. Dübner, P. Knochel, Tetrahedron, 2000, 
41, 9233; c) H. Malda, A. W. van Zijl, L. A. Arnold, B. L. Feringa, Org. Lett. 2001, 3, 1169; d) C. A. Falciola, A. 
Alexakis, Eur. J. Org. Chem. 2008, 3765; e) K. Geurts, S. P. Fletcher, A. W. van Zijl, A. J. Minnaard, B. L. 
Feringa, Pure Appl. Chem. 2008, 5, 1025; f) E. Erdik, M. Koçoğlu, J. Organomet. Chem. 2009, 694, 1890.   
29 a) E. Nakamura, I. Kuwajima, J. Am. Chem. Soc. 1982, 106, 3368; b) P. Knochel, M. Yeh, S. Berk, J. Talbert, 
J. Org. Chem. 1988, 53, 2390; c) P. Knochel, S. A. Rao, J. Am. Chem. Soc. 1990, 112, 6146.   
30 a) E. Negishi, A. O. King, N. Okukado, J. Org. Chem. 1977, 42, 1821; b) E. Negishi, L. F. Valente, M. 
Kobayashi, J. Am. Chem. Soc. 1980, 102, 3298; c) G. Wang, N. Yin, E. Negishi, Chem. Eur. J. 2011, 17, 4118; 
d) E. Negishi, X. Zeng, Z. Tan, M. Qian,Q. Hu, Z. Huang in Metal-Catalyzed Cross-Coupling Reactions (Eds.: F. 
Diederich, A. de Meijere), 2nd ed., Wiley-VCH, Weinheim, 2004; e) A. A. Zemtsov, N. S. Kondratyev, V. V. 
Levin, M. I. Struchkova, A D. Dilman J. Org. Chem. 2014, 79, 818.   
31 a) S. Bernhardt, G. Manolikakes, T. Kunz, P. Knochel, Angew. Chem. Int. Ed. 2011, 50, 9205; b) C. I. Stathakis, 
S. Bernhardt, V. Quint, P. Knochel, Angew. Chem. Int. Ed. 2012, 51, 9428; c) C. I. Stathakis, S. M. Manolikakes, 
P. Knochel, Org. Lett. 2013, 15, 1302; d) J. R. Colombe, S. Bernhardt, C. Stathakis, S. L. Buchwald, P. Knochel, 
Org. Lett. 2013, 15, 5754; e) S. M. Manolikakes, M. Ellwart, C. I. Stathakis, P. Knochel, Chem. Eur. J. 2014, 20, 
12289. f) M. Ellwart, P. Knochel, Angew. Chem. Int. Ed. 2015, 54, 10662. g) T.J. Greshock, K. P. Moore, R. T. 
McClain, A. Bellomo, C. K. Chung, S. D. Dreher, P.S. Kutchikian, Z. Peng, I. W. Davies, P. Vachal, M. Ellwart, 
S. M. Manolikakes, P.  Knochel, P. G. Natermet, Angew. Chem. Int. Ed. 2016, 55, 13714–13718 h) J. M. 
Hammann, F. H. Lutter, D. Haas, P. Knochel, Angew. Chem. Int. Ed. 2017, 56, 1082–1086. i) Y.-H. Chen, M. 
Ellwart, G. Toupalas, Y. Ebe, P. Knochel, Angew. Chem. Int. Ed. 2017, 56, 4612. 
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Scheme 7: Protocols for the preparation of (hetero-)aromatic organozinc pivalates developed by Knochel and co-
workers.31a-c,e 
Due to the presence of many different salts in these compounds, the resulting structure of these reagents 
is very complex. Mulvey and co-workers performed structural studies on the crystal as well as in 
solution. They came to the conclusion, that adding solid zinc pivalate to metalated species leads to a 
complete transmetalation to the corresponding organozinc halide and Mg(OPiv)2. This salt then acts as 
an air and moisture scavenger and is likely to be responsible for the air and moisture stability of these 
reagents.32 
Therefore, a more accurate way to describe these trimetallic clusters would be the general formula: 
“RZnX·Mg(OPiv)2·nLiCl” (X = Br, I, Cl; n = 1–2). For the sake of clarity, the abbreviation RZnOPiv 
was used in this thesis. 
3.2 Preparation of Organozinc Pivalates from (Hetero-)Aryl Halides 
As mentioned in Chapter 3.1, starting from (hetero-)aromatic or benzylic halides the magnesium 
insertion reaction in the presence of LiCl at ambient temperature followed by addition of solid 
Zn(OPiv)2 led to the corresponding organozinc pivalates. Exchange reactions were performed by using 
iPrMgCl·LiCl at low temperature and a subsequent transmetalation with Zn(OPiv)2 gave the desired 
organozinc pivalates. In both cases, the solid organozinc pivalates were obtained after solvent 
evaporation in high vacuum (0.1 mbar, 3–6 h). Thus, the addition of iPrMgCl·LiCl to 5-bromo-2,4-
dimethoxypyrimidine (28) and a subsequent transmetalation with solid Zn(OPiv)2 led to the solid, air-
stable zinc reagent 29. This reagent underwent a carbocupration in the presence of CuCN·2LiCl with 
diethyl but-2-ynedioate (30), which was trapped with water furnishing the desired alkyne in 63% yield 
in which the Z-isomer was the major product (Z/E = 9:1).31e Starting from 1-(chloromethyl)-3-
(trifluoromethyl)benzene (31) the insertion of magnesium in the presence of the THF-soluble salt 
Zn(OPiv)2·2LiCl led to the benzylic zinc reagent 32, which after addition of 2 mol% PEPPSI-IPr and 
aryl bromide 33 produces the cross-coupling product 34 in 66% yield. Furthermore, Knochel and co-
 
32 A. Hernán-Gómez, E. Herd, E. Hevia, A. R. Kennedy, P. Knochel, K. Koszinowski, S. M. Manolikakes, R. E. 
Mulvey, C. Schnegelsberg, Angew. Chem. Int. Ed. 2014, 53, 2706.   
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workers recently found out, that zinc pivalates also undergo cobalt-catalyzed cross-coupling 
reactions.31g Thus, the addition of Zn(OPiv)2 to the freshly prepared Grignard reagent from the 
corresponding aryl bromide 35 lead to the solid zinc reagent 36 in quantitative yields. In a subsequent 
cobalt-catalyzed cross-coupling reaction the heteroaryl-heteroaryl compound 37 was obtained in 81 % 
yield (Scheme 8).  
 
 
Scheme 8: Preparation of solid, salt stabilized organozinc reagents and their application in carbometalations, 
Negishi cross-coupling reactions and in cobalt-catalyzed heteroaryl-heteroaryl cross-coupling reactions.31a,e,g 
After further investigation it was found, that zinc pivalates do not only show an excellent reactivity in 
Negishi cross-couplings. They also react in carbocuprations,33 1,4-additions34 as well as acylation 
reactions, allylation and additions to aldehydes (Scheme 9).31e 
 
33 a) A. Abramovitch, I. Marek, Eur. J. Org. Chem. 2008, 4924; b) J. P. Das, H. Chechik, I. Marek, Nat. Chem. 
2009, 1, 128; c) B. Dutta, N. Gilboa, I. Marek, J. Am. Chem. Soc. 2010, 132, 5588; d) C. Dunst, A. Metzger, E. 
A. Zaburdaeva, P. Knochel, Synthesis 2011, 3453; e) A. Frischmuth, P. Knochel, Angew. Chem. Int. Ed. 2013, 
52, 10084; f) Y. Minko, M. Pasco, H. Chechik, I. Marek, Beilstein J. Org. Chem. 2013, 9, 526; g) W. Gati, F. 
Couty, T. Boubaker, M. M. Rammah, M. B. Rammah, G. Evano, Org. Lett. 2013, 15, 3122; For reviews on 
carbocupration reactions see also: h) J. F. Normant, A. Alexakis, Synthesis 1981, 841; i) N. Krause in Modern 
Organocopper Chemistry (Ed.: N. Krause), Wiley-VCH, Weinheim, 2002; j) N. Chinkov, D. Tene, I. Marek in 
Metal-Catalyzed Cross-Coupling Reactions (Eds.: F. Diederich, A. de Meijere), 2nd ed. Wiley-VCH, Weinheim, 
2004. 
34 Rh-catalysis: a) M. Sakai, H. Hayashi, N. Miyaura, Organometallics 1997, 16, 4229; b) T. Hayashi, K. 
Yamasaki, Chem. Rev. 2003, 103, 2829; c) T. Hayashi, Russ. Chem. Bull. Int. Ed. 2003, 52, 2595; d) J. Le Nôtre, 
D. van Mele, C. G. Frost, Adv. Synth. Catal. 2007, 349, 432; e) J. C. Allen, G. Kociok-Köhn, C. G. Frost, Org. 
Biomol. Chem. 2012, 10, 32; Cu-catalysis: f) E. Nakamura, S. Matsuzawa, Y. Horiguchi, I. Kuwajima, 
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Scheme 9: Selected examples for the extended applications of arylzinc pivalates.31  
3.3 Preparation of Organozinc Pivalates by Metalation 
In addition, Knochel and co-workers developed a procedure for the direct metalation of aryl compounds 
using the sterically hindered base TMPMgCl·LiCl (17). The obtained magnesium compound was 
directly transmetalated with Zn(OPiv)2 and after evaporation of the solvent the solid zinc pivalates of 
type 38 were obtained. This procedure opens the scope to various arenes and heteroarenes furnishing 
solid zinc reagents with a very high stability towards air and moisture. As a general trend, the activity 
of the new zinc compounds is higher than 94% after 2 h exposure and even after 4 h these reagents still 
show an activity greater than 85% (Scheme 10).31b  
 
Scheme 10: Selected examples for the metalation of arenes and heterocycles using TMPMgCl·2LiCl (17) 
followed by addition of Zn(OPiv)2 and evaporation of the solvent. 
 
Tetrahedron Lett. 1986, 34, 4029; g) V. Wendisch, N. Sewald, Tetrahedron Asymmetry, 1997, 8, 1253; h) M. 
Kitamura, T. Miki, K. Nakano, R. Noyori, Bull. Chem. Soc. Jpn. 2000, 73, 999; i) M. Tissot, A. Pérez Hernández, 
D. Müller, M. Mauduit, A. Alexakis, Org. Lett. 2011, 13, 1524.   
A. INTRODUCTION   13 
Furthermore, these zinc pivalates can be stored over several months under nitrogen or argon in a sealed 
flask. They can always be redissolved in dry THF and undergo several reactions like acylations, 
allylations or cross-coupling reactions. Hence, the pyrazole derivative 39 was transformed into a zinc 
pivalate using the TMP-base 17 at –30 °C for 30 min followed by transmetalation with Zn(OPiv)2. After 
titration with iodine an exact amount of this solid was dissolved in THF under argon and underwent a 
palladium-catalyzed Negishi cross-coupling reactions obtaining the desired heterocyclic compound 42 
in 91% (Scheme 11). The same transformation was performed in technical grade THF and in air. 
Surprisingly, the yield only dropped by just 85%, which displays the moisture scavenger ability of the 
Mg(OPiv)2. In addition, the performance of zinc pivalates compared to their corresponding zinc 
chlorides was investigated. The zinc chloride of 2,6-dichloro-9-(methoxymethyl)-9H-purine (43a) 
underwent a Negishi cross-coupling with 4-iodoanisol (44) furnishing the desired product 45 in 62% 
yield. The corresponding zinc pivalate 43b lead to the same product with 81% over 12 h reaction time. 
 
Scheme 11: Preparation of the zinc pivalate 40 and Negishi cross-coupling reaction in different qualities of THF 
and under argon or in air. Comparison of the reactivity of 2,6-dichloropurinylzinc pivalate 43b and the 
corresponding zinc chloride 43a in Negishi cross-coupling with 4-iodoanisole 44.31b 
However, the methods for the preparation of solid organozinc reagents described above are not 
applicable for sensitive functionalities such as aldehydes or related carbonyl groups. To overcome this 
limitation Knochel and co-workers envisioned the use of a milder zinc amide base namely, 
TMPZnOPiv·Mg(OPiv)Cl·2LiCl (46) which is synthesized by addition of Zn(OPiv)2 to a solution of 
TMPMgCl·LiCl (17) in THF at 0 °C. A subsequent dilution with dry THF until a clear solution appeared 
led to a final concentration of 0.85–0.99 . This amide base is compatible with functionalities like nitro 
groups, heteroaromatic rings or aldehydes (Scheme 12).31c  
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Scheme 12: Preparation and reactivity of TMPZnOPiv·Mg(OPiv)Cl·2LiCl (46) and selected examples for 
application and stability of the resulting organozinc pivalates.31c 
Thus, using TMPZnOPiv·Mg(OPiv)Cl·2LiCl (46; abbreviated as TMPZnOPiv) readily metalated 1-
methyl-1H-indole-3-carbaldehyde (47) in 2-position. After evaporation of the solvent, the zinc pivalate 
48 was obtained as a solid in 88%. After determination of the activity by titration with iodine, the solid 
was dissolved in THF and underwent a smooth copper-catalyzed allylation, furnishing the desired 
product 49 in 98% yield. In addition, the air and moisture stable cumarin zinc pivalate 51 underwent a 
palladium catalyzed Negishi cross-coupling, obtaining the desired product 53 in 96% yield.31c 
( 
3.4 Preparation of Organozinc Pivalates from Allyl Halides 
Allylic zinc reagents are powerful and useful reagents in modern synthetic chemistry. They possess a 
high reactivity while having a tolerance to a broad scope of functional groups like esters and cyano 
functions.35 In addition, these zinc compounds are easily synthesized through zinc insertion into the 
corresponding allyl halide of type 54. Consequently, Knochel and co-workers developed a procedure 
to obtain solid allylic zinc reagents with an enhanced air and moisture stability.31f Using an insertion 
with Zn in the presence of LiCl and freshly prepared Mg(OPiv)2 into several allylic halides of type 54 
the corresponding zinc pivalates 55 were obtained in 51–91% yield. This reaction tolerates functional 
 
35 a) P. Knochel , R. Singer, Chem. Rev. 1993, 93, 2117; b) Y. Tamaru, A. Tanaka, K. Yasui, S. Goto, S. Tanaka, 
Angew. Chem. Int. Ed. 1995, 34, 787; c) M. Uchiyama, M. Koike, M. Kameda, Y. Kondo, T. Sakamoto, J. Am. 
Chem. Soc. 1996, 118, 8733; d) M. Nakamura, A. Hirai, M. Sogi, E. Nakamura, J. Am. Chem. Soc. 1998, 120, 
5846; e) A. Côté, A. B. Charette, J. Am. Chem. Soc. 2008, 130, 2771; f) J. P. Das, H. Chechik, I. Marek, Nat. 
Chem. 2009, 1, 128; g) W. Shi , C. Liu, A. Lei, Chem. Soc. Rev. 2011, 40, 2761.  
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groups such as esters and nitriles. Even though these solids react easily with air and moisture, they can 
be stored under argon and –24 °C for several months with a half time up to two years (Scheme 13). 
 
Scheme 13: Preparation of functionalized solid allylic zinc pivalates of type 55.31f 
In addition, it was found that LiCl was able to activate the zinc powder, whereas the Mg(OPiv)2 was 
found to be the key reagents for the long-term stability of the solid allylic reagents. As mentioned in 
chapter 3.3, zinc pivalates sometimes lead to higher yields than their corresponding zinc chlorides. 
Thus, Knochel and co-worker performed palladium catalyzed Negishi cross-coupling reactions with the 
cyclohex-1-ene-1-carbonitrile zinc reagents 55d and 56. This time, the zinc chloride 56 was not able to 
undergo any reaction (just traces were found), whereas the corresponding zinc pivalate 55a leads to the 
desired allylated heterocycle 57 in 79% yield. Moreover, it was found that the allylic zinc reagents of 
type 55 undergo smooth reactions with electrophiles such as carbonyl derivatives or acid chlorides with 
very high regioselectivity (Scheme 14). 
 
Scheme 14: Selected applications of allylic zinc reagents of type 55. 
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3.5 Preparation and Application of Pivaloxy Zinc Amide Enolates 
The arylation of enolates is an important transformation in organic chemistry. The so-called 
Reformatsky reagents are in situ generated ester zinc enolates.36 They have proven their utility in 
organic synthesis including palladium-catalyzed arylations, even though their lack of air and moisture 
stability.37 Like all other zinc pivalates, after evaporation of the solvent these compounds are obtained 
as powders with enhanced air and moisture stability. They are synthesized using the TMP-base 19 with 
a subsequent mixing with Mg(OPiv)2.31i Amides proved to be the best precursor for such a solid 
Reformatsky reagent. The use of N-morpholino acetamide (62b) furnished a stable compound, which 
could be stored for 4 weeks without an significant loss of activity (Scheme 15). 
 
Scheme 15: Preparation of several solid pivaloxy zinc amide enolates of type 62.31i 
Thus, in the presence of Pd(dba)2 (2 mol%) and DavePhos (4 mol%) the solid zinc reagent 63a 
underwent a smooth Negishi cross-coupling reaction with the aryl iodide 64, yielding the arylated 
enolate 65 in 90% yield. In addition, the zincated glycine derivate 63c reacted in a palladium-catalyzed 
benzylation with the 2-(chloromethyl)benzonitrile (66) at 25 °C over 4 h, providing the desired 
benzylated amide 67 in 91% (Scheme 16). 
 
 
36 P. G. Cozzi, Angew. Chem. 2007, 119, 2620-2623; Angew. Chem. Int. Ed. 2007, 46, 2568. 
37 a) J. F. Fauvarque, A. Jutand, J. Organomet. Chem. 1977, 132, C17-C19; b) J. F. Fauvarque, A. Jutand, J. 
Organomet. Chem. 1979, 177, 273; c) F. Orsini, F. Pelizzoni, Synth. Commun. 1987, 17, 1389; d) F. Orsini, F. 
Pelizzoni, L. M. Vallarino, J. Organomet. Chem. 1989, 367, 375; e) M. L. Hlavinka, J. R. Hagadorn, Tetrahedron 
Lett. 2006, 47, 5049-5053; f) S. Duez, S. Bernhardt, J. Heppekausen, F. F. Fleming, P. Knochel, Org. Lett. 2011, 
13, 1690. 
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Scheme 16: Arylation of solid zinc amide enolate 63a with aryl iodide 64. Palladium-catalyzed benzylation of 
the zincated glycine derivative 63cd.31i 
To demonstrate the applicability of the zinc reagents of type 63d, a synthesis of the potent anti-breast-
cancer agent (69) was performed. Starting from the readily metalated zinc reagent 63d, the desired 
product was obtained over 5-steps, including a cross-coupling and a Nenitzescu reaction, in 23% overall 
yield (Scheme 17). 
 
Scheme 17: Synthesis of the anti-breast-cancer drug candidate 69 starting from solid amide zinc enolate 63d.31i 
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4 Objectives 
Based on previous results regarding the allyl zinc pivalates we studied the preparation of the first solid 
alkynyl zinc compounds. Therefore, a novel protocol for the preparation of Mg(OPiv)2 stabilized 
reagents from corresponding alkynes using TMPZnOPiv (TMP = 2,2,6,6-tetramethylpiperidyl) as base 
was investigated. To reduce the instability against air and moisture this base was prepared without the 
additional hydroscopic LiCl. Thus, it was envisioned that the lack of LiCl might lead to less sensitive 
alkynyl zinc pivalates (Scheme 18).  
 
Scheme 18: Novel protocol for the preparation of alkynyl zinc pivalates. 
Moreover, the development of unprotected mono-pivaloyloxyzinc acetylide might be a powerful 
extension to the scope of the zinc pivalates. Such air-stable reagents are highly desirable organometallic 
building blocks, since the corresponding lithium or halogenomagnesium acetylides, which are widely 
used reagents for ethynylation, are highly air and moisture sensitive. The use of these reagents in copper 
catalyzed [3+2]-cycloadditions under a high regioselectivity in 5-position was also of large interest. To 
the best of our knowledge, this regioselectivity in 5-position has not been observed in copper-catalyzed 
regioselective azide-alkyne cycloadditions (CuAAC) so far and has only been realized by Fokin using 
a ruthenium catalyst. Furthermore, the preparation and application of bis-pivaloyloxyzinc pivalate was 
investigated (Scheme 19).  
 
 
Scheme 19: Preparation of solid mono- and bis-pivaloyloxyzinc acetylides using ethynyl magnesium bromide 
and ZnCl2. 
Another goal was, the preparation of solid (1H-tetrazol-5-yl)zinc pivalates. Thus, it was envisioned that 
the use of TMPZnOPiv might lead to the directed metalation in the 5-position of an N-protected 1H-
tetrazole to obtain the desired pivalate (Scheme 20). 
 
Scheme 20: Preparation of (1H-tetrazol-5-yl)zinc pivalates using TMPZnOPiv. 
 
B. RESULTS AND DISCUSSION    19 
 
 
 
 
B. RESULTS AND DISCUSSION 
  
B. RESULTS AND DISCUSSION    20 
1 A New Class of Solid Polyfunctional Alkynylzinc Pivalates with Enhanced 
Air and Moisture Stability for Organic Synthesis 
1.1 Introduction 
Polyfunctional alkynes are important target molecules in material and medicinal chemistry.38 They are 
also key intermediates for the synthesis of other common functional groups such as E- and Z- alkenes.39 
Alkynyl organometallics are privileged reagents for the synthesis of various functionalized alkynes.40  
Recently, we have reported41 a new class of zinc organometallics of the general formula 
RZnX·Mg(OPiv)2·nLiCl (abbreviated as RZnOPiv).32 The nature of R can be quite diverse: aryl31a,b,h, 
heteroaryl,31c,d benzyl,31g,42 alkynyl,43 ethynyl,44 allyl31f and C-enolates.31i Due to the presence of 
Mg(OPiv)2 these new zinc reagents show an enhanced air and moisture stability.32 These zinc 
organometallics were found to be valuable reagents for the performance of high-throughput screenings 
of biomolecules.31gc Related solid Reformatsky-enolates have been used for organic synthesis. Aryl- 
and heteroaryl-zinc pivalates proved to be unique bench-stable solid reagents for the performance of 
cobalt-catalyzed cross- couplings.31hd 
 
38 Recent reviews: a) B. M. Trost, C.-J. Li, in Modern Alkyne Chemistry, Wiley-VCH Weinheim, 2014, 424 pp; 
b) A. Fürstner, Angew. Chem. Int. Ed. 2013, 52, 2794; c) C. Torborg, M. Beller, Adv. Synth. Catal. 2009, 351, 
3027. 
39 B. M. Trost, J. T. Masters, Chem. Soc. Rev. 2016, 45, 2212. 
40 a) S. M. Rummelt, G.-J. Cheng, P. Gupta, W. Thiel, A. Fürstner, Angew. Chem. Int. Ed. 2017, 56, 3599; b) B. 
M. Trost, J. T. Masters, F. L. Le Vaillant, J.-P. Lumb, J. Org. Chem. 2016, 81, 10023; c) S. Thapa, A. Kafle, S. 
K. Gurung, A. Montoya, P. Riedel, R. Giri, Angew. Chem. Int. Ed. 2015, 54, 8236; d) S. Tang, L. Zeng, Y. Liu, 
A. Lei, Angew. Chem. Int. Ed. 2015, 54, 15850; e) G. A. Molander, B. W. Katona, F. Machrouhi, J. Org. Chem. 
2002, 6667, 8416; f) M. Sonoda, A. Inaba, K. Itahashi, Y. Tobe, Org. Lett. 2001, 3, 2419; g) T. Ooi, T. Miura, K. 
Takaya, H. Ichikawa, K. Maruoka, Tetrahedron, 2001, 57, 867; h) M. J. Dabdoub, V. B. Dabdoub, J. P. Marino, 
Tetrahedron Lett. 2000, 41, 437; i) D. Tzalis, P. Knochel, Angew. Chem. Int. Ed. 1999, 38, 1463; j) J. H. Babler, 
V. P. Liptak, N. Phan, J. Org. Chem. 1996, 61, 416. 
41 a) Y.-H. Chen, M. Ellwart, V. Malakhov, P. Knochel Synthesis 2017, 49, 3215; b) S. Manolikakes, M. Ellwart, 
C. I. Stathakis, P. Knochel Chem. Eur. J. 2014, 20, 12289. 
42 Y.-H. Chen, S. Graßl, P. Knochel Angew. Chem. Int. Ed. 2018, 57, 1108.   
43 a) Y.-H. Chen, C. P. Tüllmann, M.  Ellwart, P. Knochel Angew. Chem. Int. Ed. 2017, 56, 9236; b) 
J. M. Hammann, L. Thomas, Y.-H. Chen, D. Haas, P. Knochel Org. Lett. 2017, 19, 3847. 
44 C. P. Tüllmann, Y.-H. Chen, R.J.  Schuster, P. Knochel Org. Lett. 2018, 15, 4601. 
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1.2 Preparation of Polyfunctional Alkynyl Zinc Pivalates 
Thus, the preparation of a new class of alkynylzinc pivalates of type 71 bearing various functional 
groups and displaying an enhanced air and moisture stability was described. They are obtained in high 
yields from the corresponding alkynes of type 70 by deprotonation using the mixed zinc-magnesium 
base TMPZnCl·Mg(OPiv)2 (3; TMP = 2,2,6,6-tetramethylpiperidyl; abbreviated as TMPZnOPiv). 
Further, the utility of alkynylzinc reagents of type 71 for the formation of new carbon-carbon bonds 
including their participation in 1,3-dipolar-cycloadditions without the cleavage of the carbon-zinc bond 
was demonstrated. An application to the preparation of a carboxyamidotriazole with significant anti-
cancer activity completed our study.   
Preliminary studies have shown that the deprotonation of trimethylsilylacetylene (70a) with 
TMPZnOPiv·LiCl (46) proceeded smoothly  but produced a solid alkynylzinc reagent (71a) with 
moderate air stability (44% activity after 4 h in air). We speculated that this problematic air and moisture 
sensitivity was due to the presence of LiCl and designed therefore a new synthesis of TMPZnOPiv (73) 
which did not contain LiCl.  
Thus, the treatment of TMP-H (72) with benzylmagnesium chloride in THF45 (40 °C, 12 h) followed 
by the addition of Zn(OPiv)2 provided TMPZnOPiv (73) in quantitative yield. The deprotonation of 70a 
with TMPZnOPiv (73, 1.2 equiv) afforded after solvent evaporation the corresponding alkynylzinc 
pivalate 71a with highly improved air stability (90% yield, determined after 4 h exposure to air) as 
shown in Scheme 21. This behaviour proved to be general and a range of polyfunctional alkynylzinc 
pivalates 71a–m) were obtained in 43-90% yield after 4 h of air exposure at 25 °C. Remarkably, a range 
of important functional groups such as a ketone, a nitrile or an ester are tolerated in the zinc reagents of 
type 71. 
 
45 X. Zhang, T. J. Emge, K. C. Hultzsch, Angew. Chem. Int. Ed. 2012, 51, 394; Angew. Chem. 2012, 124, 406. 
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Scheme 21: Preparation of alkynylzinc pivalates of type 71 from the corresponding alkynes of type 70 using 
TMPZnCl·Mg(OPiv)2 (73; abbreviated as TMPZnOPiv). aAlkynylzinc chlorides and Mg(OPiv)2 complexes are 
abbreviated as alkynylzinc pivalates for clarity. bThe indicated yields are obtained after 4 h of exposure to air. 
cPreparation with TMPZnOPiv in the presence of LiCl (1 equiv). 
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1.3 Application of Solid Alkynyl Zinc Pivalates in Negishi Cross-Coupling Reactions 
Furthermore, we examined the reactivity of these new solid alkynylzinc pivalates of type 71 for the 
performance of Negishi cross-coupling reactions46 with various aryl halides. The screening of several 
palladium catalytic systems showed that the Buchwald ligand, DavePhos47, gave the best results in 
combination with Pd(dba)2 (2 mol%; dba = dibenzylideneacetone). Under these conditions, a range of 
aryl or heteroaryl iodides, bromides or chlorides of type 75–77 underwent smooth Negishi cross-
couplings producing arylated alkynes of type 74 (Table 1). Remarkably, a variety of sensitive functional 
groups were tolerated in these cross-couplings such as a ketone (entry 1), an aldehyde (entry 3), an 
unprotected indole (entry 4) or an amide (entry 7). The use of ethyl 6-chloronicotinate (76) provided 
alkyne 74b in 74% yield (entry 2) which was a key intermediate for the synthesis of tazarotene.48  
Table 1: Pd-catalyzed Negishi cross-coupling with solid alkynylzinc reagents of type 71 with various aryl 
halides leading to alkynes of type 74.a 
 
Entry Alkynylzinc reagent Electrophile Producta 
    
1 71a 75a 74a: 89% (25 °C, 6 h) 
    
2 71a 76 74b: 74% (60 °C, 16 h) 
  
 
 
3 71b 77 74c: 76% (40 °C, 12 h) 
  
 
 
4 71d 75b 74d: 68% (50 °C, 2 d) 
 
46 a) E.-i. Negishi, G. Wang, H. Rao, Z. Xu, J. Org. Chem. 2010, 75, 3151; b) E.-i. Negishi, M. Qian, F. Zeng, L. 
Anastasia, D. Babinski, Org. Lett. 2003, 5, 1597; c) E.-i. Negishi, L. Anastasia, Chem. Rev. 2003, 103, 1979; d) 
A. O. King, E.-i. Negishi, J. Org. Chem. 1978, 43, 358; e) A. O. King, N. O. Okukado, E.-i. Negishi, J. Chem. 
Soc., Chem. Comm. 1977, 683-684.  
47 a) R. Martin, S. L. Buchwald, Acc. Chem. Res. 2008, 41, 1461; b) D. S. Surry, S. L. Buchwald, Chem. Sci. 2011, 
2, 27. 
48 S. Frigoli, C. Fuganti, L. Malpezzi, S. Serra, Org. Process Res. Dev.  2005, 9, 646. 
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5 71e 75c 74e: 91% (40 °C, 14 h) 
  
 
 
6 71j 75d 74f: 93% (40 °C, 16 h) 
  
 
 
7 71j 75e 74g: 87% (50 °C, 2 d) 
  
 
 
8 71k 75f 74h: 80% (40 °C, 12 h) 
  
 
 
9 71l 75g 74i: 92% (40 °C, 12 h) 
aYield of analytically pure isolated product. . 
1.4 Acylation, Allylation and Aldehyde Addition of Solid Alkynyl Zinc Pivalates 
We also found that the alkynylzinc pivalates 71 undergo a smooth Pd-catalyzed acylation using 
thioesters as acylation reagents, a reaction pioneered by Fukuyama.49 The use of 4% DavePhos in 
combination with 2% Pd(dba)2 proved to be an excellent catalytic system. Thus, the alkynylzinc pivalate 
1e reacted with the thioester 78 providing alkynyl ketone 80 in 76% yield (Scheme 22). Furthermore 
the alkynylzinc pivalate 71i underwent a copper-catalyzed allylation with allyl bromide (79) using  
CuCN·2LiCl50  (10 mol%) as catalyst to afford the enyne 81 in 84% yield. Although such alkynylzinc 
reagents did not react readily with ketones, a smooth addition to aldehydes was promoted by AlMe3 as 
reported by Woodward.51 Thus, the alkynylzinc pivalate 71 added to benzaldehydes 82a–b at 25 °C 
within 16 h leading to propargylic alcohols 83a-b in 70-79% yield.  
 
 
49 H. Tokuyama, S. Yokoshima, T. Yamashita, T. Fukuyama, Tetrahedron Lett. 1998, 39, 3189. 
50 P. Knochel, M. C. P. Yeh, S. C. Berk, J. Talbert, J. Org. Chem. 1988, 53, 2390. 
51 J. Shannon, D. Bernier, D. Rawson, S. Woodward, Chem. Commun. 2007, 3945. 
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Scheme 22: Acylation, allylation and aldehyde addition using a solid alkynylzinc pivalates of type 71. 
1.5 Application of Solid Alkynylzinc Pivalates in Copper-catalyzed regioselective Azide-alkyne 
Cycloaddition 
In 2002, Sharpless, Fokin and Meldal reported copper-catalyzed regioselective azide−alkyne 
cycloaddition (CuAAC) leading to 1,4-substituted triazoles.52 This reaction is widely used in organic 
synthesis, drug discovery, biochemistry and polymer chemistry.53  
Now, we have found that the robust zinc reagents of type 71 underwent copper-catalyzed 1,3-dipolar 
cycloadditions54 with in situ generated benzyl azide 84 (from NaN3 and benzyl bromide) or aryl azides 
85a-b with complete regioselectivity.55 Smooth deuterolysis, allylation, amination56 or arylation proved 
the integrity of the carbon-zinc bond in intermediate 8 and produced the valuable 1,2,3-triazoles 87a-d 
 
52 a) V. V. Rostovtsev, L. G. Green, V. V. Fokin, K. B. Sharpless, Angew. Chem. Int. Ed. 2002, 41, 2596; b) C. 
W. Tornøe, C. Christensen, M. Meldal, J. Org. Chem. 2002, 67, 3057. 
53 a) P. Thirumurugan, D. Matosiuk, K. Jozwiak, Chem. Rev. 2013, 113, 4905; b) S. G. Agalave, S. R. Maujan, 
V. S. Pore, Chem. Asian J. 2011, 6, 2696; c) J. E. Hein, V. V. Fokin, Chem. Soc. Rev. 2010, 39, 1302; d) S. K. 
Mamidyala, M. G. Finn, Chem. Soc. Rev. 2010, 39, 1252; e) P. L. Golas, K. Matyjaszewski, Chem. Soc. Rev. 
2010, 39, 1338; f) J. C. Jewett, C. R. Bertozzi, Chem. Soc. Rev. 2010, 39, 1272; g) M. Meldal, C. W. Tornøe, 
Chem. Rev. 2008, 108, 2952; h) J. E. Moses, A. D. Moorhouse, Chem. Soc. Rev. 2007, 36, 1249. 
54 R. Huisgen, Angew. Chem. Int. Ed. 1963, 2, 565. 
55 The regioselectivity was confirmed by 1H-NMR, 13C-NMR, NOESY, HSQC and HMBC. 
56 a) A. M. Berman, J. S. Johnson, J. Am. Chem. Soc. 2004, 126, 5680; b) A. M. Berman, J. S. Johnson, J. Org. 
Chem. 2005, 70, 364; c) A. M. Berman, J. S. Johnson, J. Org. Chem. 2006, 71, 219; d) M. Campbell, J. S. Johnson, 
Org. Lett. 2007, 9, 1521; e) S. L. McDonald, Q. Wang, Chem. Commun. 2014, 50, 2535. 
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in 69-91% yield (Table 2).57 To the best of our knowledge, copper-catalyzed 1,3-dipolar cycloadditions 
with alkynylzinc derivatives have not been reported yet.58  
 
Table 2: Copper-catalyzed dipolar cycloadditions with alkynylzinc pivalates of type 71 providing 1,2,3-triazoles 
of type 87 via zinc intermediates 86. 
 
Entry Alkynylzinc reagent Electrophile Product 
  CH3CO2D 
 
1 71f 88 87a: 91% 
   
 
2 71g 79 87b: 87% 
  
 
 
3 71h 89 87c: 69% 
  
 
 
4 71d 41 87d: 72% 
 
 
57 Copper-catalyzed synthesis of 5-metallotriazoles using metal acetylides [Sn, Cu, Bi, Al and Au]: a) F. Wei, T. 
Zhou, Y. Ma, C.-H. Tung, Z. Xu, Org. Lett. 2017, 19, 2098; b) W. Wang, X. Peng, F. Wei, C.-H. Tung, Z. Xu, 
Angew. Chem. Int. Ed. 2016, 55, 649; c) W. Wang, F. Wei, Y. Ma, C.-H. Tung, Z. Xu, Org. Lett. 2016, 18, 4158; 
d) F. Wei, W. Wang, Y. Ma, C.-H. Tung, Z. Xu, Chem. Commun. 2016, 52, 14188; e) F. Wei, H. Li, C. Song, Y. 
Ma, L. Zhou, C.-H. Tung, Z. Xu, Org. Lett. 2015, 17, 2860; f) B. T. Worrell, S. P. Ellery, V. V. Fokin, Angew. 
Chem. Int. Ed. 2013, 52, 13037. 
58 Synthesis of 4-metallotriazole from metal acetylides (Mg, Zn) without copper catalyst: a) A. Krasiński, V. V. 
Fokin, K. B. Sharpless, Org. Lett. 2004, 6, 1237; b) A. Akao, T. Tsuritani, S. Kii, K. Sato, N. Nonoyama, T. Mase, 
N. Yasudab, Synlett, 2007, 31; c) C. D. Smith, M. F. Greaney, Org. Lett. 2013, 15, 4826; d) Y. Li, X. Qi, Y. Lei, 
Y. Lan, RSC Adv. 2015, 5, 49802. 
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1.6  Synthesis of Carboxyamidotriazole using Alkynyl Zinc Pivalates  
The synthetic utility of alkynylzinc pivalates is further demonstrated in the preparation of an orally-
active agent carboxyamidotrazole (96) with potential antineoplastic activity (Scheme 23).59 Thus, the 
protection of commercially available benzylic alcohol 80 with TIPSCl produced the silyl ether 91 which 
was smoothly magnesiated at position 4 with TMP2Mg·LiCl60 followed by copper-mediated acylation50 
with 4-chlorobenzoyl chloride. After desilylation using TBAF (tetra-n-butylammonium fluoride), the 
benzylic alcohol 92 was isolated in 82% yield. The resulting alcohol was brominated with PBr3 at 25 °C 
affording benzylic bromide 93 in 94% yield.  
 
Scheme 23: Synthesis of carboxyamidotriazole 96 using the alkynyl zinc pivalate 71c. 
This benzylic bromide 93 was treated with NaN3 and the ester-substituted alkynylzinc pivalate 71c in 
the presence of 10% CuI in DMF at 25 °C for 18 h affording the 1,2,3-triazolylzinc pivalate 94 which 
was directly aminated with benzoyloxy-diallylamine 8956  furnishing the trisubstituted 1,2,3-triazole 95 
 
59 a) R. Ju, L. Guo, J. Li, L. Zhu, X. Yu, C. Chen, W. Chen, C. Ye, D. Zhang , Cancer Lett. 2016, 370, 232; b) M. 
J. Soltis, H. J. Yeh, K. A. Cole, N. Whittaker, R. P. Wersto, E. C. Kohn, Drug Metab. Dispos. 1996, 24, 799. 
60 A. Unsinn, C. J. Rohbogner, P. Knochel, Adv. Synth. Cat. 2013, 355, 1553. 
B. RESULTS AND DISCUSSION    28 
in 84% yield via a 4-component one-pot synthesis.61 After a Pd-catalyzed deallylation62 and an 
amidation using Mg3N2 as reported by Ley,[28] the desired carboxyamidotriazole (96) was obtained in 
89% yield (8 steps, 55% overall yield). 
 
2 Preparation and Reactions of Mono- and Bis-Pivaloyloxyzinc Acetylides 
2.1 Introduction 
Organozinc reagents are important reagents in organic synthesis, since they tolerate a variety of 
functional groups and react with various electrophiles in the presence of an appropriate transition metal 
catalyst.63 For instance, alkynylzinc pivalates43a tolerate a broad range of functionalities and represent a 
reactive class of versatile csp-centered nucleophiles that are stable for several hours when exposed to 
air. 
2.2 Preparation and Activity of Mono-pivaloyloxyzinc Acetylide (98) and Bis-pivaloyloxyzinc 
Acetylide (99). 
We reported the preparation and reactivity of two new alkynylzinc pivalates, namely mono-
pivaloyloxyzinc acetylide (98) and bis-pivaloyloxyzinc acetylide (99) as storable solids with 
appreciable air and moisture stability (Scheme 24).44 
 
 
Scheme 24: Preparation of mono-pivaloyloxyzinc acetylide (98) and bis-pivaloyloxyzinc acetylide (99). 
 
61 a) C. Zhou, J. Zhang, P. Liu, J. Xie, B. Dai, RSC Adv. 2015, 5, 6661; b) Y. Jiang, D. Kong, J. Zhao, W. Zhang, 
W. Xu, W. Li, G. Xu, Tetrahedron Lett. 2014, 55, 2410; c) T. Cook, J. A. Walker Jr, J. Mack, Green. Chem. 2013, 
15, 617; d) S. Mohammeda, A. K. Padalaa, B. A. Darb, B. Singhb, B. Sreedharc, R. A. Vishwakarma, Tetrahedron, 
2012, 68, 8156. 
62 F. Garro-Helion, A. Merzouk, F. Guibé, J. Org. Chem. 1993, 58, 6109. 
63 (a) Handbook of Functionalized Organometallics: Applications in Synthesis; P. Knochel 2nd Ed.; Wiley: 
Weinheim, 2005; (b) Organometallics in Synthesis: Third Manual; M. Schlosser, Ed.; Wiley: Weinheim, 2013. 
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Such air-stable reagents are highly desirable organometallic building blocks, since the corresponding 
lithium or halogenomagnesium acetylides, which are widely used reagents for ethynylation,64 are highly 
air and moisture sensitive. Additionally, lithium acetylide is prone to undergo disproportionation to 
dilithium acetylide and acetylene in the absence of stabilizing agents above -25 °C.65 The zinc reagents 
98 and 99 were conveniently prepared in almost quantitative yields from commercially available 
ethynylmagnesium bromide (97; see Scheme 24). Thus, the treatment of a solution of 97 with ZnCl2 in 
THF at -20 °C for 2 h, followed by the addition of a freshly prepared solution of Mg(OPiv)32 at 25 °C 
for 20 min, produced after evaporation of the solvent, a white-yellowish powder of mono-
pivaloyloxyzinc acetylide (98) in 98% yield. Notably, the direct addition of Zn(OPiv)2 to 97 afforded a 
mixture of 98 and 99 in the ratio of 4:1. Bis-pivaloyloxyzinc acetylide (99) was prepared selectively by 
treating ethynylmagnesium bromide (97) with EtMgBr (1.1 equiv) at 50 °C for 12 h, followed by the 
addition of ZnCl2 (2.1 equiv) at -20 °C for 2 h and Mg(OPiv)2 (2.1 equiv) at 25 °C for 0.5 h. After 
solvent evaporation, 99 was obtained as a white powder in quantitative yield as indicated by a titration 
with iodine.66 A scale-up to 50 mmol was readily performed with the same yield. The resulting powders 
can be handled for a short time on the benchtop and have a half-life time in air of about 5 h at 25 °C 
(Table 3). 
Table 3: Activity of mono-pivaloyloxyzinc acetylide (98) and bis-pivaloyloxyzinc acetylide (99) after exposure 
to air at 25 °C. 
Zinc species 0 h 1 h 2 h 4 h 
 
100%a 88%a 75%a 65%a 
 
100%a 85%a 73%a 65%a 
aActivity determined by titration with iodine.66 
 
64 a) M. M. Midland, F. Gallou, F. 2006; Lithium Acetylide; e-EROS Encyclopedia of Reagents for Organic 
Synthesis; b) A. V. Rama Rao 2001; Dilithium Acetylide; e-EROS Encyclopedia of Reagents for Organic 
Synthesis; c) M. M. Midland 2001; Ethynylmagnesium Bromide; e-EROS Encyclopedia of Reagents for Organic 
Synthesis; d) R. Schmid, P. L. Huesmann, W. S. J. Johnson J. Am. Chem. Soc. 1980, 102, 5123; e) G. Stork, J. M.  
Stryker Tetrahedron Lett. 1983, 24, 4887; f) K. M. Brummond, M. M. Davis, C. Huang J. Org. Chem. 2009, 74, 
8314; g) H. Zhou, Q. Zhou, Q. Zhou, L. Ni, Q. Chen RSC Adv. 2015, 5, 12161; h) L. C. Burrow, L. T. Jesikiewicz, 
G.  Lu, S. J. Geib, P. Liu, K. M. Brummond J. Am. Chem. Soc. 2017, 139, 15022. 
65 a) O. F. Beumel, R. F. Harris,  J. Org. Chem. 1963, 28, 2775; b) J. Mortier, M. Vaultier, F. Carreaux, J.-
M. Douin J. Org. Chem. 1998, 63, 3515. 
66 A. Krasovskiy, P. Knochel, Synthesis 2006, 5, 890. 
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2.3 Application of Solid Mono-pivaloyloxyzinc Acetylide (98) in Negishi Cross-Coupling 
Reactions 
Mono-pivaloyloxyzinc acetylide (98) underwent Negishi cross-couplings46 with aryl iodides of 
type 100 leading to aryl- and heteroaryl-alkynes of type 101 (see Table 4). These reactions proceeded 
at 25 °C within 1 h in the presence of 1% Pd(PPh3)4 producing the desired ethynylated arenes. Electron-
rich aryl iodides (entries 1 and 2), electron-poor aryl iodides (entries 3-5) as well as 3-iodothiophene 
(100f, entry 6) gave the desired cross-coupling products 101a-f in 76-98% yields.67 Thus, reagent 98 
directly provided a range of terminal alkynes without the need of using a silyl protecting group as 
usually done to introduce an ethynyl moiety.68  
Table 4: Negishi cross-coupling reactions between mono-pivaloyloxyzinc acetylide (98) and various aryl 
iodides of type 100. 
 
Entry Electrophile Product 
   
1 100a 101a: 98% 
   
2 100b 101b: 86% 
   
3 100c 101c: 81% 
   
4 100d 101d: 76% 
   
5 100e 101e: 95% 
 
67 Aryl chlorides were found unreactive; aryl bromides gave mixtures of aryl alkynes and bis-arylated alkynes 
under various conditions. 
68 a) R. Severin, J. Reimer, S.  Doye J. Org. Chem. 2010, 75, 3518; b) T. Kim, K. H. Jeong, Y. Kim, T. Noh, 
J. Choi, J.; J. Ham Eur. J. Org. Chem. 2017, 17, 2425; c) S. Qiu, C. Zhang, R. Qiu, G. Yin, J. Huang Adv. Synth. 
Catal. 2018, 360, 313. 
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6 100f 101f: 80% 
2.4 One-pot Synthesis of  Non-symmetrical bis-arylated Acetylenes (102) using Mono-
pivaloyloxyzinc Acetylide (98) 
Furthermore, non-symmetrical bis-arylated alkynes of type 102 were prepared in a one-pot reaction 
using, at first, the previously developed Negishi cross-coupling performed in the presence of 2% 
PdCl2(PPh3)2, followed by a Sonogashira cross-coupling69 using 10 mol% CuI and Et3N (2.0 equiv) at 
25 °C for 12 h (see Table 5). The successive cross-coupling of 98 with 100, followed by a Sonogashira 
coupling with the (hetero)aryl iodides 100c and 100f–i resulted in the corresponding non-symmetrical 
bis-arylated alkynes of type 102 in 74-90% yields (entries 1-4). Remarkably, this reaction tolerates 
sensitive functional groups such as ketones, esters and nitro-arenes (entries 5 and 6) resulting in the 
desired alkynes 100e–f in 65–75% yields.  
Table 5: One-pot synthesis of non-symmetrical bis-arylated acetylenes of type 102. 
 
Entry (Hetero)aryliodides (100) Product 
 
   
1 100a 100g 102a: 88% 
 
   
2 100a 100h 102b: 90% 
 
   
3 100a 100i 102c: 81% 
 
 
 
 
 
69 a) K. Sonogashira, Y. Tohda, N. Hagihara Tetrahedron Lett. 1975, 16, 4467; b) R. Chinchilla, C. Nájera Chem. 
Rev. 2007, 107, 874–922; c) R. Chinchilla, C. Nájera Chem. Rev. 2011, 40, 5084. 
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4 100a 100f 102d: 74% 
 
 
  
5 100e 100c 102e: 65% 
 
   
6 100d 100i 102f: 75% 
2.5 Synthesis of 1,5-disubstituted Triazoles 105 using Mono-pivaloyloxyzinc Acetylide (98)  
As shown in chapter 2.4, we reported that alkynylzinc pivalates readily undergo 1,3-dipolar 
cycloadditions with retention of the carbon-zinc bond.43a Thus, we have performed copper-catalyzed 
regioselective azide-alkyne cycloadditions (CuAAC)70 with mono-pivaloyloxyzinc acetylide (98) with 
in situ generated benzyl azides (Table 6). Only one regioisomeric cyclo-addition product 105 was 
formed under the usual copper-catalyzed conditions (10% CuI in DMF at 25 °C for 6 h).71 To the best 
of our knowledge, this regioselectivity has not been observed in CuAACs so far and has only been 
realized by Fokin using a ruthenium catalyst.72 The heterocyclic zinc pivalate 103 was trapped with 
several electrophiles. Thus, zinc reagent 103 underwent a smooth allylation when it was treated with 
allyl bromide (79) leading to the corresponding 1,5-disubstitued 1,2,3-triazole 105a in 49% yield 
(entry 1). Furthermore, a subsequent Negishi cross-coupling was performed with 2 mol% PdCl2(PPh3)2 
at 50 °C for 12 h leading to the arylated triazole 105b in 82% yield (entry 2).43a Notably, the addition 
of hydroxylamine benzoates 104 and 89 gave the aminated 1,2,3-triazoles 105c–d in 51%-74% yields 
(entries 3–4).  
Table 6: Synthesis of 1,5-disubstituted triazoles (105). 
 
Entry Electrophile Producta 
 
 
 
1 79 105a: 49%b 
 
70 a) V. V. Rostovtsev, L. G.  Green, V. V. Fokin, K. B. Sharpless Angew. Chem. Int. Ed. 2002, 41, 2596; b) 
C. W. Tornøe, C. Christensen, M. Meldal J. Org. Chem. 2002, 67, 3057. 
71 The regioselectivity was confirmed by 1H-NMR, 13C-NMR, NOESY, HSQC and HMBC. 
72 a) J.E. Hein, V. V. Fokin Chem. Soc. Rev. 2010, 39, 1302; b) Y. Li, X. Qi, Y.  Lan RSC Adv. 2015, 5, 49802. 
B. RESULTS AND DISCUSSION    33 
 
 
 
2 100a 105b: 82%c 
 
 
 
3 104 105c: 74%d 
 
 
 
4 89 105d: 51%d 
aIsolated yield, bReaction was treated with allylbromide (79) (2.5 equiv), cReaction was performed with 2 mol% 
of PdCl2(PPh3)2 at 50 °C for 12 h, dReaction was treated with hydroxylamines benzoates 104 and 89 (1.2 equiv).  
2.6 Application of Solid Bis-pivaloyloxyzinc Acetylide (99) in Negishi Cross-Coupling Reactions 
Next, we have examined the Negishi cross-coupling of bis-pivaloyloxyzinc acetylide (99) with aryl and 
heteroaryl iodides or bromides. Due to the low solubility of 99 in THF, DMSO was the preferred solvent 
for these reactions. All cross-coupling reactions were completed within 3 h at 25 °C using 3 mol% 
Pd(dba)2 (dba = dibenzylideneacetone) and 6 mol% SPhos73 providing the desired bis-arylated alkynes 
106a-f in 74-98% yields (Table 7). Both electron-rich aryl iodides (entries 1-3) and electron-poor aryl 
iodides (entries 4-6) smoothly underwent these cross-couplings. Encouraged by these results, we further 
tested the scope of this cross-coupling with various aryl bromides affording the desired bis-arylated 
products of type 106 in 75-94% yield (entries 1 and 5-10) using 5 mol% Pd(dba)2 and 5 mol% 
XantPhos74 as ligand at 40 °C.75 Notably, the reaction was compatible with sensitive functional groups 
such as primary amines, nitriles, ketones and esters. 
 
 
 
 
 
 
73 T. E. Barder, S. D. Walker, J. R. Martinelli, S. L. Buchwald J. Am. Chem. Soc. 2005, 127, 4685. 
74 M. Kranenburg, Y. E. M. van der Burgt, P. C. J. Kamer, P. W. N. M. van Leuuwen, K. Goubitz, J. Fraanje  
Organometallics 1995, 14, 3081. 
75 Aryl chlorides were found unreactive under various conditions. 
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Table 7: Negishi cross-couplings reactions between zinc pivalate 99 and various aryl halides.  
 
Entry Electrophile Product[b] 
   
1 
100a: X=I 
75h: X=Br 
106a: X=I: 98%b 
        X=Br: 82%c 
   
2 100j 106b: 93%b 
   
3 100k 106c: 93%b 
   
4 100l 106d: 74%b 
   
5 
100h: X=I 
75d: X=Br 
106e: X=I: 88%b 
            X=Br: 84%c 
   
6 
100e: X=I 
75i: X=Br 
106f: X=I: 95%b 
           X=Br: 75%c 
 
 
 
7 75j 106g: 88%c 
   
8 75c 106h: 88%c 
   
9 75k 106i: 82%c 
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10 75l 106j: 94%c 
aIsolated yield, bPerformed with 3 mol% Pd(dba)2 and 6 mol% SPhos, cPerformed with  5 mol% 
Pd(dba)2 and 5 mol% Xantphos. 
2.7 Synthesis of 1,2,5-Trisubstituted Triazole 108 followed by a Ring-closing Metathesis to 
generate the Benzotriazole Derivative 109 
The bis-pivaloyloxyzinc acetylide (99) also underwent a [3+2]-cycloaddition in the presence of 
10 mol% CuI leading to the 1,2-bis-zincated triazole 107 with two reactive zinc functionalities 
(Scheme 25). After quenching with allyl bromide (3.0 equiv, 25 °C, 1 h), the triazole 108 was obtained 
in 66% yield.76 This bis-allylated triazole 108 underwent a ring-closing metathesis77 in the presence of 
5 mol% Hoveyda-Grubbs catalyst (2nd generation)78 in DCM at 50 °C leading to the 1,2,3-triazole 109 
in 82% yield. To the best of our knowledge, compounds 108 and 109 were not previously synthesized 
and can be an interesting addition to the triazole-class.79 
 
 
 
Scheme 25: Synthesis of 1,2,5-trisubstituted triazole 108 followed by a ring-closing metathesis to benzotriazole 
derivative 109. 
 
76 A differentiation of the two nucleophilic positions of triazole 107 could not be achieved. 
77 Handbook of Metathesis, Volume 2: Applications in Organic Synthesis; R. H. Grubbs, D. J. O’Leary 2nd Ed.; 
Wiley: Weinheim, 2015. 
78 a) S. B. Garber, J. S. Kingsbury, B. L. Gray, A. H. Hoveyda J. Am. Chem. Soc. 2000, 122, 8168; b) S. Gessler, 
S. Randl, S. Blechert Tetrahedron 2000, 41, 9973. 
79 a) M. Wijtmann, C. de Graaf, G. de Kloe, E. P. Istyastono, J. Smit, H. Lim, R. Boonnak, S. Nijmeijer, R. A. 
Smits, A. Jongejan, O. Zuiderveld, I. J. P. de Esch, R. Leurs J. Med. Chem. 2011, 54, 1693; b) W. Yan, X. Ye, N. 
G. Akhmedov, J. L. Petersen, X. Shi Org. Lett. 2012, 14, 2358; c) H. Y. V. Ching, X. Wang, M. He, N. P. Holland, 
R. Guillot, C. Slim, S. Griveau, H. C. Bertrand, C. Policar, F. Bedioui, M. Fontecave Inorg. Chem. 2017, 56, 
2966; d) M. R. Jones, E. Mathieu, C. Dyrager, S. Faissner, Z. Vaillancourt, K. J. Korshavn, M. H. Lim, A. 
Ramamoorthy, V. W. Yong, S. Tsutsui, P. K. Stys, T. Storr Chem. Sci. 2017, 8, 5636. 
B. RESULTS AND DISCUSSION    36 
3 Preparation and Reactions of (1H-tetrazol-5-yl)zinc Pivalates 
3.1 Introduction 
The 1H-tetrazole scaffold is a popular building block in pharmaceutical chemistry and materials 
science.80 It has been used for many different purposes, for example as ligands81, explosives82 or 
propellants.83 5-Substituted-1H-tetrazoles play also an important role in medicinal chemistry and 
biology. Based on steric and electrophilic considerations, they are considered as non-classical isosteres 
or bioisosteres of the carboxylic acid moiety. Interestingly, they possess very similar physicochemical 
and biological properties. Both are planar and acidic molecules with a related pKa value (around 4.2 to 
4.9) and thus, both are ionized at a physiological pH value of 7.4.84 Due to these useful pharmacological 
properties, 1H-tetrazoles have been incorporated in several target drug molecules including anticancer85 
or antiviral86 medication, such as anti-HIV87 and others. Candesartan is as a famous drug that is applied 
for the treatment of hypertension and heart failure. Losartan is mainly used to treat high blood pressure 
(Scheme 1).88–89 
 
Scheme 26: Pharmaceuticals containing a 1H-tetrazole ring. 
5-substituted-1H-tetrazoles can be synthesized in a number of ways. The most common way is via 
[3+2]-dipolar cycloadditions reaction between azides and nitriles. Other methods available include the 
 
80 V. A. Ostrovskii, G. I. Koldobskii, R. E. Trifonov, Comprehensive Heterocyclic Chemistry III, Vol.6, Elsevier, 
Oxford, UK, 2008. 
81 S. Mukhopadhyay, J. Lasri, M. F. C. G. da Silva, M. A. J. Charmier, A. J. L. Pombeiro, Polyhedron 2008, 27, 
2883. 
82 R. P. Singh, R. D. Verma, D. T. Meshri, J. M. Shreeve, Angew. Chem. Int. Ed. 2006, 45, 3584. 
83 K. Koguro, T. Oga, S. Mitsui, R. Orita, Synthesis 1998, 6, 910. 
84 B. C. Bookser, Tetrahedron Lett. 2000, 41, 2805. 
85 A. O. De Souza, M. T. Pedrosa, J. B. Alderete, A. F. Cruz, M. A. Prado, R. B. Alves, C. L. Silva, Pharmazie 
2005, 60, 396. 
86 E. Vieira, J. Huwyler, S. Jolidon, F. Knoflach, V. Mutel, J. Wichmann, Bioorg. Med. Chem. Lett. 2005, 15, 
4628. 
87 A. Gagnon, S. Landry, R. Coulombe, A. Jakalian, I. Guse, B. Thavonekham, P. R. Bonneau, C. Yoakim, B. 
Simoneau, Bioorg. Med. Chem. Lett. 2009, 19, 1199. 
88 V. Aureggi, G. Sedelmeier, Angew. Chem. Int. Ed. 2007, 46, 8440. 
89 A. Alonen, J. Jansson, S. Kallonen, A. Kiriazis, O. Aitio, M. Finel, R. Kostiainen, Bioorg. Chem. 2008, 36, 148. 
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reaction of an amidrazone with sodium nitride in acetic acid or the synthesis based on the reaction of 
triethoxymethane with sodium azide and ammonium chloride.90  
Until now, the usage of 1H-tetrazoles as nucleophilic reagents has been limited to lithium,91 tin,84 
potassium and magnesium reagents.92 Langille and co-workers have achieved a zinc insertion in the 5-
position and have used the zincated tetrazole for a subsequent Negishi cross-coupling.92  
3.2 Preparation and Activity of (1H-tetrazol-5-yl)zinc Pivalates of Type 111 
Consequently, we reported the preparation and reactivity of new organozinc pivalates, namely (1H-
tetrazol-5-yl)zinc pivalates (111a–b) as storable solids with appreciably air and moisture stability (91–
92% activity, determined after 4 h exposure to air; see Table 8). They are obtained in high yields from 
the N-protected 1H-tetrazoles of type 110 by deprotonation using the mixed zinc–magnesium base 
TMPZnCl·Mg(OPiv)2 (73)43  in THF at room temperature for 1 h. After solvent evaporation, 111a and 
111b were obtained as white powders in quantitative yield as indicated by a titration with iodine.66 The 
resulting powders can be handled for a short time on the benchtop and retain more than 91% activity 
after an air exposure of 4 h at 25 °C (Table 8) 
 
Table 8: Activity of (1H-tetrazol-5-yl)zinc pivalates of type 111 after exposure to air at 25 °C. 
 
Zinc species 0 1 2 4 
 
100%a 96%a 93%a 91%a 
 
100%a 97%a 95%a 92%a 
aActivity determined by titration with iodine.  
 
 
90 J. A. Joule, K. Mills, Heterocyclic Chemistry, 5th edition, Wiley-Blackwell, Oxford, UK, 2010. 
91 Y. Satoh, J. Moliterni Synlett 1998, 5, 528. 
92 S. H. Wiedemann, M. M. Bio, L. M. Brown, K. B. Hansen, N. F. Langillle Synlett 2012, 23, 2231.  
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3.3 Application of (1H-tetrazol-5-yl)zinc pivalate 111b in Negishi Cross-Coupling Reactions 
Furthermore, we examined the reactivity of these new solid (1H-tetrazol-5-yl)zinc pivalates (111a–b) 
in Negishi cross-coupling reactions46 with various aryl halides using the more air stable tetrazole 111b. 
The screening of several palladium catalysts showed that the Buchwald ligand, SPhos (10 mol%),73 
gave the best results in combination with Pd(OAc)2 (5 mol%). Under these conditions, a range of 
(hetero)aryl bromides of type 75 underwent smooth Negishi cross-couplings producing arylated 
tetrazoles of type 112 in 58–90% yields (Table 9). Remarkably, a variety of sensitive functional groups 
were tolerated in these cross-couplings such as an amide (entry 2), an aldehyde (entry 3), an ester (entry 
4), a nitrile (entry 5), either a protected or unprotected amine (entries 6 – 7) and an unprotected indole 
(entry 8) were tolerated in these cross-coupling reactions.  
Table 9: Negishi cross-coupling of (1H-tetrazol-5-yl)zinc pivalate 111b with Aryl Bromides (75) 
 
Entry Electrophile Product 
 
 
 
1 75h 112a: 90% 
 
 
 
2 75m 112b: 67% 
 
 
 
3 75n 112c: 82% 
 
 
 
4 75c 112d: 58% 
 
 
 
5 75d 112e: 65% 
 
 
 
6 75o 112f: 74% 
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7 75p 112g: 68% 
   
8 75q 112h: 62% 
3.4 Deprotection of arylated 1H-tetrazoles 112 
Next, we have examined the debenzylation of several previously obtained arylated tetrazoles of type 
112. The use of ammonium formate with palladium on charcoal (5 mol%) in iPrOH/H2O (1:1) at 60  °C 
for 24 h proved to be an excellent catalytic system93 giving the desired unprotected 1H-tetrazoles 113 
in 88–95% yield (Scheme 27). 
 
 
Scheme 27: Debenzylation of Arylated 1H-tetrazoles (112). 
3.5 Amination of (1H-tetrazol-5-yl)zinc Pivalate 111b 
In addition, the metalated tetrazole 111b underwent a copper-catalyzed electrophilic amination using 
N-hydroxyl amine benzoates.94 Thus, the zincated tetrazole 111b was aminated with hydroxylamine 
benzoates of type 114 in the presents of copper(II)-triflate (10 mol%) in THF at 25 °C for 2 h leading 
 
93 M. Seki Synthesis 2014, 46, 3249.  
94 a) A. M. Berman, J. S. Johnson J. Am. Chem. Soc. 2004, 126, 5680; b) S. L. McDonald, C. E. Hendrick, Q. 
Wang Angewandt. Chem. Int. Ed. 2014, 53, 4667. 
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to different 5-amino-1H-tetrazoles of type 115 in 71–93% yield. Hydroxylamine benzoates derived 
from biological active molecules such as a nicotinic acid (115a) or sertraline (115c)95 have been 
functionalized using this method (Scheme 28). 
 
Scheme 28: Amination of (1H-tetrazol-5-yl)zinc pivalate 111b using hydroxylamine benzoates of type (114) in 
the presence of catalytic amounts of Cu(OTf)2. 
 
95 R. S. Obach, L. M. Cox, L. M. Tremaine Drug Metabolism and Disposition 2006, 33, 262.  
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4 Summary 
This work focused on the development of solid alkynylzinc reagents prepared from the corresponding 
alkynes through a deprotonation under mild conditions using TMPZnCl·Mg(OPiv)2 as base. After 
evaporation of the solvent, the resulting solid alkynyl zinc pivalates can be handled in air for several 
hours without significant decomposition. These zinc reagents show an excellent reactivity in various 
carbon-carbon bond forming reactions including 1,3-dipolar cycloadditions. Such an alkynylzinc 
pivalate has been used to prepare a carboxyamidotriazole with potential antineoplastic activity in eight 
steps in 55% overall yield. In addition, the preparation of mono- and bis-pivaloyloxyzinc acetylides, 
which display enhanced air and moisture stability was examined. Mono-zinc acetylide pivalate 
underwent Negishi cross-couplings to form (hetero)aryl alkynes. A subsequent Sonogashira cross-
coupling led to the synthesis of asymmetric bis-arylated alkynes without employing silyl protection 
steps.  Furthermore, this zinc reagent underwent a copper-catalyzed azide-alkyne cycloaddition 
(CuAAC), which selectively led to 1,5-disubstituted 1,2,3-triazoles. In addition, bis-pivaloyloxyzinc 
acetylide reacted in Negishi cross-couplings with aryl halides, yielding symmetrical bis-arylated 
alkynes. Finally, the preparation of (1H-tetrazol-5-yl)zinc pivalates as storable solids with appreciably 
high air and moisture stability was developed. They were obtained in high yields from protected 1H-
tetrazoles by deprotonation using TMPZnCl·Mg(OPiv)2. Subsequent cross-couplings and copper-
catalyzed aminations using hydroxylamino benzoates gave access to functionalized 1H-tetrazoles while 
tolerating many functional groups. 
4.1 New Class of Solid Polyfunctional Alkynylzinc Pivalates with Enhanced Air and Moisture 
Stability for Organic Synthesis 
The preparation of solid and air-stable polyfunctionalized alkynylzinc pivalates from the corresponding 
alkynes using TMPZnOPiv as base has been reported. These organozinc pivalates were obtained as 
powders under mild conditions in excellent yields and can be handled in air for several hours without 
significant decomposition (Scheme 29). 
 
Scheme 29: Preparation of alkynylzinc pivalates from the corresponding alkynes using TMPZnCl·Mg(OPiv)2.  
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The reactivity of this novel alkynyl zinc pivalates in Pd-catalyzed Negishi cross-coupling reactions with 
various aryl halides in the presence of various Pd-catalysts was examined. In our hands DavePhos 
(10 mol%) gave the best results in combination with Pd(dba)2 (5 mol%). In addition, the solid alkynyl 
zinc reagents reacted with other reactions such as acylation, allylation and aldehyde addition 
(Scheme 30).  
 
Scheme 30: DavePhos/Pd(dba)2-catalyzed Negishi cross-couplings and reaction with various electrophiles. 
Furthermore it was found, that the robust zinc reagents underwent copper-catalyzed 1,3-dipolar 
cycloadditions with in situ generated benzyl or aryl azides with complete regioselectivity. Smooth 
allylation, amination or arylation proved the integrity of the carbon-zinc bond in the intermediate and 
produced valuable 1,2,3-triazoles of in 72–91% yields (Scheme 31). 
 
Scheme 31: Copper-catalyzed dipolar cycloadditions with alkynylzinc pivalates providing 1,2,3-triazoles via 
stable zinc intermediates. 
4.2 Preparation and Reactions of Mono- and Bis-Pivaloyloxyzinc Acetylides 
Mono-pivaloyloxyzinc acetylide and bis-pivaloyloxyzinc acetylide were selectively prepared from 
ethynylmagnesium bromide in quantitative yields. These zinc reagents were conveniently prepared in 
almost quantitative yields from commercially available ethynylmagnesium bromide (Scheme 32). The 
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resulting powders can be handled for a short time on the benchtop and have a half-life time in air of 
about 5 h at 25 °C. 
 
Scheme 32: Preparation of mono-pivaloyloxyzinc acetylide and bis-pivaloyloxyzinc acetylide. 
Furthermore, mono-pivaloyloxyzinc acetylide underwent Negishi cross-couplings with aryl iodides to 
aryl- and heteroaryl-alkynes in 76–98% yields (Scheme 33). In addition, non-symmetrical bis-arylated 
alkynes were prepared in a one-pot reaction using, at first, the previously developed Negishi cross-
coupling performed in the presence of PdCl2(PPh3)2 (2 mol%), followed by a Sonogashira cross-
coupling using CuI (10 mol%) and NEt3 (2.0 equiv).  
 
Scheme 33: Negishi cross-coupling reactions between mono-pivaloyloxyzinc acetylide and various aryl iodides 
and one-pot synthesis of non-symmetrical bis-arylated acetylenes. 
Remarkably mono-pivaloyloxyzinc acetylide readily underwent 1,3-dipolar copper-catalyzed 
regioselective azide-alkyne cycloadditions with retention of the carbon-zinc bond (Scheme 34). Only 
one regioisomeric cyclo-addition product was formed under the usual copper-catalyzed conditions (10 
mol% CuI in DMF at 25 °C for 6 h). Thus, mono-pivaloyloxyzinc acetylide underwent a subsequent 
allylation, cross-coupling and amination under retention of the position. 
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Scheme 34: Synthesis of 1,5-disubstituted triazoles. 
Next, the Negishi cross-coupling reaction of bis-pivaloyloxyzinc acetylide with aryl and heteroaryl 
iodides or bromides was examined. Due to the low solubility of the organozinc reagent in THF, DMSO 
was the preferred solvent for these reactions. Notably, the reaction was compatible with sensitive 
functional groups such as primary amines, nitriles, ketones and esters. 
 
Scheme 35: Negishi cross-couplings reactions between bis-pivaloyloxyzinc acetylide and various aryl halides.  
4.3 Preparation and reactions of (1H-tetrazol-5-yl)zinc pivalates 
Finally, we reported the preparation and reactivity of new organozinc pivalates, namely (1H-tetrazol-
5-yl)zinc pivalates as storable solids with appreciably air and moisture stability. They are obtained in 
high yields from the protected 1H-tetrazoles by deprotonation using TMPZnCl·Mg(OPiv)2 in THF at 
0 °C for 30 min. Furthermore, the reactivity of these new solid (1H-tetrazol-5-yl)zinc pivalates in 
Negishi cross-coupling reactions with various aryl halides was investigated using the more air stable 
(1-(4-methoxybenzyl)-1H-tetrazol-5-yl)zinc pivalate (Scheme 36). The screening of several palladium 
catalysts showed that the Buchwald ligand, SPhos (10 mol%), gave the best results in combination with 
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Pd(OAc)2 (5 mol%). Under these conditions, a range of (hetero)aryl bromide underwent smooth 
Negishi cross-couplings producing arylated tetrazoles in 62–90% yields . 
 
Scheme 36: Negishi Cross-coupling of (1-(4-methoxybenzyl)-1H-tetrazol-5-yl)zinc pivalate with aryl bromides . 
In addition, the (1-(4-methoxybenzyl)-1H-tetrazol-5-yl)zinc underwent a copper-catalyzed 
electrophilic amination using N-hydroxylamine benzoates. Thus, zinc reagent was aminated with 
hydroxylamine benzoates in the presence of copper(II)-triflate (10 mol%) in THF. Hydroxylamine 
benzoates derived from biological active molecules such as a nicotinic acid or sertraline have been 
functionalized using this method (Scheme 37). 
 
Scheme 37: Amination of (1-(4-methoxybenzyl)-1H-tetrazol-5-yl)zinc pivalate using hydroxylamine benzoates 
in the presence of catalytic amounts of Cu(OTf)2. 
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1 General Considerations 
If not otherwise stated, all reactions have been carried out using standard Schlenk-techniques in flame-
dried glassware under argon. Syringes which were used to transfer anhydrous solvents or reagents were 
purged with argon prior to use. Yields refer to isolated yields of compounds estimated to be >95% pure 
as determined by 1H-NMR (25 °C) and capillary GC. 
1.1 Solvents 
Solvents were dried according to standard methods by distillation from drying agents as stated below 
and were stored under argon. Otherwise they were obtained from commercial sources and used without 
further purification. 
 
THF was continuously refluxed and freshly distilled from sodium benzophenone ketyl under nitrogen 
and stored over molecular sieves.  
Et2O was freshly distilled from sodium benzophenone ketyl under argon and stored over molecular 
sieves.  
nHexane was continuously refluxed and freshly distilled from sodium benzophenone ketyl under 
nitrogen and stored over molecular sieves. 
Dichloromethane was continuously refluxed and freshly distilled from CaH2 under nitrogen. 
Solvents for column chromatography were distilled prior to use. 
1.2 Reagents 
All reagents were obtained from commercial sources and used without further purification unless 
otherwise stated. 
iPrMgCl•LiCl was prepared by careful addition of iPrCl (78.54 g, 91.3 mL, 1.00 mol, 1.0 equiv.) to a 
suspension of Mg (26.74 g, 1.1 mol, 1.1 equiv.) and LiCl (46.63 g, 1.1 mol, 1.1 equiv.) in dry THF 
(900 mL). The reaction mixture was stirred for 12 h and afterwards the floating particles were allowed 
to settle. The solution was cannulated into a flame-dried and argon flushed Schlenk-flask and its 
concentration was determined by titration against I2 in THF.96 
nBuLi, sBuLi, tBuLi solutions in hexane were purchased from Albemarle and their concentration was 
determined by titration against N-benzylbenzamide in THF at −20 °C.97 
TMPH was purchased from Albemarle, freshly distilled from CaH2 and stored over argon. 
CuCN•2LiCl solution (1.00 M in THF) was prepared by drying CuCN (44.78 g, 500 mmol, 1.0 equiv.) 
and LiCl (42.39 g, 1.00 mol, 2.0 equiv.) in a Schlenk-flask under vacuum for 5 h at 150 °C. After 
 
96 A. Krasovskiy, P. Knochel, Synthesis 2006, 5, 890. 
97 A. F. Burchat, J. M. Chong, N. Nielsen, J. Organomet. Chem. 1997, 542, 281. 
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cooling to 25 °C, dry THF (480 mL) was added and the suspension was stirred until all salts were 
dissolved. Then dry THF was added until a previously set 500 mL mark was matched. 
MgCl2 solution (0.50 M in THF) was prepared by suspending Mg turnings (6.68 g, 275 mmol) in dry 
THF (500 mL) in a flame-dried and argon flushed Schlenk-flask. Then 1,2-dichloroethane (24.74 g, 
19.70 mL, 250 mmol) was added carefully over 1 h (strong gas evolution), while the temperature was 
kept below 25 °C. The reaction mixture was stirred overnight at 25 °C until gas evolution was complete.  
ZnCl2 solution (1.00 M in THF) was prepared by drying ZnCl2 (68.15 g, 500 mmol, 1.0 equiv.) in a 
Schlenk-flask under vacuum for 5 h at 150 °C. After cooling to 25 °C, dry THF (480 mL) was added 
and stirred until all salts were dissolved. Then, dry THF was added until a previously set 500 mL mark 
was matched. 
TMPLi solution in THF was prepared by addition of nBuLi (38.2 mL, 2.62 M in hexane, 100 mmol, 
1.00 equiv.) to a solution of TMPH (14.13 g, 16.87 mL, 100 mmol, 1.0 equiv.) in THF (100 mL) 
at −40 °C. The mixture was allowed to warm up to 0 °C and its concentration was determined by 
titration against N-benzylbenzamide in THF at –20 °C. 
TMPMgCl•LiCl was prepared by addition of TMPH (14.83 g, 17.72 mL, 105 mmol, 1.05 equiv.) to 
iPrMgCl•LiCl (95.24 mL, 1.05 M, 100 mmol, 1.00 equiv.) at 25 °C. The mixture was stirred for 48 h 
until all gas evolution ceased. The concentration was determined by titration against benzoic acid in 
THF using 4-(phenylazo)diphenylamine as indicator. 
TMPZnCl·Mg(OPiv)2 was prepared by placing TMPH (5.94 g, 7.14 mL, 42 mmol) in a dry and argon-
flushed 100 mL Schlenk-flask, equipped with a magnetic stirring bar and a septum, and dissolving in 
dry THF (20 mL). To that solution benzylmagnesium chloride was added (20 mL, 2.0 m in THF, 40 
mmol) over a period of 5 min at room temperature. The resulting solution was continued to stir at 40 °C 
for 12 hours (a white precipitation was formed). The reaction mixture was cooled to room temperature 
followed by the addition of Zn(OPiv)2 (10.70 g, 40.0 mmol) in one portion. Stirring was continued at 
room temperature for 1 h, during which time a clear orange solution was formed to afford the base 
solution (0.6-0.7 m determined by titration with benzoic acid).   
Titration of Organozinc Reagents Using Iodine 
Accurately weighted aliquots (350 mg) of the crude organozinc material were dissolved in dry THF, so 
that the total volume of the solution was 2 mL. To the resulting solution, a standard solution of iodine 
(1 M, in dry THF) was added until the complete appearance of the dark brown color of iodine. Thus, 
the concentration of the active species (in mmol/g) is determined and thereof the yield of the zinc 
reagent formation. 
Stability Studies of Zinc Reagents in Air 
To evaluate the stability of organozinc reagents in air, accurately weighed aliquots of the solid material 
were placed in opened Schlenk-flasks at 25 °C. After exposure to air for a given time, the flask was 
closed, evacuated, filled with argon and dissolved in THF. The resulting solution was titrated against 
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iodine, according to the procedure described above and the measured concentration was compared to 
the one before the exposure to air.  
1.3 Chromatography 
Flash column chromatography was performed using SiO2 (0.040–0.063 mm, 230–400 mesh ASTM) 
from Merck.  
Thin layer chromatography (TLC) was performed using aluminum plates covered with SiO2 (Merck 
60, F–254). Spots were visualized by UV light irradiation and/or by staining of the TLC plate with one 
of the solutions below, followed by heating with a heat gun. 
• KMnO4 (0.3 g), K2CO3 (20 g) and KOH (0.3 g) in water (300 mL). 
• Ce(SO4)2 (5.0 g), (NH4)6Mo7O24•4H2O (25 g) and concentrated H2SO4 (50 mL) in water 
(450 mL). 
• Neat iodine absorbed on silica gel. 
1.4 Analytical data 
NMR spectra were recorded on Bruker ARX 200, AC 300, WH 400 or AMX 600 instruments. 
Chemical shifts are reported as δ-values in parts-per-million (ppm) relative to the residual solvent peak: 
CDCl3 (δH: 7.26; δC: 77.16). For the observation of the observed signal multiplicities, the following 
abbreviations and combinations thereof were used: s (singlet), d (doublet), t (triplet), q (quartet), quint 
(quintet), sext (sextet), sept (septet), m (multiplet) and br (broad). If not otherwise noted, the coupling 
constants given are either H-H or H-F coupling constants for proton signals and C-F coupling constants 
for carbon signals.  
Melting points are uncorrected and were measured on a Büchi B.540 apparatus.  
Infrared spectra were recorded from 4000–650 cm−1 on a Perkin Elmer Spectrum BX-59343 
instrument. For detection a Smiths Detection DuraSampl IR II Diamond ATR sensor was used. The 
main absorption peaks are reported in cm−1.  
Gas chromatography (GC) was performed with instruments of the type Hewlett-Packard 6890 or 5890 
Series II, using a column of the type HP 5 (Hewlett-Packard, 5% phenylmethylpolysiloxane; length: 
10 m, diameter: 0.25 mm, film thickness 0.25 μm). The detection was accomplished using a flame 
ionization detector.  
Mass spectra (MS) and high resolution mass spectra (HRMS) were recorded on a Finnigan MAT 95Q 
or Finnigan MAT 90 instrument for electron impact ionization (EI). For the combination of gas 
chromatography with mass spectroscopic detection, a GC–MS of the type Hewlett-Packard 6890/MSD 
5793 networking was used (column: HP 5–MS, Hewlett–Packard; 5% phenylmethylpolysiloxane; 
length: 15 m, diameter: 0.25 mm, film thickness: 0.25 μm). 
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2 New Class of Solid Polyfunctional Alkynylzinc Pivalates with Enhanced 
Air and Moisture Stability for Organic Synthesis.  
2.1 Typical Procedures (TP) 
TP1: Typical Procedure for the Preparation of the Solid Alkynylzinc Pivalates 
A dry and argon-flushed Schlenk-flask equipped with a magnetic stirring bar and a septum was charged 
with the corresponding alkynes of type 70 (10.0 mmol). TMPZnOPiv (73, 0.6 M in THF, 12.0 mmol) 
was added. After stirring the reaction mixture for 1-2 h at room temperature, the solvent was removed 
in vacuo (at least 6 h) and the dried solid alkynylzinc pivalate (71) (having the aspect of a fine powder) 
was titrated using iodine in order to determine the yield. 
 
TP2: Typical Procedure for Negishi Couplings Using Alkynylzinc Pivalates 
A dry and argon-flushed flask equipped with a magnetic stirring bar and a septum was charged with the 
solid alkynylzinc pivalate of type 71 (0.50 mmol), Pd(dba)2 (2 mol%), DavePhos (4 mol%) and THF (1 
mL) to give a 0.5 M solution to the respective zinc pivalate. The electrophile (0.42 mmol) was added 
and the resulting solution was stirred at the given temperature for the given time. The reaction mixture 
was quenched with sat. aq. NH4Cl solution (2 mL) and extracted with EtOAc (3 × 2 mL). The combined 
organic layers were washed with sat. aq. NaCl solution (3 mL) and dried over MgSO4. After filtration, 
the solvent was removed in vacuo. Purification via flash column chromatography yielded the Negishi 
cross-coupling product. 
 
TP3: Typical Procedure for the Aldehyde Addition Using Alkynylzinc Pivalates 
A dry and argon-flushed flask equipped with a magnetic stirring bar and a septum was charged with the 
solid alkynylzinc pivalate of type 71 (1.0 mmol) and diluted in THF (1 mL). To this solution was added 
a solution of AlMe3 (0.8 M in toluene, 1.0 mmol) at the given temperature and was stirred for 10 min. 
A solution of the electrophile (0.25 M in toluene, 0.8 mmol) was added dropwise and the resulting 
solution was stirred at the given temperature for the given time. The reaction mixture was quenched 
with 10 % aq. potassium sodium tartrate tetrahydrate solution (5 mL) und stirred for 1 h. The mixture 
was extracted with EtOAc (3 x 2 ml) and the combined organic layers were dried over MgSO4. After 
filtration, the solvent was removed in vacuo. Purification via flash column chromatography yielded the 
desired product.  
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2.2 Stability of Alkynylzinc reagents of Type 71 in Air 
 
 
71a 
 
71b  
71c 
 
71d  
71e 
t[h] 
In air Remaining active alkynylzinc species[a] 
1 98% 94% 93% 97% 98% 
2 95% 88% 88% 92% 95% 
4 90% 71% 73% 82% 80% 
 
 
 
71f 71g 
 
71h 71i 
 
71j 
t[h] 
In air Remaining active alkynylzinc species[a] 
1 99% 98% 99% 97% 97% 
2 95% 97% 97% 92% 92% 
4 90% 90% 87% 86% 82% 
 
71k 
 
71l 71m   
t[h] 
In air Remaining active alkynylzinc species[a] 
1 85% 99% 84%   
2 74% 97% 70%   
4 68% 90% 43%   
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2.3 Catalysts screening for Negishi Cross-coupling 
 
Entry Catalyst Conversion 
1 Pd[P(tBu)3] 20% 
2 PEPPSI ND 
3 Pd(OAC)2/SPhos (1:1) ND 
4 Pd(PPh3)4 8% 
5 Pd(dba)2/DavePhos (1:2) 91% 
6 Pd(dba)2/tBuDavePhos 
(1:2) 
15% 
 
Procedure: To a solution of solid zinc reagent in THF (0.5 M) was treated with ethyl 4-bromobenzoate 
(1 equiv) and catalyst (2 mol%). The resulting solution was stirred at 40 °C overnight. The conversion 
was identified via GC analysis.  
2.4 Preparation of the Solid Alkynylzinc Pivalates 
((Trimethylsilyl)ethynyl)zinc pivalate (71a) 
 
According to TP1 TMPZnOPiv (12.0 mmol) was added to trimethylsilyl acetylene 70a (983 mg, 10.0 
mmol). The mixture was stirred for 2 h at room temperature followed by removal of the solvent to 
furnish the title compound as a white solid. Determination of the content of active zinc species by 
titration96 with iodine indicated a concentration of 1.10 mmol/g corresponding in 99% yield. 
 
(Hex-1-yn-1-yl)zinc pivalate (71b) 
 
According to TP1 TMPZnOPiv (12.0 mmol) was added to 1-hexyne 70b (847 mg, 10.0 mmol). The 
mixture was stirred for 2 h at room temperature followed by removal of the solvent to furnish the title 
compound as a white solid. Determination of the content of active zinc species by titration96 with iodine 
indicated a concentration of 1.08 mmol/g corresponding in 98% yield. 
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(3-Ethoxy-3-oxoprop-1-yn-1-yl)zinc pivalate (71c) 
 
According to TP1 TMPZnOPiv (7.2 mmol) was added to ethyl propiolate 70d (590 mg, 6.0 mmol). 
The mixture was stirred for 1 h at room temperature followed by removal of the solvent to furnish the 
title compound as a yellowish solid. Determination of the content of active zinc species by titration96 
with iodine indicated a concentration of 1.15 mmol/g corresponding in 99% yield. 
 
(Cyclohexylethynyl)zinc pivalate (71d) 
 
According to TP1 TMPZnOPiv (12.0 mmol) was added to cyclohexylacetylene 70c (1.1 g, 10.0 mmol). 
The mixture was stirred for 2 h at room temperature followed by removal of the solvent to furnish the 
title compound as a white solid. Determination of the content of active zinc species by titration96 with 
iodine indicated a concentration of 1.13 mmol/g corresponding in 98% yield. 
 
((4-Methoxyphenyl)ethynyl)zinc pivalate (71e) 
 
According to TP1 TMPZnOPiv (12.0 mmol) was added to 4-ethynylanisole 70e (1.33 g, 10.0 mmol). 
The mixture was stirred for 2 h at room temperature followed by removal of the solvent to furnish the 
title compound as a light yellowish solid. Determination of the content of active zinc species by 
titration96 with iodine indicated a concentration of 1.10 mmol/g corresponding in 99% yield. 
 
((2-(Ethoxycarbonyl)phenyl)ethynyl)zinc pivalate (71f) 
 
According to TP1 TMPZnOPiv (6.1 mmol) was added to 2-ethynyl benzoic Acid ethylester 70f 
(888 mg, 5.10 mmol). The mixture was stirred for 1 h at room temperature followed by removal of the 
solvent to furnish the title compound as a light yellowish solid. Determination of the content of active 
zinc species by titration96 with iodine indicated a concentration of 1.15 mmol/g corresponding in 97% 
yield. 
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((4-(Ethoxycarbonyl)phenyl)ethynyl)zinc pivalate (71g) 
 
According to TP1 TMPZnOPiv (6.43 mmol) was added to 4-ethynyl benzoic Acid ethylester 70g 
(934 mg, 5.40 mmol). The mixture was stirred for 1 h at room temperature followed by removal of the 
solvent to furnish the title compound as a light yellowish solid. Determination of the content of active 
zinc species by titration96 with iodine indicated a concentration of 1.11 mmol/g corresponding in 97% 
yield. 
 
((4-Cyanophenyl)ethynyl)zinc pivalate (71h) 
 
According to TP1 TMPZnOPiv (7.2 mmol) was added to 4-ethynylbenzonitrile 70h (788 mg, 6.0 
mmol). The mixture was stirred for 1 h at room temperature followed by removal of the solvent to 
furnish the title compound as a light yellowish solid. Determination of the content of active zinc species 
by titration96 with iodine indicated a concentration of 1.05 mmol/g corresponding in 98% yield. 
 
((4-(tert-Butyl)phenyl)ethynyl) zinc pivalate (71i) 
 
According to TP1 TMPZnOPiv (12.0 mmol) was added to 4-tert-butylphenylacetylene 70i (1.7 g, 10.0 
mmol). The mixture was stirred for 2 h at room temperature followed by removal of the solvent to 
furnish the title compound as a white solid. Determination of the content of active zinc species by 
titration96 with iodine indicated a concentration of 1.11 mmol/g corresponding in 98% yield. 
 
((1-((Trimethylsilyl)oxy)cyclohexyl)ethynyl)zinc pivalate (71k) 
 
According to TP1 TMPZnOPiv (6.0 mmol) was added to alkyne 70k (982 mg, 5.0 mmol). The mixture 
was stirred for 2 h at room temperature followed by removal of the solvent to furnish the title compound 
as a white solid. Determination of the content of active zinc species by titration96 with iodine indicated 
a concentration of 0.88 mmol/g corresponding in 93% yield. 
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(Thiophen-3-ylethynyl)zinc pivalate (71l) 
 
According to TP1 TMPZnOPiv (6.0 mmol) was added to 3-ethynylthiophene 70l (541 mg, 5.0 mmol). 
The mixture was stirred for 1.5 h at room temperature followed by removal of the solvent to furnish the 
title compound as a light yellowish solid. Determination of the content of active zinc species by 
titration96 with iodine indicated a concentration of 1.13 mmol/g corresponding in 98% yield. 
 
(((8R,9S,10R,14S,17S)-17-((trimethylsilyl)oxy)-2,3,6,7,8,9,10,11,12,13,14,15,16,17-
tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)ethynyl)zinc pivalate (71m) 
 
According to TP1 TMPZnOPiv (3.6 mmol) was added to alkyne 70m (1.03 g, 3.00 mmol). The mixture 
was stirred for 2 h at room temperature followed by removal of the solvent to furnish the title compound 
as a light yellowish solid. Determination of the content of active zinc species by titration96 with iodine 
indicated a concentration of 0.95 mmol/g corresponding in 94% yield. 
2.5 Preparation of Negishi Cross-Coupling Products 
1-(3-((Trimethylsilyl)ethynyl)phenyl)ethanone (74a) 
 
According to TP2 3-bromoacetophenone 75a (93 mg, 0.46 mmol) was added to a solution of 
((trimethylsilyl)ethynyl)zinc pivalate 71a (0.55 mmol), Pd(dba)2 (5 mg, 2 mol%) and DavePhos (7 mg, 
4 mol%)  in THF (1 mL) at 25 °C. The resulting solution was stirred at 25 °C for 6 h. Purification of 
the crude product by flash chromatography (silica gel, isohexane/EtOAc = 15:1) afforded the title 
compound as a yellowish oil (88 mg, 89% yield). 
1H-NMR (800 MHz, CDCl3): δ / ppm = 8.03 (t, J = 1.7 Hz, 1H), 7.90 (dt, J = 7.8, 1.5 Hz, 1H), 7.64 
(dt, J = 7.6, 1.4 Hz, 1H), 7.40 (t, J = 7.7 Hz, 1H), 2.60 (s, 3H), 0.26 (s, 9H). 
13C-NMR (201 MHz, CDCl3): δ / ppm = 197.5, 137.2, 136.3, 132.1, 128.7, 128.2, 123.9, 104.0, 95.7, 
26.8, 0.0. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2960, 2899, 2156, 1689, 1596, 1574, 1477, 1422, 1358, 1275, 
1249. 
MS (EI, 70 eV): m/z (%) = 216 (M+, 13), 202 (19), 201 (100), 73 (25), 43 (17). 
HRMS (EI): m/z calc. for [C13H16OSi]: 216.0970; found: 216.0963 (M+). 
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Ethyl 6-((trimethylsilyl)ethynyl)nicotinate (74b) 
 
According to TP2, ethyl 6-chloropyridine-3-carboxylate 76 (154 mg, 0.83 mmol) was added to a 
solution of ((trimethylsilyl)ethynyl)zinc pivalate 71a (1.00 mmol), Pd(dba)2 (10 mg, 2 mol%) and 
DavePhos (13 mg, 4 mol%)  in THF (2 mL) at 25 °C. The resulting solution was stirred at 60 °C for 
16 h. Purification of the crude product by flash chromatography (silica gel, isohexane/EtOAc = 5:1 to 
3:1) afforded the title compound as a yellowish solid (152 mg, 74% yield). 
M.p. (°C): 61.3–64.0. 
1H-NMR (600 MHz, CDCl3): δ / ppm = 9.14 (dd, J = 2.1, 0.9 Hz, 1H), 8.23 (dd, J = 8.1, 2.2 Hz, 1H), 
7.51 (dd, J = 8.1, 0.9 Hz, 1H), 4.40 (q, J = 7.1 Hz, 2H), 1.40 (t, J = 7.1 Hz, 3H), 0.27 (s, 9H). 
13C-NMR (151 MHz, CDCl3): δ / ppm = 164.9, 151.1, 146.6, 137.2, 126.8, 125.2, 103.2, 98.4, 61.7, 
14.4, -0.3. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2962, 1721, 1590, 1468, 1368, 1286, 1251, 1223, 1111. 
MS (EI, 70 eV): m/z (%) = 247 (M+, 9), 233 (11), 232 (100), 218 (19), 204 (65), 176 (12). 
HRMS (EI): m/z calc. for [C13H17NO2Si]: 247.1029; found: 247.1019 (M+).  
 
5-(Hex-1-yn-1-yl)-2-methoxybenzaldehyde (74c) 
 
According to TP2, ethyl 5-iodo-2-methoxybenzaldehyde 77 (149 mg, 0.57 mmol) was added to a 
solution of hexynyl zinc pivalate 71b (0.52 mmol), Pd(dba)2 (7 mg, 2 mol%) and DavePhos (9 mg, 4 
mol%) in THF (1 mL) at 25 °C. The resulting solution was stirred at ambient temperature for 16 h. 
Purification of the crude product by flash chromatography (silica gel, isohexane/EtOAc = 9:1) afforded 
the title compound as a colorless liquid (85 mg, 76% yield). 
1H-NMR (600 MHz, CDCl3): δ / ppm = 10.41 (s, 1H), 7.86 (d, J = 2.2 Hz, 1H), 7.56 (dd, J = 8.6, 2.2 
Hz, 1H), 6.91 (d, J = 8.7 Hz, 1H), 3.93 (s, 3H), 2.39 (t, J = 7.0 Hz, 2H), 1.64 – 1.37 (m, 4H), 0.95 (t, J 
= 7.2 Hz, 3H). 
13C-NMR (151 MHz, CDCl3): δ / ppm = 189.3, 161.0, 138.8, 132.0, 124.8, 117.0, 111.8, 90.2, 79.2, 
56.0, 30.9, 22.2, 19.2, 13.8. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2958, 2862, 1687, 1605, 1496, 1264, 1166, 1027, 818. 
MS (EI, 70 eV): m/z (%) = 216 (M+, 78), 201 (87), 173 (100), 158 (77), 115 (62) 
HRMS (EI): m/z calc. for [C14H16O2]: 216.1150; found: 216.1147 (M+).  
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5-(Cyclohexylethynyl)-1H-indole (74d) 
 
According to TP2, 5-bromoindole 75b (90 mg, 0.46 mmol) was added to a solution of zinc pivalate 
71d (0.73 mmol), Pd(dba)2 (6 mg, 2 mol%) and DavePhos (8 mg, 4 mol%) in THF (1.5 mL) at 25 °C. 
The resulting solution was stirred at 50 °C for 48 h. Purification of the crude product by flash 
chromatography (silica gel, isohexane/EtOAc = 5:1 to 2:1) afforded the title compound as a brownish 
solid (70 mg, 68% yield). 
1H-NMR (600 MHz, CDCl3): δ / ppm = 8.17 (bs, 1H), 7.84 – 7.64 (m, 1H), 7.33 – 7.23 (m, 2H), 7.19 
(dd, J = 3.2, 2.4 Hz, 1H), 6.51 (ddd, J = 3.1, 2.0, 0.9 Hz, 1H), 2.62 (tt, J = 9.2, 3.8 Hz, 1H), 2.02 – 1.84 
(m, 2H), 1.79 (dtt, J = 8.6, 6.5, 2.7 Hz, 2H), 1.65 – 1.50 (m, 3H), 1.44 – 1.28 (m, 3H). 
13C-NMR (151 MHz, CDCl3): δ / ppm = 135.2, 127.9, 125.9, 124.9, 124.4, 115.4, 111.0, 102.8, 91.8, 
81.8, 33.1, 29.9, 26.2, 25.1. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3413, 2925, 2851, 1616, 1574, 1467, 1414, 1308, 1235, 1090. 
MS (EI, 70 eV): m/z (%) = 247 (M+, 9), 233 (11), 232 (100), 218 (19), 204 (65), 176 (12). 
HRMS (EI): m/z calc. for [C13H17NO2Si]: 247.1029; found: 247.1019 (M+). 
 
Ethyl 4-((4-methoxyphenyl)ethynyl)benzoate (74e) 
 
According to TP2, ethyl 4-bromobenzoate 75c (101 mg, 0.44 mmol) was added to a solution of zinc 
pivalate 71e (0.53 mmol), Pd(dba)2 (5 mg, 2 mol%) and DavePhos (7 mg, 4 mol%)  in THF (1.0 mL) 
at 25 °C. The resulting solution was stirred at 40 °C for 14 h. Purification of the crude product by flash 
chromatography (silica gel, isohexane/EtOAc = 15:1) afforded the title compound as a white solid (112 
mg, 91% yield). 
M.p. (°C): 90.1–92.4. 
1H-NMR (800 MHz, CDCl3): δ / ppm = 8.02 – 8.00 (m, 2H), 7.58 – 7.53 (m, 2H), 7.51 – 7.47 (m, 2H), 
6.91 – 6.87 (m, 2H), 4.38 (q, J = 7.1 Hz, 2H), 3.83 (s, 3H), 1.40 (t, J = 7.2 Hz, 3H). 
13C-NMR (201 MHz, CDCl3): δ / ppm = 166.3, 160.1, 133.4, 131.4, 129.6, 129.6, 128.4, 114.9, 114.2, 
92.6, 87.7, 61.2, 55.5, 14.5. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2983, 2842, 2215, 1705, 1599, 1518, 1500. 
MS (EI, 70 eV): m/z (%) = 280 (M+, 100), 252 (14), 235 (30), 164 (11), 163 (12). 
HRMS (EI): m/z calc. for [C18H16O3]: 280.1099; found: 280.1095 (M+).   
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4-((3-Isobutyrylphenyl)ethynyl)benzonitrile (74f) 
 
According to TP2, 4-bromobenzonitrile 75d (184 mg, 1.0 mmol) was added to a solution of zinc 
pivalate 71j (1.2 mmol), Pd(dba)2 (12 mg, 2 mol%) and DavePhos (16 mg, 4 mol%) in THF (2.0 mL) 
at 25 °C. The resulting solution was stirred at 40 °C for 16 h. Purification of the crude product by flash 
chromatography (silica gel, isohexane/EtOAc = 10:1) afforded the title compound as a yellowish solid 
(253 mg, 93% yield). 
M.p. (°C): 99.9–101.5. 
1H-NMR (600 MHz, CDCl3): δ / ppm = 8.11 (td, J = 1.8, 0.7 Hz, 1H), 7.95 (ddd, J = 7.9, 1.8, 1.1 Hz, 
1H), 7.71 (dt, J = 7.7, 1.4 Hz, 1H), 7.67 – 7.58 (m, 4H), 7.49 (td, J = 7.8, 0.6 Hz, 1H), 3.55 (p, J = 6.9 
Hz, 1H), 1.24 (d, J = 6.9 Hz, 6H). 
13C-NMR (151 MHz, CDCl3): δ / ppm = 203.7, 136.7, 135.7, 132.3, 132.2, 131.8, 129.1, 128.9, 127.9, 
123.0, 118.6, 112.0, 92.8, 88.6, 35.7, 19.2. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2972, 2933, 2873, 2227, 1685, 1604, 1217. 
MS (EI, 70 eV): m/z (%) = 273 (M+, 16), 230 (17), 229 (100), 201 (19), 200 (15). 
HRMS (EI): m/z calc. for [C19H15NO]: 273.1154; found: 273.1148 (M+). 
 
4-((3-Isobutyrylphenyl)ethynyl)benzamide (74g) 
 
According to TP2, 4-bromobenzonitrile 75e (184 mg, 1.0 mmol) was added to a solution of zinc 
pivalate 71j (1.2 mmol), Pd(dba)2 (12 mg, 2 mol%) and DavePhos (16 mg, 4 mol%) in THF (2.0 mL) 
at 25 °C. The resulting solution was stirred at 40 °C for 16 h. Purification of the crude product by flash 
chromatography (silica gel, isohexane/EtOAc = 10:1) afforded the title compound as a yellowish solid 
(253 mg, 93% yield). 
M.p. (°C): 183.8–187.5. 
1H-NMR (600 MHz, CDCl3): δ / ppm = 8.11 (t, J = 1.7 Hz, 1H), 7.94 (ddd, J = 7.9, 1.8, 1.1 Hz, 1H), 
7.85–7.78 (m, 2H), 7.7 –7.69 (m, 1H), 7.66–7.60 (m, 2H), 7.50–7.46 (m, 1H), 6.08 (bs, 1H), 5.68 (bs, 
1H), 3.56 (p, J = 6.9 Hz, 1H), 1.24 (d, J = 6.9, 6H). 
13C-NMR (151 MHz, CDCl3): δ / ppm = 203.8, 168.5, 136.6, 135.7, 133.0, 132.0, 131.7, 129.0, 128.5, 
127.6, 126.9, 123.5, 91.1, 89.4, 35.7, 19.2. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3371, 3180, 2971, 2934, 1682, 1644, 1618, 1415. 
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MS (EI, 70 eV): m/z (%) = 291 (M+, 23), 249 (15), 248 (100), 220 (10), 176 (15). 
HRMS (EI): m/z calc. for [C19H17NO2]: 291.1259; found: 291.1252 (M+).  
 
N,N-Dimethyl-4-((1-((trimethylsilyl)oxy)cyclohexyl)ethynyl)aniline (74h) 
 
According to TP2, 4-bromo-N,N-dimethylaniline 75f (128 mg, 0.64mmol) was added to a solution of 
zinc pivalate 71k (0.77 mmol), Pd(dba)2 (7.4 mg, 2 mol%) and DavePhos (10 mg, 4 mol%) in THF 
(2.0 mL) at 25 °C. The resulting solution was stirred at 40 °C for 16 h. Purification of the crude product 
by flash chromatography (silica gel, isohexane/EtOAc = 50:1) afforded the title compound as a colorless 
liquid (156 mg, 78% yield). 
1H-NMR (600 MHz, CDCl3): δ / ppm = 7.31 (d, J = 9.0 Hz, 2H), 6.64 (d, J = 9.0 Hz, 2H), 2.97 (s, 
6H), 1.94–1.92 (m, 2H), 1.74 1.42 (m, 8H), 0.22 (s, 9H). 
13C-NMR (151 MHz, CDCl3): δ / ppm = 150.1, 132.6, 112.0, 110.6, 91.1, 86.4, 70.6, 41.7, 40.4, 25.6, 
23.5, 2.2. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2932, 2856, 2215, 1608, 1519, 1355, 1246, 1084, 837. 
MS (EI, 70 eV): m/z (%) = 315 (M+, 89), 286 (20), 271 (100),  
HRMS (EI): m/z calc. for [C19H29ONSi]: 315.2018; found: 215.2015 (M+). 
 
2-(Thiophen-3-ylethynyl)pyridine (74i) 
 
According to TP2, 2-bromopyridine 75g (52 mg, 0.3 mmol) was added to a solution of zinc 
pivalate 71l (0.4mmol), Pd(dba)2 (4 mg, 2 mol%) and DavePhos (5 mg, 4 mol%)  in THF (2.0 mL) at 
25 °C. The resulting solution was stirred at 40 °C for 16 h. Purification of the crude product by flash 
chromatography (silica gel, isohexane/EtOAc = 8:2) afforded the title compound as a yellowish liquid 
(56 mg, 92% yield). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.63–8.59 (m, 1H), 7.70–7.60 (m, 2H), 7.51(dt, J = 7.9, 1.1 
Hz, 1H), 7.31 (dd, J = 5.0, 3.0 Hz, 1H), 7.28–7.17 (m, 2H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 150.0, 143.4, 136.2, 130.2, 130.0, 127.0, 125.5, 122.7, 121.4, 
88.2, 84.6. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3106, 2926, 2212, 1581, 1461, 1276, 989, 871, 776. 
MS (EI, 70 eV): m/z (%) = 185 (M+, 100) 159 (18), 141 (14), 128 (5). 
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HRMS (EI): m/z calc. for [C11H7NS]: 185.0299; found: 185.0292 (M+). 
2.6 Fukuyama coupling, allylation and aldehyde addition 
1-(4-Methoxyphenyl)pent-1-yn-3-one (80) 
 
According to TP2, S-ethyl thiopropionate 78 (95 mg, 0.1 mL, 0.8 mmol) was added to a solution of 
zinc pivalate (71e; 0.95 mmol), Pd(dba)2 (10 mg, 2 mol%) and DavePhos (13 mg, 4 mol%) in THF (2.0 
mL) at 25 °C. The resulting solution was stirred at 25 °C for 16 h. Diethyl ether (5 mL) was added and 
the suspension was passed through a pad of celite. The filtrate was washed with 1N HC1, sat. NaHCO3, 
brine and dried over Na2SO4. Filtration and concentration on rotary evaporator afforded a crude product. 
Purification of the crude product by flash chromatography (silica gel, isohexane/EtOAc = 10:1 to 5:1) 
afforded the title compound (114 mg, 76% yield).  
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.55 (d, J = 8.8 Hz, 2H), 6.92 (d, J = 8.8 Hz, 2H), 3.87 (s, 
3H), 2.70 (q, J = 7.4 Hz, 2H), 1.24 (t, J = 7.4 Hz, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 188.8, 161.7, 135.2, 114.5, 112.0, 91.9, 87.7, 55.6, 38.8, 8.4. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2975, 2938, 2190, 1665, 1603, 1509, 1253, 1112, 1045. 
MS (EI, 70 eV): m/z (%) = 188 (M+, 8), 160 (11), 159 (100), 144 (11). 
HRMS (EI): m/z calc. for [C12H12O2]: 188.0837; found: 188.0831 (M+).  
 
1-(tert-Butyl)-4-(pent-4-en-1-yn-1-yl)benzene (81) 
 
To a solution of alkynylzinc reagent 71i (0.50 mmol) in THF (1.0 mL) was added CuCN·2LiCl 
(10 mol%) and allylbromide (79; 41 mg, 0.33 mmol) at 25 °C. The solution was stirred for 36 h at 25 °C 
before quenched with sat. aq. NH4Cl solution. The extractions were performed with EtOAc (3 × 1 mL). 
The combined organic layers were washed with sat. aq. NaCl solution (2 mL) and dried over Na2SO4. 
After filtration, the solvent was removed in vacuo. Purification via flash column chromatography (pure 
isohexane) furnished the title compound (54 mg, 82% yield). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.36 (d, J = 8.2 Hz, 2H), 7.31 (d, J = 8.3 Hz, 2H), 5.90 (ddt, 
J = 17.1, 10.2, 5.2 Hz, 1H), 5.46–5.35 (m, 1H), 5.16 (dd, J = 10.0, 1.8 Hz, 1H), 3.19 (dd, J = 5.0, 2.3 
Hz, 2H), 1.30 (s, 9H). 
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13C-NMR (101 MHz, CDCl3): δ / ppm = 151.1, 132.7, 131.4, 125.3, 120.8, 116.3, 85.9, 83.1, 34.8, 
31.3, 23.9. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3085, 2963, 2361, 1642, 1503, 1268, 1109, 915, 834. 
MS (EI, 70 eV): m/z (%) = 198 (M+, 41), 184 (16), 183 (100), 1128 (9). 
HRMS (EI): m/z calc. for [C15H18]: 198.1409; found: 198.1402 (M+).  
 
1-(3-Chlorophenyl)-3-cyclohexylprop-2-yn-1-ol (83a) 
 
According to TP3, to the solution of zinc pivalate 71d (1.0 mmol) was added a solution of AlMe3 (0.8 
M in toluene, 1.0 mmol) at the ambient temperature and was stirred for 10 min. A solution of 3-
chlorobenzaldehyde 82g (0.25 M in toluene, 0.8 mmol) was added dropwise and the resulting solution 
was stirred at ambient temperature for 16 h. The reaction mixture was quenched with 10 % aq. 
potassium sodium tartrate tetrahydrate solution (5 mL) und stirred for 1 h. The mixture was extracted 
with EtOAc (3 x 2 ml) and the combined organic layer were dried over MgSO4. Purification of the 
crude product by flash chromatography (silica gel, isohexane/EtOAc = 9:1) afforded the title compound 
as a colourless liquid (196 mg, 79% yield). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.56 (d, J = 2.1 Hz, 1H), 7.4 –7.39 (m, 1H), 7.33–7.27 (m, 
2H), 5.44 (d, J = 1.8 Hz, 1H), 2.51–2.39 (m, 1H), 1.83 (dq, J = 12.7, 3.5 Hz, 2H), 1.71 (tdd, J = 12.4, 
6.5, 3.7 Hz, 2H), 1.49 (dtd, J = 22.6, 9.4, 7.6, 4.5 Hz, 3H), 1.32 (qd, J = 10.4, 5.2 Hz, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 143.3, 134.5, 129.9, 128.4, 127.0, 124.9, 92.4, 79.4, 64.3, 
32.6, 29.2, 25.9, 25.0. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3323, 2928, 2853, 2228, 1597, 1448, 1190, 986, 786, 717. 
MS (EI, 70 eV): m/z (%) = 248 (M+, 15), 213 (100), 157 (13), 138 (33), 128 (18), 115 (15). 
HRMS (EI): m/z calc. for [C15H17O]: 248.0968; found: 248.0964 (M+).  
 
3-Cyclohexyl-1-(4-nitrophenyl)prop-2-yn-1-ol (83b) 
 
According to TP3, to the solution of zinc pivalate 71d (1.0 mmol) was added a solution of AlMe3 (0.8 M 
in toluene, 1.0 mmol) at the ambient temperature and was stirred for 10 min. A solution of 4-
nitrobenzaldehyde 82b (0.25 M in toluene, 0.8 mmol) was added dropwise and the resulting solution 
was stirred at ambient temperature for 16 h. The reaction mixture was quenched with 10 % aq. 
potassium sodium tartrate tetrhydrate solution (5 mL) und stirred for 1 h. The mixture was extracted 
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with EtOAc (3 x 2 ml) and the combined organic layer were dried over MgSO4. Purification of the 
crude product by flash chromatography (silica gel, isohexane/EtOAc = 8:2) afforded the title compound 
as a colorless liquid (81 mg, 70% yield). 
1H-NMR (400 MHz, CDCl3): δ / ppm = δ 8.23 (d, J = 8.5 Hz, 2H), 7.72 (d, J = 8.5 Hz, 2H), 5.56 (d, J 
= 1.8 Hz, 1H), 2.52–2.37 (m, 1H), 1.82 (dq, J = 12.4, 3.5 Hz, 2H), 1.70 (h, J = 5.4 Hz, 2H), 1.49 (dqd, 
J = 25.8, 9.5, 3.2 Hz, 3H), 1.30 (ddd, J = 21.1, 11.8, 6.3 Hz, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 148.3, 147.8, 127.5, 123.9, 93.1, 79.0, 63.9, 32.6, 29.2, 25.9, 
25.0. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3382, 2929, 2854, 2226, 1606, 1520, 1346, 986, 853. 
MS (EI, 70 eV): m/z (%) = 258 (M+, 1), 212 (24), 160 (75), 135 (100), 107 (85), 79 (92). 
HRMS (EI): m/z calc. for [C15H16NO3]: 259.1208; found: 258.1130 (M+). 
 
2.7 Copper catalyzed 1,3-dipolar cycloaddition with solid alkynylzinc pivalates  
Ethyl 2-(1-benzyl-5D-1,2,3-triazol-4-yl)benzoate (87a) 
 
To a solution of alkynylzinc reagent 71f (0.75 mmol) in DMF (1.5 mL) was added sodium azide (45 
mg, 0.68 mmol), benzyl bromide (117 mg, 0.68 mmol) and copper iodide (13 mg, 10 mol%) under 
argon at 25 °C. The resulting solution was stirred at 25 °C for 7 h followed by the addition of 
CH3COOD/D2O (0.5 mL/0.5 mL) and stirring was continued for 30 min before quenched with saturated 
NH4Cl. The extractions were performed with ethyl acetate and organic layer was dried over Na2SO4 
followed by concentration to afford crude mixture. The residue was purified by flash chromatography 
(silica gel, isohexane/EtOAc = 2:1) to yield the title compound (190 mg, 91% yield) including 9% ethyl 
2-(1-benzyl-5H-1,2,3-triazol-4-yl)benzoate. 
M.p. (°C): 44.3–45.9. 
1H-NMR (600 MHz, CDCl3): δ / ppm = 7.82–7.78 (m, 1H), 7.78–7.75 (m, 1H), 7.52 (td, J = 7.6, 1.4 
Hz, 1H), 7.42–7.34 (m, 4H), 7.33–7.30 (m, 2H), 5.57 (s, 2H), 4.19 (q, J = 7.1 Hz, 2H), 1.17 (t, J = 7.2 
Hz, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 168.5, 146.2, 134.9, 131.4, 130.8, 130.3, 130.2, 129.7, 129.2, 
128.9, 128.2, 128.1, 122.7, 61.4, 54.3, 14.1. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 1720, 1290, 1067, 764. 
MS (EI, 70 eV): m/z (%) = 308 (M+, 3), 279 (10), 251 (17), 91 (100). 
HRMS (EI): m/z calc. for [C18H16DN3O2]: 308.1384; found: 308.1382 (M+).  
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Ethyl 4-(5-allyl-1-benzyl-1H-1,2,3-triazol-4-yl)benzoate (87b) 
 
To a solution of alkynylzinc reagent 71g (0.50 M in DMF, 0.9 mL, 0.45 mmol), sodium azide (27 
mg, 0.41 mmol), benzyl bromide (70 mg, 0.41 mmol) and copper iodide (8 mg, 0.04 mmol) at 25 °C. 
The reaction mixture was stirred at 25 °C for 7 h before the addition of allyl bromide (79; 54 mg, 0.45 
mmol). The resulting solution was stirred for 1 h before quenched with sat. aq. NH4Cl solution (2 mL). 
The mixture was extracted with EtOAc (3 × 2 mL). The combined organic layers were washed with sat. 
aq. NaCl solution and dried over Na2SO4. After filtration, the solvent was removed in vacuo. 
Purification of the crude product by flash chromatography (silica gel, isohexane/EtOAc = 2:1 to 1:1) 
afforded the title compound (125 mg, 87% yield).  
1H-NMR (600 MHz, CDCl3): δ / ppm = 8.10 (d, J = 8.1 Hz, 2H), 7.78 (d, J = 8.1 Hz, 2H), 7.39–7.29 
(m, 3H), 7.22–7.18 (m, 2H), 5.82 (ddt, J = 16.3, 10.4, 5.2 Hz, 1H), 5.55 (d, J = 1.1 Hz, 2H), 5.17 (dd, J 
= 10.2, 1.7 Hz, 1H), 4.91 (dd, J = 17.2, 1.9, Hz, 1H), 4.39 (q, J = 7.1 Hz, 2H), 3.48 (d, J = 5.0 Hz, 2H), 
1.40 (t, J = 7.1 Hz, 3H). 
13C-NMR (151 MHz, CDCl3): δ / ppm = 166.5, 145.0, 135.7, 134.8, 131.9, 131.3, 130.1, 129.8, 129.2, 
128.6, 127.4, 126.9, 118.2, 61.2, 52.3, 27.2, 14.5. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2981, 1710, 1614, 1366, 1272, 1101. 
MS (EI, 70 eV): m/z (%) = 347 (M+, 12), 299 (12), 298 (100), 91 (21). 
HRMS (EI): m/z calc. for [C21H21N3O2]: 347.1634; found: 347.1628 (M+).  
 
4-(5-(Diallylamino)-1-(2-fluorophenyl)-1H-1,2,3-triazol-4-yl)benzonitrile (87c) 
 
To a solution of alkynylzinc reagent 71h (0.76 mmol) in DMF (1.5 mL) was added 1-azido-2-
fluorobenzene (0.5 M in tbutyl methyl ether, 1.38 mL, 0.69 mmol) and copper iodide (13 mg, 10 mol%) 
under argon at 25 °C. The resulting solution was stirred at 25 °C for 21 h followed by the addition of 
electrophile 89 (166 mg, 0.76 mmol) and continued strring for 1.5 h before quenched with saturated 
NH4Cl. The extractions were performed with ethyl acetate and the combined organic layers were dried 
over Na2SO4 followed by concentration to afford crude mixture. The residue was purified by flash 
chromatography (silica gel, isohexane/EtOAc = 2:1 to 1:1) to yield the title compound (170 mg, 69% 
yield). 
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M.p. (°C): 96.2–100.7. 
1H-NMR (600 MHz, CDCl3): δ / ppm = 7.98–7.93 (m, 2H), 7.77–7.71 (m, 2H), 7.60–7.56 (m, 1H), 
7.52–7.46 (m, 1H), 7.40–7.29 (m, 2H), 5.58 (ddt, J = 16.8, 10.1, 6.5 Hz, 2H), 5.14–4.85 (m, 4H), 3.48 
(dt, J = 6.5, 1.3 Hz, 4H). 
13C-NMR (151 MHz, CDCl3): δ / ppm = 157.2 (d, J = 254.3 Hz), 143.3, 136.4, 135.8, 133.2, 132.2, 
129.2, 127.6, 124.8, 124.6 (d, J = 12.6 Hz, 4H), 119.1 (d, J = 29.7 Hz), 119.0, 117.1 (d, J = 19.3 Hz), 
111.2, 54.9. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3079, 2847, 2226, 1610, 1577, 1506, 1417, 1382, 1269, 1234, 
1109, 981. 
MS (EI, 70 eV): m/z (%) = 359 (M+, 6.7), 331 (27), 330 (24), 316 (30), 290 (20), 236(11), 223 (100). 
HRMS (EI): m/z calc. for [C21H18FN5]: 359.1546; found: 359.1535 (M+). 
 
Ethyl 4-(4-cyclohexyl-1-(4-fluorophenyl)-1H-1,2,3-triazol-5-yl)benzoate (87d) 
 
To a solution of alkynylzinc reagent 71d (0.5 mmol) in DMF (1.0 mL) was added 1-azido-4-
fluorobenzene (0.5 M in tbutyl methyl ether, 0.91 mL, 0.46 mmol) and copper iodide (9 mg, 10 mol%) 
under argon at 25 °C. The resulting solution was stirred at 25 °C for 21 h followed by the addition of 
ethyl 4-iodobenzoate 41 (100 mg, 0.36 mmol), Pd(dba)2 (6 mg, 2 mol%) and DavePhos (8 mg, 4 mol%). 
The reaction continued strring for 18 h at 50 °C before quenched with aq. sat. NH4Cl solution. The 
extractions were performed with ethyl acetate and the combined organic layers were dried over Na2SO4 
followed by concentration to afford crude mixture. The residue was purified by flash chromatography 
(silica gel, isohexane/EtOAc = 5:1 to 1:1) to yield the title compound (101 mg, 72% yield). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.08–8.02 (m, 2H), 7.26–7.23 (m, 2H), 7.23–7.20 (m, 2H), 
7.07–7.02 (m, 2H), 4.39 (q, J = 7.1 Hz, 2H), 2.65 (tt, J = 11.6, 3.5 Hz, 1H), 1.93–1.60 (m, 7H), 1.39 (t, 
J = 7.1 Hz, 3H), 1.32–1.21 (m, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 165.8, 162.4 (d, J = 250.0 Hz), 151.1, 132.7, 132.1 (d, J = 7.0 
Hz), 131.0, 130.0, 129.7, 126.9 (d, J = 8.8 Hz), 116.4 (d, J = 23.0 Hz), 61.3, 34.9, 33.0, 26.5, 25.8, 14.3. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2928, 2854, 1714, 1512, 1272, 1225, 1105. 
MS (EI, 70 eV): m/z (%) = 365 (39), 336 (44), 322 (100), 294 (76), 292 (26), 249 (72), 248 (64), 202 
(63), 135 (59). 
HRMS (EI): m/z calc. for [C23H24FN3O2]: 393.1853; found: 392.1766 (M+-H). 
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2.8 Synthesis of Carboxyamidotriazole (96) 
((3,5-Dichlorobenzyl)oxy)triisopropylsilane (91) 
 
In a 50 mL round-bottom flask with 3,5-dichlorobenzylalcohol 90 (1.06 g, 6 mmol) was dissolved in 
anhydrous THF (12 mL) followed the addition of nBuLi (2.55 M solution in hexane, 2.47 mL, 6.3 mmol) 
dropwise at -50 oC. The resulting solution was stirred at -50 °C for 10 min followed by the addition of 
DMAP (5 mol%) and TIPSCl (1.41 mL, 6.6 mmol). The reaction was stirred at 25 °C for 3 h before 
quenched quenched with aq. sat. NH4Cl solution. The extractions were performed with ethyl acetate 
and the combined organic layers were dried over Na2SO4 followed by concentration to afford crude 
mixture. The residue was purified by flash chromatography (silica gel, isohexane/EtOAc = 1:0 to 15:1) 
to yield the title compound (1.90 g, 95% yield). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.23 (s, 3H), 4.78 (s, 2H), 1.26–1.12 (m, 3H), 1.09 (s, 18H).  
13C-NMR (101 MHz, CDCl3): δ / ppm = 145.3, 134.9, 127.0, 124.2, 64.0, 18.1, 12.1.  
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2944, 2866, 1593, 1572, 1462, 1430, 1122. 
MS (EI, 70 eV): m/z (%) = 291 (40), 289 (58), 263 (24), 261 (37), 235 (22), 233 (35), 219 (30), 161 
(62), 159 (100), 125 (37). 
HRMS (EI): m/z calc. for [C16H26Cl2OSi]: 332.1130; found: 332.0577 (M+-iPr).  
 
(4-Chlorophenyl)(2,6-dichloro-4-(hydroxymethyl)phenyl)methanone (92) 
 
In a 20 mL round-bottom flask with compound 91 (667 mg, 2 mmol) was dissolved in anhydrous THF 
(3.0 mL) followed the addition of TMP2Mg·LiCl (2.2 mmol) at 0 oC dropwise. The resulting solution 
was stirred at 0 °C for 1.5 h then cooled down to -20 °C before the addition of CuCN·2LiCl (2.2 mmol) 
and 4-chlorobenzoyl chloride (0.22 mL, 1.66 mmol). The reaction mixture was warmed up slowly and 
stirred at 25 °C over night before quenched with aq. sat. NH4Cl solution. The extractions were 
performed with ethyl acetate and the combined organic layers were dried over Na2SO4 followed by 
concentration to afford crude mixture which was run through a short plug of silica and used for next 
steps without further purification. The residue in THF (2 mL) was added TBAF (1.0 M solution in THF, 
2.2 mL, 2.2 mmol) at 25 °C and stirred at 50 °C for 1.5 h and quenched with aq. sat. NH4Cl solution. 
The extractions were performed with ethyl acetate and the combined organic layers were dried over 
Na2SO4 followed by concentration to afford crude mixture. The residue was purified by flash 
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chromatography (silica gel, isohexane/EtOAc = 5:1 to 2:1) to yield the title compound (430 mg, 82% 
yield). 
M.p. (°C): 142.5–144.5. 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.75 (d, J = 8.6 Hz, 2H), 7.46 (d, J = 8.6 Hz, 2H), 7.39 (s, 
2H), 4.75 (d, J = 5.5 Hz, 2H), 2.08 (t, J = 5.8 Hz, 1H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 191.7, 145.0, 141.1, 136.1, 134.0, 132.1, 131.1, 129.5, 126.2, 
63.6. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3413, 2927, 2866, 1671, 1586, 11550, 1399, 1270, 1091. 
MS (EI, 70 eV): m/z (%) = 316 (21), 314 (M+, 22), 205 (31), 203 (49), 141 (33), 139 (100). 
HRMS (EI): m/z calc. for [C14H9Cl3O2]: 313.9668; found: 313.9662 (M+). 
 
(4-(Bromomethyl)-2,6-dichlorophenyl)(4-chlorophenyl)methanone (93) 
 
To a solution of benzyl alcohol 92 (316 mg, 1.0 mmol) in THF (2.0 mL) was added phosphorus 
tribromide (0.1 mL, 1 mmol) under argon at 25 °C. The resulting solution was stirred at 25 °C for 18 h 
before quenched with aq. sat. NaHCO3 solution. The extractions were performed with ethyl acetate and 
the combined organic layers were dried over Na2SO4 followed by concentration to afford crude mixture. 
The residue was purified by flash chromatography (silica gel, isohexane/EtOAc = 20:1 to 15:1) to yield 
the title compound (354 mg, 94% yield). 
M.p. (°C): 83.7–84.7. 
1H-NMR (600 MHz, CDCl3): δ / ppm = 7.78–7.74 (m, 2H), 7.49–7.44 (m, 2H), 7.42 (s, 2H), 4.43 (s, 
2H). 
13C-NMR (151 MHz, CDCl3): δ / ppm = 191.1, 141.4, 141.2, 137.1, 133.8, 132.3, 131.1, 129.6, 128.8, 
30.4. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 1676, 1588, 1548, 1398, 1268, 1235, 1160, 1093. 
MS (EI, 70 eV): m/z (%) = 380 (24), 378 (38), 375 (M+, 19), 301 (31), 299 (98), 297 (100), 271 (40), 
139 (37). 
HRMS (EI): m/z calc. for [C14H8BrCl3O]: 375.8824; found: 375.8821 (M+).  
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Ethyl 5-(diallylamino)-1-(3,5-dichloro-4-(4-chlorobenzoyl)benzyl)-1H-1,2,3-triazole-4-
carboxylate (95) 
 
To a solution of alkynylzinc reagent 71l (0.74 mmol) in DMF (1.5 mL) was added benzyl bromide 93 
(267 mg, 0.70 mmol), sodium azide (48 mg, 0.74 mmol) and copper iodide (16 mg, 10 mol%) 
successively under argon at 25 °C. The resulting solution was stirred at 25 °C for 18 h followed by the 
addition of electrophile 89 (127 mg, 0.58 mmol) and continued stirring for 2 h before quenched with 
aq. sat. NH4Cl solution. The extractions were performed with ethyl acetate and the combined organic 
layers were dried over Na2SO4 followed by concentration to afford crude mixture. The residue was 
purified by flash chromatography (silica gel, isohexane/EtOAc = 3:1 to 2:1) to yield the title compound 
(261 mg, 84% yield). 
M.p. (°C): 125.8–127.2. 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.70 (d, J = 8.6 Hz, 2H), 7.44 (d, J = 8.6 Hz, 2H), 7.26 (s, 
2H), 5.60 (ddt, J = 16.8, 10.0, 6.7 Hz, 2H), 5.45 (s, 2H), 5.20–5.01 (m, 4H), 4.46 (q, J = 7.1 Hz, 2H), 
3.69 (dd, J = 6.7, 1.2 Hz, 4H), 1.45 (t, J = 7.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 190.9, 161.1, 148.4, 141.3, 138.7, 137.2, 133.7, 133.5, 133.5, 
132.6, 131.0, 129.6, 127.5, 119.7, 61.5, 56.4, 49.0, 14.5. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3079, 2981, 1713, 1679, 1587, 1552, 1454, 1400, 1270, 1160. 
MS (EI, 70 eV): m/z (%) = 532 (M+, 0.28), 492 (16), 301 (16), 299 (51), 297 (50), 271 (39), 199 (28), 
139 (46), 111 (23), 96 (38), 41 (100). 
HRMS (EI): m/z calc. for [C25H23Cl3N4O3]: 532.0836; found: 532.0836 (M+). 
 
Ethyl 5-amino-1-(3,5-dichloro-4-(4-chlorobenzoyl)benzyl)-1H-1,2,3-triazole-4-carboxylate  
 
In a 10 mL round-bottom flask with triazole 95 (55 mg, 0.1 mmol) was dissolved in anhydrous CH2Cl2 
(1 mL) followed the addition of N,N-dimethylbarbituric acid (94 mg, 0.6 mmol) and 
tetrakis(triphenylphosphine)palladium(0) (12 mg, 0.01 mmol). The resulting solution was stirred at 40 
oC for 24 h and another batch of catalyst (12 mg, 0.01 mmol) was added. The reaction mixture was 
stirred 24 h at 40 °C before quenching with saturated NH4Cl. The extractions were performed with ethyl 
acetate and organic layer was dried over Na2SO4 followed by concentration to afford crude mixture. 
The residue was purified by flash chromatography (silica gel, isohexane/EtOAc = 3:1 to 1:1) to yield 
title compound (41 mg, 91% yield). 
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M.p. (°C): 223.9-231.6 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.72 (d, J = 8.5 Hz, 2H), 7.46 (d, J = 8.6 Hz, 2H), 7.21 (s, 
2H), 5.42 (s, 2H), 5.16 (s, 2H), 4.43 (q, J = 7.1 Hz, 2H), 1.43 (t, J = 7.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 191.0, 162.7, 145.8, 141.5, 137.6, 137.6, 133.6, 133.1, 131.1, 
129.7, 126.9, 122.0, 61.1, 48.8, 14.6. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3452, 3324, 2982, 1681, 1632, 1588, 1514, 1401, 1272, 1093. 
MS (EI, 70 eV): m/z (%) = 454 (20), 452 (M+, 26), 382 (31), 381 (22), 380 (35), 379 (46), 377 (41), 
353 (67), 352 (28), 351 (71), 277 (50), 262 (42), 207 (26), 199 (51), 139 (100). 
HRMS (EI): m/z calc. for [C19H15Cl3N4O3]: 452.0210; found: 452.0202 (M+). 
 
5-Amino-1-(3,5-dichloro-4-(4-chlorobenzoyl)benzyl)-1H-1,2,3-triazole-4-carboxamide (96) 
 
To a stirred solution of ethyl ester triazole (30 mg, 0.07 mmol) in methanol (1.0 mL) at 0 °C in a 
microwave vial was added magnesium nitride (34 mg, 0.34 mmol) in a single portion. The vial was 
sealed immediately and allowed to warm to room temperature. After 1 hour the reaction was heated at 
80 °C for 24 h. The reaction was allowed to cool to room temperature and diluted with chloroform (5 
mL) and water (5 mL). The aqueous layer was neutralised with 2N HCl and the organic layer separated. 
The aqueous layer was further extracted with chloroform (2 x 5 mL) and the organic layers combined, 
dried with Na2SO4 and concentrated in vacuo to afford the title compound (29 mg, 98% yield). 
1H-NMR (400 MHz, DMSO-d6): δ / ppm = 7.80–7.72 (m, 2H), 7.70–7.60 (m, 2H), 7.46 (s, 2H), 6.51 
(s, 2H), 5.52 (s, 2H). 
13C-NMR (101 MHz DMSO-d6): δ / ppm = 190.7, 164.1, 144.9, 140.6, 140.1, 135.7, 133.2, 131.0, 
130.7, 129.8, 127.5, 121.8, 47.0. 
MS (EI, 70 eV): m/z (%) = 427 (27), 426 (14), 425 (66), 423 (M+, 61), 379 (60), 377 (52), 271 (31), 
199 (44), 141 (36), 139 (100). 
HRMS (EI): m/z calc. for [C17H12Cl3N5O2]: 423.0057; found: 423.0042 (M+).  
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3 Preparation and Reactivity of Ethynylzinc Pivalate and Dipivaloyoxyzinc 
acetylene 
3.1 Preparation of Zinc pivalates 
Preparation of mono-pivaloyloxyzinc acetylide (98)  
 
A dry and argon-flushed Schlenk-flask equipped with a magnetic stirring bar and a septum was charged 
with a solution of ethnynyl magnesium bromide in THF (30 mL, 0.5 M, 15 mmol) and cooled to -20 °C. 
A solution of ZnCl2 in THF (16.5 mL, 1 M, 16.5 mmol) was added dropwise at -20 °C and the reaction 
was stirred for 2 h at room temperature. To that reaction mixture was added a freshly prepared solution 
of Mg(OPiv)232 in THF (30 mL, 0.5 M, 15 mmol) at room temperature and stirred for another 30 min. 
The solvent was removed in vacuo for at least 6 h and the dried solid ethynylzinc pivalate (1) was 
obtained as a white-yellowish powder in 98% yield.98 
 
Preparation of bis-pivaloyloxyzinc acetylide (99) 
 
A dry and argon-flushed Schlenk-flask equipped with a magnetic stirring bar and a septum was charged 
with a solution of ethyl magnesium bromide in THF (16.5 mL, 1 M, 16.5 mmol) and heated to 40 °C. 
A solution of ethnynyl magnesium bromide in THF (30 mL, 0.5 M, 15 mmol) was added and the reaction 
was stirred for 12 h. The reaction mixture was cooled to -20 °C and a solution of ZnCl2 in THF (16.5 
mL, 1 M, 16.5 mmol) was added dropwise at that temperature. After stirring the reaction mixture for 2 
h at room temperature a freshly prepared solution of Mg(OPiv)Error! Bookmark not defined. in THF (30 mL, 0
.5 M, 15 mmol) was added dropwise at room temperature and the reaction was stirred for another 30 
min. The solvent was removed in vacuo for at least 6 h and the dried solid dipivaloyoxyzinc acetylene 
(2) was obtained as a white powder in 93% yield.98 
3.2 Typical Procedures (TP) 
TP4: Typical procedure for the preparation of arylacetylenes using mono-pivaloyloxyzinc 
acetylide (98) 
A dry and argon-flushed flask equipped with a magnetic stirring bar and a septum was charged with the 
ethynylzinc pivalate (0.75 mmol), Pd(PPh3)4 (1 mol%) and THF (2 mL). The electrophile (0.5 mmol) 
was added and the resulting solution was stirred at 25 °C for 1 h. The reaction mixture was quenched 
with sat. aq. NH4Cl solution (2 mL) and extracted with EtOAc (3 × 2 mL). The combined organic layers 
 
98 Determined by titration with iodine.66  
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were washed with sat. aq. NaCl solution (3 mL) and dried over MgSO4. After filtration, the solvent was 
removed in vacuo. Purification via flash column chromatography yielded the desired product. 
 
TP5: Typical procedure for a one-pot synthesis of non-symmetrical bis-arylated acetylenes 
A dry and argon-flushed flask equipped with a magnetic stirring bar and a septum was charged with the 
ethynylzinc pivalate (0.375 mmol), Pd(PPh3)2Cl2 (2 mol%) and THF (3 mL). The first electrophile of 
type 100 (0.25 mmol) was added and the resulting solution was stirred at 25 °C for 1 h. To that reaction 
mixture the second electrophileof type 100 (0.3 mmol), CuI (10 mol%) and NEt3 (0.5 mmol)  were 
added at 25 °C and stirred for 12 h. The reaction mixture was quenched with sat. aq. NH4Cl solution (2 
mL) and extracted with EtOAc (3 × 2 mL). The combined organic layers were washed with sat. aq. 
NaCl solution (3 mL) and dried over MgSO4. After filtration, the solvent was removed in vacuo. 
Purification via flash column chromatography yielded the desired product. 
 
TP6: Typical procedure for the preparation of symmetrical bis-arylated acetylenes using bis-
pivaloyloxyzinc acetylide (99) and aryl iodides 
A dry and argon-flushed flask equipped with a magnetic stirring bar and a septum was charged with the 
bis-zinc acetylide pivalate (0.25 mmol), Pd(dba)2 (7 mg, 0.0125 mmol), SPhos (10 mg, 0.025 mmol)  
and DMSO (2 mL). The aryl iodide (0.55 mmol) was added and the resulting solution was stirred at 
25 °C for 12 h. The reaction mixture was quenched with sat. aq. NH4Cl solution (2 mL) and extracted 
with EtOAc (3 × 2 mL). The combined organic layers were washed with sat. aq. NaCl solution (3 mL), 
water (2x 10 mL) and dried over MgSO4. After filtration, the solvent was removed in vacuo. Purification 
via flash column chromatography yielded the desired product. 
 
TP7: Typical procedure for the preparation of symmetrical bis-arylated acetylenes using bis-
pivaloyloxyzinc acetylide (99) and aryl bromides 
A dry and argon-flushed flask equipped with a magnetic stirring bar and a septum was charged with the 
bis-pivaloyloxyzinc acetylide (0.25 mmol), Pd(dba)2 (5 mol%), Xantphos74  (5%) and DMSO (2 mL). 
The aryl bromide (0.55 mmol) was added and the resulting solution was stirred at 25 °C for 12 h. The 
reaction mixture was quenched with sat. aq. NH4Cl solution (2 mL) and extracted with EtOAc (3 × 
2 mL). The combined organic layers were washed with sat. aq. NaCl solution (3 mL), water (2x 10 mL) 
and dried over MgSO4. After filtration, the solvent was removed in vacuo. Purification via flash column 
chromatography yielded the desired product. 
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3.3 Preparation of the aryl acetylenes (101) 
1-Ethynyl-4-methoxybenzene (101a) 
 
According to TP4 1-iodo-4-methoxybenzene (100a; 117 mg, 0.5 mmol) was added to a solution of 
mono-pivaloyloxyzinc acetylide (98; 0.75 mmol) and Pd(PPh3)4 (5.8 mg, 0.05 mmol) in THF (2 mL) at 
25 °C. The resulting solution was stirred at 25 °C for 1 h. Purification of the crude product by flash 
chromatography (silica gel, isohexane/EtOAc = 19:1) afforded the title compound as a yellowish oil 
(65 mg, 98% yield). 
1H NMR (400 MHz, CDCl3) δ / ppm = 7.46 (d, J = 8.8, 2H), 6.86 (s, 1H), 3.84 (s, 3H), 3.02 (s, 1H). 
13C NMR (100 MHz, CDCl3) δ / ppm = 159.9, 133.5, 113.9, 83.6, 75.7, 55.2. 
MS (EI, 70 eV): m/z (%) 132 (100), 117 (31), 89 (60), 63 (10). 
HRMS (EI): m/z calc. for [C9H8O]: 132.0575; found: 132.0567 (M+). 
The 1H and 13C-NMR data are in accordance with those reported in the literature.99 
 
(2-Ethynylphenoxy)triisopropylsilane (101b) 
 
According to TP4 (2-iodophenoxy)triisopropylsilane (100b; 188 mg, 0.5 mmol) was added to a solution 
of mono-pivaloyloxyzinc acetylide (98; 0.75 mmol) and Pd(PPh3)4 (5.8 mg, 0.05 mmol) in THF (2 mL) 
at 25 °C. The resulting solution was stirred at 25 °C for 1 h. Purification of the crude product by flash 
chromatography (silica gel, 100% isohexane) afforded the title compound as a red oil (118 mg, 86% 
yield). 
1H NMR (400 MHz, CDCl3) δ / ppm = 7.44 (dd, J = 7.6, 1.7, 1H), 7.22 (td, J = 7.8, 1.7, 1H), 6.95–
6.81 (m, 2H), 3.21 (s, 1H), 1.41–1.25 (m, 3H), 1.15 (d, J = 7.4, 19H). 
13C NMR (101 MHz, CDCl3) δ / ppm = 157.6, 134.0, 129.9, 120.7, 119.1, 114.3, 81.1, 80.8, 18.0, 13.0. 
MS (EI, 70 eV): m/z (%) = 231 (M+, 32), 189 (35), 179 (34), 161 (100), 115 (40), 91 (18). 
HRMS (EI): m/z calc. for [C17H26OSi]: 274.1753; found: 272.1590 (M+). 
The 1H and 13C-NMR data are in accordance with those reported in the literature.100 
 
 
99 A. Rosiak, W. Frey, J. Christoffers, Eur. J. Org.Chem. 2006, 17, 4044. 
100  M. D. Morin; Y. Wang, B. T. Jones, L. Su, M. M. R. P. Surakattula, M. Berger,  H. Huang, E. K. Beutler, H. 
Zhang, B. Beutler, D. L. Boger, J. Med. Chem. 2016, 59, 4812. 
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Ethyl 4-ethynylbenzoate (101c) 
 
According to TP4 ethyl 4-iodobenzoate (100c; 138 mg, 0.5 mmol) was added to a solution of mono-
pivaloyloxyzinc acetylide (98; 0.75 mmol) and Pd(PPh3)4 (5.8 mg, 0.05 mmol) in THF (2 mL)  at 25 °C. 
The resulting solution was stirred at 25 °C for 1 h. Purification of the crude product by flash 
chromatography (silica gel, isohexane/EtOAc = 19:1) afforded the title compound as a yellowish oil 
(82 mg, 94% yield). 
1H NMR (400 MHz, CDCl3) δ / ppm = 8.02 (d, J = 8.2, 2H), 7.57 (d, J = 8.1, 2H), 4.40 (q, J = 7.1, 
2H), 3.25 (s, 1H), 1.42 (t, J = 7.1, 3H). 
13C NMR (100 MHz, CDCl3) δ / ppm = 165.9, 132.0, 130.4, 129.4, 126.6, 82.8, 79.9, 61.2, 14.3. 
MS (EI, 70 eV): m/z (%) = 174 (5), 146 (51), 129 (100), 101 (19), 75 (11) 
HRMS (EI): m/z calc. for [C11H10O2]: 174.0681; found: 174.0669 (M+). 
The 1H and 13C-NMR data are in accordance with those reported in the literature.101 
 
1-Ethynyl-4-nitrobenzene (101d) 
 
According to TP4 iodo-4-nitrobenzene (100d, 125 mg, 0.5 mmol) was added to a solution of mono-
pivaloyloxyzinc acetylide (98; 0.75 mmol) and Pd(PPh3)4 (5.8 mg, 1 mol%) in THF (2 mL) at 25 °C. 
The resulting solution was stirred at 25 °C for 1 h. Purification of the crude product by flash 
chromatography (silica gel, isohexane/EtOAc = 100:1) afforded the title compound as a yellowish oil 
(59 mg, 80% yield). 
1H NMR (400 MHz CDCl3) δ / ppm = 8.20 (d, J = 8.8 Hz, 2H), 7.64 (d, J = 8.8 Hz, 2H), 3.36 (s, 1H). 
13C NMR (100 MHz, CDCl3) δ / ppm: 132.9, 128.8, 123.5, 82.0, 81.5. 
MS (EI, 70 eV): m/z (%) = 147 (100), 129 (28), 117 (76), 101 (21), 89 (65), 75 (51), 74 (17).  
HRMS (EI): m/z calc. for [C8H5O2N]: 147.0320; found: 147.0314 (M+). 
The 1H and 13C NMR data are in accordance with those reported in the literature.102 
 
 
101 Y. Tang, K. Ogawa, G. P. Lopez, K. S. Schanze, D. G. Whitten, Langmuir 2009, 25, 21.   
102 Y. Wang, B.  Huang, S. Sheng, M. Cai, J. Chem. Res. 2007, 12, 728. 
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1-(4-Ethynylphenyl) ethan-1-one (101e) 
 
According to TP4 (4-iodophenyl)ethan-1-one (100e; 123 mg, 0.5 mmol) was added to a solution of 
mono-pivaloyloxyzinc acetylide (98; 0.75 mmol) and Pd(PPh3)4 (5.8 mg, 0.05 mmol) in THF (2 mL)  
at 25 °C. The resulting solution was stirred at 25 °C for 1 h. Purification of the crude product by flash 
chromatography (silica gel, isohexane/EtOAc = 50:1) afforded the title compound as a yellowish oil 
(68 mg, 95% yield). 
1H NMR (600 MHz, CDCl3) δ / ppm = 7.91 (d, J = 7.8, 2H), 7.57 (d, J = 7.8, 2H), 7.26 (s, 1H), 3.25 
(d, J = 0.8, 1H), 2.61 (s, 3H). 
13C NMR (100 MHz, CDCl3) δ / ppm: 197.2, 136.4, 132.2, 128.7, 126.8, 82.7, 80.3, 26.6. 
MS (70 eV, EI) m/z (%): 144 (12), 130 (10), 129.04 (18), 129.03 (100), 101 (11), 75 (9), 
HRMS (EI): m/z calc. for [C10H8O]: 144.0575; found: 144.0568 (M+). 
The 1H and 13C NMR data are in accordance with those reported in the literature.102 
 
3-Ethynylthiophene (101f) 
 
According to TP4 3-iodo-thiophene (100f; 105 mg, 0.5 mmol) was added to a solution of mono-
pivaloyloxyzinc acetylide (98; 0.75 mmol) and Pd(PPh3)4 (5.8 mg, 0.05 mmol) in THF (2 mL)  at 25 °C 
The resulting solution was stirred at 25 °C for 1 h. Purification of the crude product by flash 
chromatography (silica gel, 100% isohexane) afforded the title compound as a yellowish oil (43 mg, 
80% yield). 
1H NMR (400 MHz, CDCl3) δ / ppm = 7.50 (dd, J = 3.0, 1.2, 1H), 7.27–7.23 (m, 1H), 7.13 (dd, J = 
5.1, 1.2, 1H), 3.02 (s, 1H). 
13C NMR (100 MHz, CDCl3) δ / ppm = 130.0, 130.0, 125.3, 121.2, 78.8, 76.9. 
MS (70 eV, EI) m/z (%): 108 (100), 81 (13), 68 (5). 
HRMS (EI): m/z calc. for [C10H8O]: 108.0034; found: 108.0027 (M+). 
The 1H and 13C-NMR data are in accordance with those reported in the literature.103 
 
 
 
 
103 M. Beshai, B. Dhudshia, R. Mills, A. N. Thadani, Tetrahedron Lett. 2008, 49, 6794. 
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3.4 Preparation of Asymmetrical Bis-arylated Alkynes (102) 
1-Methoxy-4-(p-tolylethynyl)benzene (102a) 
 
According to TP5 1-iodo-4-methoxybenzene (100a; 59 mg, 0.25 mmol) was added to a solution of 
mono-pivaloyloxyzinc acetylide (98; 0.375 mmol) and Pd(PPh3)2Cl2 (3.5 mg, 0.005 mmol) in THF (2 
mL) at 25 °C. The resulting solution was stirred at 25 °C for 1 h. To that reaction mixture 4-iodo-toluene 
(100g; 65 mg, 0.3 mmol), CuI (4.8 mg, 0.025 mmol) and NEt3 (70 µl, 0.5 mmol)  were added at 25 °C 
and stirred for 12 h. Purification of the crude product by flash chromatography (silica gel, 
isohexane/EtOAc = 19:1) afforded the title compound as a yellowish oil (48 mg, 88% yield). 
1H NMR (400 MHz, CDCl3) δ / ppm = 7.48–7.41 (m, 2H), 7.39 (d, J = 8.1, 2H), 7.16–7.07 (m, 2H), 
6.91–6.76 (m, 2H), 3.81 (s, 3H), 2.35 (s, 3H). 
13C NMR (101 MHz, CDCl3) δ / ppm = 159.5, 138.0, 132.9, 131.3, 129.0, 120.5, 115.6, 113.9, 88.6, 
88.2, 55.3, 21.4. 
MS (70 eV, EI) m/z (%): 222 (100), 207 (65), 179, (42), 178 (66), 152 (36), 43 (29).  
HRMS (EI): m/z calc. for [C16H14O]: 222.1045; found: 222.1039 (M+). 
The 1H and 13C-NMR data are in accordance with those reported in the literature.104 
 
4-((4-Methoxyphenyl)ethynyl)benzonitrile (102b) 
 
According to TP5 1-iodo-4-methoxybenzene (100a; 59 mg, 0.25 mmol) was added to a solution of 
mono-pivaloyloxyzinc acetylide (98; 0.375 mmol) and Pd(PPh3)2Cl2 (3.5 mg, 0.005 mmol) in THF (2 
mL) at 25 °C. The resulting solution was stirred at 25 °C for 1 h. To that reaction mixture 4-iodo-
benzonitrile (100h) (69 mg, 0.3 mmol), CuI (4.8 mg, 0.025 mmol) and NEt3 (70 µl, 0.5 mmol) were 
added at 25 °C and stirred for 12 h. Purification of the crude product by flash chromatography (silica 
gel, isohexane/EtOAc = 10:1) afforded the title compound as a yellowish oil (52 mg, 90% yield). 
1H NMR (400 MHz, CDCl3) δ / ppm = 7.67–7.57 (m, 4H), 7.54–7.49 (m, 2H), 6.96–6.89 (m, 2H), 3.87 
(s, 3H). 
13C NMR (100 MHz, CDCl3) δ / ppm = 160.3, 134.1, 133.4, 132.0, 131.9, 128.7, 118.7, 114.2, 111.1, 
94.1, 86.7, 55.4. 
MS (70 eV, EI) m/z (%): 233 (100), 218 (59), 207 (18), 190 (73), 163 (20), 128 (11).   
HRMS (EI): m/z calc. for [C16H11ON]: 233.0841; found: 233.0836 (M+). 
The 1H and 13C-NMR data are in accordance with those reported in the literature.105 
 
 
104 K. G. Thakur, G. Sekar, Synthesis 2009, 16, 2785. 
105 M. L. N. Rao, D. N. Jadhav,  Dasgupta, P.; Org. Lett. 2010, 9, 2048. 
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3-((4-Methoxyphenyl)ethynyl)pyridine (102c) 
 
According to TP5 1-iodo-4-methoxybenzene (100a; 59 mg, 0.25 mmol) was added to a solution of 
mono-pivaloyloxyzinc acetylide (98; 0.375 mmol) and Pd(PPh3)2Cl2 (3.5 mg, 0.005 mmol) in THF (2 
mL) at 25 °C. The resulting solution was stirred at 25 °C for 1 h. To that reaction mixture 3-iodo-
pyridine (100i; 62 mg, 0.3 mmol), CuI (4.8 mg, 0.0025 mmol) and NEt3 (70 µl, 0.5 mmol)  were added 
at 25 °C and stirred for 12 h. Purification of the crude product by flash chromatography (silica gel, 
isohexane/EtOAc = 2:1) afforded the title compound as a yellowish oil (42 mg, 81% yield). 
1H NMR (400 MHz, CDCl3) δ / ppm = 8.73 (s, 1H), 8.51 (d, J = 4.9, 1H), 7.76 (dt, J = 7.9, 2.0, 1H), 
7.51–7.43 (m, 2H), 7.26 (dd, J = 5.0, 0.9, 1H), 6.88 (d, J = 8.9, 2H), 3.82 (s, 3H). 
13C NMR (100 MHz, CDCl3) δ / ppm = 160.0, 152.1, 148.2, 138.2, 133.2, 122.9, 114.6, 114.1, 92.7, 
84.7, 77.3, 77.2, 77.0, 76.7, 55.3. 
MS (70 eV, EI) m/z (%): 209 (100), 194 (60), 166 (35), 149 (40), 113 (8).   
HRMS (EI): m/z calc. for [C14H11ON]: 209.0841; found: 209.0836 (M+). 
The 1H and 13C-NMR data are in accordance with those reported in the literature104  
 
3-((4-Methoxyphenyl)ethynyl)thiophene (102d) 
 
According to TP5 1-iodo-4-methoxybenzene (100a; 59 mg, 0.25 mmol) was added to a solution of 
mono-pivaloyloxyzinc acetylide (98; 0.375 mmol) and Pd(PPh3)2Cl2 (3.5 mg, 0.005 mmol) in THF (2 
mL) at 25 °C. The resulting solution was stirred at 25 °C for 1 h. To that reaction mixture 3-iodo-
thiophene (100f; 63 mg, 0.3 mmol), CuI (4.8 mg, 0.0025 mmol) and NEt3 (70 µl, 0.5 mmol) were added 
at 25 °C and stirred for 12 h. Purification of the crude product by flash chromatography (silica gel, 
isohexane/EtOAc = 19:1) afforded the title compound as a white solid (40 mg, 75% yield). 
1H NMR (400 MHz, CDCl3) δ / ppm = 7.46 (dd, J = 3.0, 1.2, 1H), 7.45–7.40 (m, 2H), 7.27 (dd, J = 
5.0, 3.0, 1H), 7.16 (dd, J = 5.0, 1.2, 1H), 6.90–6.81 (m, 2H), 3.81 (s, 3H). 
13C NMR (100 MHz, CDCl3) δ / ppm = 159.6, 132.9, 129.8, 128.0, 125.2, 122.6, 115.3, 114.0, 88.7, 
83.1, 55.3. 
MS (70 eV, EI) m/z (%): 214 (100), 199 (85), 171 (50), 155 (12), 127 (9).   
HRMS (EI): m/z calc. for [C13H10OS]: 214.0452; found: 214.0448 (M+). 
The 1H and 13C-NMR data are in accordance with those reported in the literature.106 
 
 
 
106 B. G. Van den Hoven, H. J. Alper, Org. Chem. 1999, 64, 9640. 
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Ethyl 4-((4-acetylphenyl)ethynyl)benzoate (102e) 
 
According to TP5 1-(4-iodophenyl)ethan-1-one (100e; 59 mg, 0.25 mmol) was added to a solution of 
mono-pivaloyloxyzinc acetylide (98; 0.375 mmol) and Pd(PPh3)2Cl2 (3.5 mg, 0.005 mmol) in THF 
(2 mL) at 25 °C. The resulting solution was stirred at 25 °C for 1 h. To that reaction mixture ethyl 4-
iodobenzoate (100c) (83 mg, 0.3 mmol), CuI (4.8 mg, 0.025 mmol) and NEt3 (70 µl, 0.5 mmol) were 
added at 25 °C and stirred for 12 h. Purification of the crude product by flash chromatography (silica 
gel, isohexane/EtOAc = 9:1 to 3:1) afforded the title compound as a yellowish solid (47 mg, 64% yield). 
1H NMR (600 MHz, CDCl3) δ / ppm = 8.07 – 8.03 (m, 2H), 7.97 – 7.94 (m, 2H), 7.65 – 7.59 (m, 4H), 
4.39 (q, J = 7.1, 2H), 2.62 (s, 3H), 1.41 (t, J = 7.2, 3H). 
13C NMR (150 MHz, CDCl3) δ / ppm = 197.3, 166.0, 136.6, 131.8, 131.6, 130.3, 129.5, 128.3, 127.6, 
127.2, 91.8, 91.2, 61.2, 26.7, 14.3. 
MS (70 eV, EI) m/z (%): 292 (30), 249 (43), 247 (26), 204 (18), 176 (100), 165 (17), 150 (32), 116 
(18), 88 (20).   
HRMS (EI): m/z calc. for [C19H16O3]: 292.1099; found: 292.1090 (M+). 
The 1H and 13C-NMR data are in accordance with those reported in the literature.107 
 
3-((4-Nitrophenyl)ethynyl)pyridine (102f) 
 
According to TP5 1-iodo-4-nitrobenzene (100d; 62 mg, 0.25 mmol) was added to a solution of mono-
pivaloyloxyzinc acetylide (98; 0.375 mmol) and Pd(PPh3)2Cl2 (3.5 mg, 0.005 mmol) in THF (2 mL) at 
25 °C. The resulting solution was stirred at 25 °C for 1 h. To that reaction mixture 3-iodopyridine (100i) 
(62 mg, 0.3 mmol), CuI (4.8 mg, 0.025 mmol) and NEt3 (70 µl, 0.5 mmol) were added at 25 °C and 
stirred for 12 h. Purification of the crude product by flash chromatography (silica gel, isohexane/EtOAc 
= 3:1) afforded the title compound as a yellowish solid (42 mg, 75% yield). 
1H NMR (600 MHz, CDCl3) δ / ppm = 8.81 (s, 1H), 8.62 (s, 1H), 8.28–8.22 (m, 2H), 7.85 (dt, J = 7.9, 
1.9, 1H), 7.74–7.66 (m, 2H), 7.34 (dd, J = 7.9, 4.8, 1H). 
13C NMR (150 MHz, CDCl3) δ / ppm = 152.4, 149.5, 147.4, 138.7, 132.6, 132.4, 129.4, 123.8, 123.7, 
90.9, 90.5, 77.2, 77.0, 76.8. 
MS (70 eV, EI) m/z (%): 224 (100), 194 (41), 177 (32), 166 (32), 151 (32), 150 (39), 139 (25). 
HRMS (EI): m/z calc. for [C13H8O2N2]: 224.0586; found: 224.0579 (M+). 
The 1H and 13C-NMR data are in accordance with those reported in the literature.108 
 
107 C. He, J. Ke, H. Xu, A. Lei, Angew. Chem. Int. Ed. 2013, 52, 1527. 
108 G. Chelucci, F. Capitta, S. Baldino, Tetrahedron 2008, 64, 10250. 
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3.5 Preparation of 1,5-disubstituted 1,2,3-triazoles (105) 
5-Allyl-1-benzyl-1H-1,2,3-triazole (105a)  
 
To a solution of mono-pivaloyloxyzinc acetylide (98; 0.325 mmol) in DMF (1.5 mL) was added sodium 
azide (16 mg, 0.25 mmol), benzyl bromide (83; mg, 0.25 mmol) and copper iodide (48 mg, 0.25 mmol) 
under argon at 25 °C. The reaction mixture was stirred at 25 °C for 12 h before the addition of allyl 
bromide (63 mg, 0.625 mmol). The resulting solution was stirred for 1 h before quenched with sat. aq. 
NH4Cl solution (2 mL). The mixture was extracted with EtOAc (3 × 2 mL). The combined organic 
layers were washed with sat. aq. NaCl solution, water (2x 10 mL) and dried over Mg2SO4. After 
filtration, the solvent was removed in vacuo. Purification of the crude product by flash chromatography 
(silica gel, isohexane/EtOAc = 7:3) afforded the title compound as a yellowish liquid (25 mg, 49% 
yield). 
1H NMR (400 MHz, CDCl3) δ / ppm = 7.51 (s, 1H), 7.40–7.29 (m, 3H), 7.17–7.10 (m, 2H), 5.79 (ddt, 
J = 16.5, 10.1, 6.3, 1H), 5.52 (s, 2H), 5.16 (dq, J = 10.1, 1.4, 1H), 5.05 (dq, J = 17.0, 1.6, 1H), 3.27 
(dq, J = 6.3, 1.4, 2H). 
13C NMR (100 MHz, CDCl3) δ / ppm = 134.9, 134.8, 133.4, 132.1, 129.0, 128.3, 127.1, 118.2, 77.4, 
77.1, 76.7, 51.7, 27.4. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3062, 1641, 1548, 1455, 1359, 1236, 1095, 985, 921, 826, 714, 
694. 
MS (EI, 70 eV): m/z (%) = 170 (53), 117 (14), 91 (100), 65 (11). 
HRMS (EI): m/z calc. for [C12H13N3]: 199.1109 found: 199.1100 (M+).  
 
1-Benzyl-5-(4-methoxyphenyl)-1H-1,2,3-triazole (105b) 
 
To a solution of mono-pivaloyloxyzinc acetylide (99; 0.325 mmol) in DMF (1.5 mL) was added sodium 
azide (16 mg, 0.25 mmol), benzyl bromide (43 mg, 0.25 mmol) and copper iodide (48 mg, 0.25 mmol) 
under argon at 25 °C. The reaction mixture was stirred at 25 °C for 12 h followed by the addition of 
ethyl 4-iodoanisole (100a; 70 mg, 0.30 mmol), Pd(Cl2(PPh3)2 (9 mg, 0.005 mmol). The reaction 
continued stirring for 12 h at 50 °C before quenched with aq. sat. NH4Cl solution. The extractions were 
performed with ethyl acetate (2 x 3 mL), washed with water (2 x 10 mL) the combined organic layers 
were dried over Na2SO4 followed by concentration to afford crude mixture. The residue was purified 
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by flash chromatography (silica gel, isohexane/EtOAc = 2:1) to yield the title compound as colorless 
oil (54 mg, 82% yield). 
1H NMR (400 MHz, CDCl3) δ / ppm = 7.72 (s, 1H), 7.36 – 7.29 (m, 3H), 7.23 – 7.15 (m, 2H), 7.14 – 
7.08 (m, 2H), 6.98 – 6.91 (m, 2H), 5.55 (s, 2H), 3.86 (s, 3H). 
13C NMR (101 MHz, CDCl3) δ / ppm = 160.5, 138.0, 135.7, 133.1, 130.3, 128.8, 128.1, 127.1, 119.0, 
114.4, 77.3, 77.0, 76.7, 55.4, 51.7. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2936, 2836, 1613, 1495, 1454, 1249, 1177, 1020, 828, 717. 
MS (EI, 70 eV): m/z (%) = 265 (15), 236 (25), 207 (65), 146 (81), 119 (19), 104 (31), 91 (100), 65 (15). 
HRMS (EI): m/z calc. for [C16H15N3O]: 265.1215; found: 265.1208 (M+-H).  
 
4-(1-Benzyl-1H-1,2,3-triazol-5-yl)morpholine (105c) 
 
To a solution of mono-pivaloyloxyzinc acetylide (98; 0.325 mmol) in DMF (1.5 mL) was added sodium 
azide (16 mg, 0.25 mmol), benzyl bromide (43 mg, 0.25 mmol) and copper iodide (48 mg, 0.25 mmol) 
under argon at 25 °C. The reaction mixture was stirred at 25 °C for 12 h before the addition of 
morpholino benzoate42 (104a; 62 mg, 0.3 mmol). The resulting solution was stirred for 1 h before 
quenched with sat. aq. NH4Cl solution (2 mL). The mixture was extracted with EtOAc (3 × 2 mL). The 
combined organic layers were washed with sat. aq. NaCl solution, water (2x 10 mL) and dried over 
Mg2SO4. After filtration, the solvent was removed in vacuo. Purification of the crude product by flash 
chromatography (silica gel, isohexane/EtOAc = 1:4) afforded the title compound as white solid (45 mg, 
74% yield). 
M.p. (°C): 80.3 – 82.1. 
1H NMR (400 MHz, CDCl3) δ / ppm = 7.41 (s, 1H), 7.40–7.30 (m, 3H), 7.28–7.24 (m, 2H), 5.46 (s, 
2H), 3.81–3.71 (m, 4H), 2.88–2.75 (m, 4H). 
13C NMR (100 MHz, CDCl3) δ / ppm = 147.0, 135.4, 128.9, 128.2, 127.4, 123.7, 66.6, 52.7, 50.5. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2959, 2852, 1555, 1452, 1261, 1237, 1114, 981, 913, 730, 695. 
MS (EI, 70 eV): m/z (%) = 244 (43), 185 (11), 157 (25), 130 (10), 91 (100). 
HRMS (EI): m/z calc. for [C13H16ON4]: 244.1324 found: 244.1320 (M+).  
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N,N-diallyl-1-benzyl-1H-1,2,3-triazol-5-amine (105d) 
 
To a solution of mono-pivaloyloxyzinc acetylide (98; 0.325 mmol) in DMF (1.5 mL) was added sodium 
azide (16 mg, 0.25 mmol), benzyl bromide (43 mg, 0.25 mmol) and copper iodide (48 mg, 0.25 mmol) 
under argon at 25 °C. The reaction mixture was stirred at 25 °C for 12 h before the addition of N,N-
diallyl-O-benzoylhydroxylamine42 (89b; 54 mg, 0.3 mmol). The resulting solution was stirred for 1 h 
before quenched with sat. aq. NH4Cl solution (2 mL). The mixture was extracted with EtOAc (3 × 2 
mL). The combined organic layers were washed with sat. aq. NaCl solution, water (2x 10 mL) and dried 
over Mg2SO4. After filtration, the solvent was removed in vacuo. Purification of the crude product by 
flash chromatography (silica gel, isohexane/EtOAc = 2:1) afforded the title compound as a white solid 
(32 mg, 51% yield). 
M.p. (°C): 84.2 – 86.3 
1H NMR (400 MHz, CDCl3) δ / ppm = 7.36 (s, 1H), 7.38–7.30 (m, 2H), 7.30–7.23 (m, 3H), 5.68 (ddt, 
J = 16.7, 10.3, 6.2, 2H), 5.44 (s, 2H), 5.19–5.08 (m, 4H), 3.45 (dt, J = 6.3, 1.4, 4H). 
13C NMR (101 MHz, CDCl3) δ / ppm = 145.8, 135.5, 133.0, 128.7, 128.1, 127.4, 125.6, 118.9, 77.3, 
77.0, 76.7, 56.3, 50.2. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3078, 2925, 2848, 1552, 1455, 1232, 991, 923, 726. 
MS (EI, 70 eV): m/z (%) = 225 (22), 211 (10), 183 (11), 135 (25), 91 (100). 
HRMS (EI): m/z calc. for [C13H16ON4]: 254.1531 found: 254.1527 (M+). 
3.6 Preparation of symmetrical bis-arylated alkynes 106) 
1,2-Bis(4-methoxyphenyl)ethyne (106a) 
 
According to TP6, 1-iodo-4-methoxybenzene (100; 128 mg, 0.55 mmol) was added to a solution of bis-
pivaloyloxyzinc acetylide (99; 0.25 mmol) and Pd(dba)2 (7 mg, 0.0125 mmol), SPhos (10 mg, 0.025 
mmol) in DMSO (2 mL) at 25 °C. The resulting solution was stirred at 25 °C for 1 h. Purification of 
the crude product by flash chromatography (silica gel, isohexane/EtOAc = 50:1) afforded the title 
compound as a white solid (58 mg, 98% yield). 
1H NMR (400 MHz, CDCl3) δ / ppm = 7.47 (d, J = 8.8, 1H), 6.89 (d, J = 8.8, 1H), 3.85 (s, 2H). 
13C NMR (101 MHz, CDCl3) δ / ppm = 159.4, 132.9, 115.7, 114.0, 87.9, 55.3. 
MS (EI, 70 eV): m/z (%) = 238 (100), 223 (89), 195 (28), 152 (24). 
HRMS (EI): m/z calc. for [C16H14O2]: 238.0994; found: 238.0986 (M+). 
The 1H and 13C-NMR data are in accordance with those reported in the literature.105 
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1,2-Diphenylethyne (106b)  
 
According to TP6, iodotoluene (100j; (111 mg, 0.55 mmol) was added to a solution of bis-
pivaloyloxyzinc acetylide (99; 0.25 mmol) and Pd(dba)2 (7 mg, 0.0125 mmol), SPhos (10 mg, 0.025 
mmol)  in DMSO (2 mL) at 25 °C. The resulting solution was stirred at 25 °C for 1 h. Purification of 
the crude product by flash chromatography (silica gel, 100% isohexane) afforded the title compound as 
a white solid (41 mg, 93% yield). 
1H NMR (400 MHz, CDCl3) δ / ppm = 7.61–7.51 (m, 2H), 7.43–7.30 (m, 8H). 
13C NMR (101 MHz, CDCl3) δ / ppm = 131.6, 128.4, 123.3, 89.4. 
MS (70 eV, EI) m/z (%): 179 (15), 178 (100), 177 (7), 176 (24), 152 (12), 151 (5), 150 (6). 
HRMS (EI): m/z calc. for [C14H10]: 178.0783; found: 178.0776 (M+). 
The 1H and 13C-NMR data are in accordance with those reported in the literature.109 
 
2,2'-(Ethyne-1,2-diyl)dianiline (106c) 
 
According to TP6, 2-iodoaniline (100k; 113 mg, 0.55 mmol) was added to a solution of bis-
pivaloyloxyzinc acetylide (99; 0.25 mmol) and Pd(dba)2 (7 mg, 0.0125 mmol), SPhos (10 mg, 0.025 
mmol)  in DMSO (2 mL) at 25 °C. The resulting solution was stirred at 25 °C for 1 h. Purification of 
the crude product by flash chromatography (silica gel, isohexane/EtOAc = 2:1) afforded the title 
compound as a white solid (48 mg, 93% yield). 
1H NMR (400 MHz, CDCl3) δ / ppm = 7.42–7.34 (m, 2H), 7.17 (m, J = 8.2, 7.3, 1.6, 2H), 6.80–6.69 
(m, 4H), 4.29 (s, 4H). 
13C NMR (101 MHz, CDCl3) δ / ppm = 147.6, 132.0, 129.7, 118.0, 114.4, 108.1, 91.1. 
MS (70 eV, EI) m/z (%): 208 (100), 207 (47), 180 (12), 104 (7), 90 (5). 
HRMS (EI): m/z calc. for [C14H12N2]: 208.1000; found: 208.0997 (M+). 
The 1H and 13C-NMR data are in accordance with those reported in the literature.110 
 
109 Y. Yoshida, K. Nogi, H. Yorimitsu, Synlett 2017, 28, 2561. 
110 A. Andranova, F.  Szydlo, F.  Teply, M. Tobrmanova, A. Volot, I. G. Stara, I. Stary, I. Rulisek, D. Saman, J. 
Cvacka, P. Fiedler, P. Voitsek; Collect. Czech. Chem. Commun 2009, 74, 189. 
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1,2-Bis(2-bromophenyl)ethyne (106d) 
 
According to TP6, 1-bromo-2-iodobenzene (100l; 155 mg, 0.55 mmol) was added to a bis-
pivaloyloxyzinc acetylide (99; 0.25 mmol), Pd(dba)2 (7 mg, 0.0125 mmol) and SPhos (10 mg, 0.025 
mmol)  in DMSO (2 mL) at 25 °C. The resulting solution was stirred at 25 °C for 1 h. Purification of 
the crude product by flash chromatography (silica gel, isohexane/EtOAc = 100:1) afforded the title 
compound as a white solid (62 mg, 74% yield). 
1H NMR (400 MHz, CDCl3) δ / ppm = 7.65 (ddd, J = 7.6, 3.9, 1.5, 4H), 7.34 (td, J = 7.6, 1.2, 2H), 
7.26–7.20 (m, 2H). 
13C NMR (100 MHz, CDCl3) δ / ppm = 133.7, 132.6, 129.8, 127.1, 125.6, 125.2, 92.3. 
MS (70 eV, EI) m/z (%): 335 (22), 176 (100), 174 (13) 150 (20) 88 (19). 
HRMS (EI): m/z calc. for [C14H8Br2]: 333.8993; found: 333.8995 (M+). 
The 1H and 13C-NMR data are in accordance with those reported in the literature.111 
 
4,4'-(ethyne-1,2-diyl)dibenzonitrile (106e) 
 
According to TP3, 4-iodobenzonitrile (100h; 99 mg, 0.55 mmol) was added to a solution bis-
pivaloyloxyzinc acetylide (99; 0.25 mmol), Pd(dba)2 (7 mg, 0.0125 mmol) and SPhos (10 mg, 0.025 
mmol)  in DMSO (2 mL) at 25 °C. The resulting solution was stirred at 25 °C for 1 h. Purification of 
the crude product by flash chromatography (silica gel, isohexane/EtOAc = 100:1) afforded the title 
compound as a white solid (50 mg, 84% yield). 
1H NMR (400 MHz, CDCl) δ / ppm = 7.69–7.57 (m, 8H). 
13C NMR (100 MHz, CDCl3) δ / ppm = 132.2, 132.2, 127.0, 118.2, 112.4, 91.5. 
MS (70 eV, EI) m/z (%): 228 (100), 201 (12), 151 (8), 98 (7), 74 (8). 
HRMS (EI): m/z calc. for [C16H8N2]: 228.0687; found: 228.0681 (M+). 
The 1H and 13C-NMR data are in accordance with those reported in the literature.112 
 
 
111 I. V. Alabugin,; K. Gilmore, S. Patil, M. Manoharan, S. V. Kovalenko, R. J. Clark, I. Ghiviriga, J. Am. Chem. 
Soc. 2008, 130, 11535. 
112 L. Melzig, A. Metzger, P. Knochel, Chem. Eur. J. 2011, 17, 2948. 
C. EXPERIMENTAL PART    82 
1,1'-(Ethyne-1,2-diylbis(4,1-phenylene))bis(ethan-1-one) (106f) 
 
According to TP6, 1-(4-iodophenyl)ethan-1-one (100e; 135 mg, 0.55 mmol) was added to a solution of 
bis-pivaloyloxyzinc acetylide (99; 0.25 mmol), Pd(dba)2 (7 mg, 0.025 mmol) and SPhos (10 mg, 0.025 
mmol) in DMSO (2 mL) at 25 °C. The resulting solution was stirred at 25 °C for 1 h. Purification of 
the crude product by flash chromatography (silica gel, isohexane/EtOAc = 9:1) afforded the title 
compound as a white solid (62 mg, 95% yield). 
1H NMR (400 MHz, CDCl3) δ / ppm = 8.02–7.93 (m, 4H), 7.71–7.61 (m, 4H), 2.65 (s, 6H). 
13C NMR (100 MHz, CDCl3) δ / ppm = 197.3, 136.6, 131.9, 128.3, 127.5, 91.7, 26.7. 
MS (70 eV, EI) m/z (%): 263 (9), 262 (46), 248 (19), 247 (100), 219 (10), 204 (13), 176 (24), 150 (8). 
HRMS (EI): m/z calc. for [C18H14O2]: 262.0994; found: 262.0987 (M+). 
The 1H and 13C-NMR data are in accordance with those reported in the literature.113 
 
1,2-Bis(4-chlorophenyl)ethyne (106g) 
 
According to TP7, 1-bromo-4-chlorobenzene (75d; 135 mg, 0.55 mmol) was added to a solution of bis-
pivaloyloxyzinc acetylide (2; 0.25 mmol), Pd(dba)2 (7 mg, 0.025 mmol) and Xantphos (7 mg, 0.0125 
mmol)  in DMSO (2 mL) at 25 °C. The resulting solution was stirred at 25 °C for 1 h. Purification of 
the crude product by flash chromatography (silica gel, 100% isohexane) afforded the title compound as 
a white solid (62 mg, 95% yield). 
1H NMR (400 MHz, Chloroform-d) δ / ppm = 7.52–7.44 (m, 4H), 7.39–7.32 (m, 4H). 
13C NMR (101 MHz, CDCl3) δ / ppm = 134.5, 132.8, 128.8, 121.4, 89.2. 
MS (70 eV, EI) m/z (%): 247 (63), 245 (100), 176 (59) 150 (11), 98 (3). 
HRMS (EI): m/z calc. for [C14H8Cl2]: 246.0003; found: 245.9996 (M+). 
The 1H and 13C-NMR data are in accordance with those reported in the literature.112  
 
Diethyl 4,4'-(ethyne-1,2-diyl)dibenzoate (106h) 
 
According to TP7, ethyl 4-bromobenzoate (75c;135 mg, 0.55 mmol) was added to a solution of bis-
pivaloyloxyzinc acetylide (99; 0.25 mmol), Pd(dba)2 (7 mg, 0.025 mmol) and Xantphos (7 mg, 0.0125 
mmol)  in DMSO (2 mL) at 25 °C. The resulting solution was stirred at 25 °C for 1 h. Purification of 
the crude product by flash chromatography (silica gel, isohexane/EtOAc = 9:1) afforded the title 
compound as a white solid (72 mg, 88% yield). 
 
113 J. Heppekausen, R. Stade, R. Goddard, A. Fürstner,  J. Am. Chem. Soc. 2010, 132, 11053. 
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1H NMR (400 MHz, CDCl3) δ / ppm = 8.07–7.93 (m, 2H), 7.66–7.53 (m, 2H), 4.38 (q, J = 7.1, 2H), 
1.39 (t, J = 7.1, 3H). 
13C NMR (101 MHz, CDCl3) δ / ppm = 165.9, 131.5, 130.3, 129.5, 127.2, 91.3, 61.2, 14.3. 
MS (70 eV, EI) m/z (%): (%): 323 (22), 322 (100), 294 (25), 278 (19), 277 (99), 266 (21), 249 (57), 
176 (51).HRMS (EI): m/z calc. for [C20H18O4]: 322.1005; found: 322.1198 (M+). 
The 1H and 13C-NMR data are in accordance with those reported in the literature.112  
 
1,2-Di(pyridin-3-yl)ethyne (106i) 
 
According to TP7, 3-bromopyridine (75k; 87 mg, 0.55 mmol) was added to a solution of bis-
pivaloyloxyzinc acetylide (299; 0.25 mmol), Pd(dba)2 (7 mg, 0.025 mmol) and Xantphos (7 mg, 0.0125 
mmol) in DMSO (2 mL) at 25 °C. The resulting solution was stirred at 25 °C for 1 h. Purification of 
the crude product by flash chromatography (silica gel, isohexane/EtOAc = 2:1) afforded the title 
compound as a white solid (37 mg, 82% yield). 
1H NMR (400 MHz, CDCl3) δ / ppm = 8.77 (dd, J = 2.2, 0.9, 2H), 8.57 (dd, J = 4.9, 1.6, 2H), 7.85 – 
7.78 (m, 2H), 7.29 (ddd, J = 7.9, 4.9, 0.9, 2H). 
13C NMR (101 MHz, CDCl3) δ / ppm = 152.3, 149.1, 138.5, 123.1, 119.7, 89.1. 
MS (70 eV, EI) m/z (%): (%): 180 (100), 179 (33), 152 (11), 127 (8), 74 (4). 
HRMS (EI): m/z calc. for [C12H8N2]: 180.0687; found: 180.0679 (M+). 
The 1H and 13C-NMR data are in accordance with those reported in the literature.114 
 
1,2-Di(thiophen-3-yl)ethyne (106j) 
 
According to TP7 3-bromothiophene (75l; 180 mg, 1.1 mmol) was added to a solution of bis-
pivaloyloxyzinc acetylide (99; 0.25 mmol), Pd(dba)2 (7 mg, 0.025 mmol) and Xantphos (7 mg, 0.0125 
mmol)  in DMSO (2 mL) at 25 °C. The resulting solution was stirred at 25 °C for 1 h. Purification of 
the crude product by flash chromatography (silica gel, 100% isohexane) afforded the title compound as 
a white solid (89mg, 94% yield). 
1H NMR (400 MHz, CDCl3) δ / ppm = 7.53 (dd, J = 3.0, 1.2, 2H), 7.32 (dd, J = 5.0, 3.0, 2H), 7.21 
(dd, J = 5.0, 1.2, 2H). 
13C NMR (101 MHz, CDCl3) δ / ppm = 129.8, 128.5, 125.4, 122.2, 84.0. 
MS (70 eV, EI) m/z (%): (%): 190 (12), 189 (100), 145 (13), 114 (6), 94 (6), 44 (10).  
HRMS (EI): m/z calc. for [C10H6S2]: 189.9911; found: 189.9898 (M+). 
 
114 M. Bindl, R. Stade, E. K. Heilmann, A. Picot, R. Goddard, A. Fürstner, J. Am. Chem. Soc. 2009, 131, 9468, 
C. EXPERIMENTAL PART    84 
The 1H and 13C-NMR data are in accordance with those reported in the literature.115 
 
Preparation of 4,5-diallyl-1-benzyl-1H-1,2,3-triazole (108) 
 
To a solution of bis-pivaloyloxyzinc acetylide (99; 7.5 mmol) in DMF (15 mL) was added sodium azide 
(325 mg, 5 mmol), benzyl bromide (855 mg, 5 mmol) and copper iodide (1.9 g, 10 mmol) under argon 
at 25 °C. The reaction mixture was stirred at 25 °C for 12 h before the addition of allyl bromide (3.6 g, 
30 mmol). The resulting solution was stirred for 1 h before quenched with sat. aq. NH4Cl solution (20 
mL). The mixture was extracted with EtOAc (3 × 20 mL). The combined organic layers were washed 
with sat. aq. NaCl solution, water (2x 100 mL) and dried over Mg2SO4. After filtration, the solvent was 
removed in vacuo. Purification of the crude product by flash chromatography (silica gel, 
isohexane/EtOAc = 2:1) afforded the title compound as a dark yellow liquid (792 mg, 66% yield). 
1H NMR (400 MHz, CDCl3) δ / ppm = 7.41–7.30 (m, 3H), 7.19–7.11 (m, 2H), 5.98 (ddt, J = 17.4, 9.7, 
6.4, 1H), 5.65 (ddt, J = 17.1, 10.1, 5.9, 1H), 5.50 (s, 2H), 5.13–5.03 (m, 3H), 4.92 (dq, J = 17.2, 1.7, 
1H), 3.46 (dt, J = 6.4, 1.6, 2H), 3.25 (dt, J = 5.9, 1.7, 2H). 
13C NMR (100 MHz, CDCl3) δ / ppm = 143.7, 135.2, 135.2, 132.2, 130.9, 128.9, 128.2, 127.1, 117.4, 
116.1, 77.3, 77.0, 76.7, 52.0, 29.9, 26.6. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3077, 2925, 1639, 1455, 1248, 992, 913, 725, 694. 
MS (EI, 70 eV): m/z (%) = 239 (18), 238 (19), 210 (9),120, (15), 91 (100), 65 (10). 
HRMS (EI): m/z calc. for [C15H17N4]: 239.1422 found: 239,1417 (M+). 
 
 
Preparation of 1-benzyl-4,7-dihydro-1H-benzo[d][1,2,3]triazole (109) 
 
 
To a solution of 4, 5-diallyl-1-benzyl-1H-1,2,3-triazole (108; 280 mg, 1.17 mmol) in DCM (10 mL) 
was added Hoveyda-Grubbs Catalyst™ 2nd generation (35 mg, 0.06 mmol) and stirred for 12 h at 45 °C. 
The resulting solution was stirred for 1 h before quenched with sat. aq. NH4Cl solution (20 mL). The 
mixture was extracted with EtOAc (3 × 20 mL). After filtration, the solvent was removed in vacuo. 
Purification of the crude product by flash chromatography (silica gel, isohexane/EtOAc = 3:1) afforded 
the title compound as a colourless solid (202 mg, 66% yield). 
M.p. (°C): 106.2 – 110.5. 
 
115 W. Zhand, H. Wu, Z. Liu, P. Zhong, L. Zhang, X. Huang, J. Cheng, Chem. Commun. 2006, 46, 
4826. 
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1H NMR (400 MHz, CDCl3) δ / ppm = 7.41–7.30 (m, 3H), 7.25–7.19 (m, 2H), 6.03–5.83 (m, 1H), 5.75 
(dtt, J = 10.1, 3.3, 2.2, 1H), 3.56–3.37 (m, 2H), 3.21–3.02 (m, 2H). 
13C NMR (101 MHz, CDCl3) δ / ppm = 141.2, 134.8, 129.5, 129.0, 128.4, 127.5, 125.2, 121.1, 52.2, 
24.1, 22.2. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3036, 2888, 2837, 1590, 1456, 1431, 1193, 1096, 950, 732, 714, 
672. 
MS (EI, 70 eV): m/z (%) = 211 (1), 182 (21), 180 (29), 91 (100), 65 (8). 
HRMS (EI): m/z calc. for [C15H17N4]: 211.1109 found: 211,1102 (M+).  
 
4 Preparation and reactions of (1H-tetrazol-5-yl)zinc pivalates 
4.1 Synthesis of protected 1H-tetrazoles of type 110 
 
1H-tetrazoles (110a–b) were synthesized according to the literature.92  
The respective benzylamine (100 mmol, 1.0 equiv), triethyl orthoformate (23.68 g, 160 mmol, 
1.6 equiv) and sodium azide (9.75 g, 150 mmol, 1.5 equiv) were suspended in acetic acid (100 mL) and 
stirred at 85 °C for 12 h. The mixture was cooled to room temperature and the solvents were evaporated 
in vacuo. The residue was diluted with water and extracted twice with ethyl acetate. The combined 
organic layers were washed with hydrochloric acid (1 M), water, a saturated NaHCO3 solution and 
brine. Subsequently, they were dried over MgSO4 and the solvent was evaporated in vacuo. The residue 
was purified by flash chromatography (silica gel, isohexane/EtOAc = 1:1). 
4.2 Synthesis of the (1H-tetrazol-5-yl)zinc pivalates of type 111 
(1-Benzyl-1H-tetrazol-5-yl)zinc pivalate (111a) 
 
A dry and argon-flushed Schlenk-flask equipped with a magnetic stirring bar and a septum was charged 
with the 1-benzyl-1H-tetrazole (110b) (5.0 mmol). TMPZnOPiv (0.6 M in THF, 6.0 mmol) was added. 
After stirring the reaction mixture for 1-2 h at room temperature at 0 °C, the solvent was removed in 
vacuo (at least 6 h) and the dried solid (1-benzyl-1H-tetrazol-5-yl)zinc pivalate (111a) was obtained as 
a fine powder in quantitative yield. 
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(1-Benzyl-1H-tetrazol-5-yl)zinc pivalate (111b) 
 
A dry and argon-flushed Schlenk-flask equipped with a magnetic stirring bar and a septum was charged 
with the 1-(4-methoxybenzyl)-1H-tetrazole (110b) (5.0 mmol). TMPZnOPiv (0.6 M in THF, 6.0 mmol) 
was added. After stirring the reaction mixture for 1-2 h at room temperature at 0 °C, the solvent was 
removed in vacuo (at least 6 h) and the dried solid (1-(4-methoxybenzyl)-1H-tetrazol-5-yl)zinc pivalate 
(111b) was obtained as a fine powder in quantitative yield. 
4.3 Typical Procedures (TP) 
TP8: Typical procedure for the metalation of tetrazoles using TMPZnOPiv and subsequent 
Negishi cross coupling with aryl halides 
A dry and argon-flushed flask equipped with a magnetic stirrer and a septum was charged with THF. 
Subsequently, 1-(4-methoxybenzyl)-1H-tetrazole (110b; 0.6 mmol, 95 mg, 1.2 equiv) was dissolved 
and TMPZnOPiv (1.25 mmol, 2.5 equiv) was added dropwise while cooling with an ice bath. The 
solution was stirred for 1 h and was allowed to warm to room temperature. Then, the electrophile (0.5 
mmol, 1.0 equiv), Pd(OAc)2 (0.025 mmol, 4 mg, 5 mol%) and SPhos (0.05 mmol, 20 mg,10 mol%) 
were added and the mixture was stirred overnight at 45 °C. The suspension was quenched with sat. aq. 
NH4Cl solution and extracted with EtOAc (3 x 15 mL). The combined organic layers were dried over 
MgSO4 and the solvent was evaporated in vacuo. The residue was purified twice via column 
chromatography und yielded the desired product. 
 
TP9: Typical procedure for the deprotection of aryl tetrazoles using ammonium formate 
A pressure resistant flask equipped with a cover and a magnetic stirrer was charged with water and 
isopropyl alcohol in equal ratio. Subsequently, the protected aryl tetrazole of type 112 (0.2 mmol, 
1.0 equiv) was suspended and palladium on charcoal (50 mg, 0.05 mmol, 5 mol%) and ammonium 
formate (198 mg, 3.15 mmol, 15 equiv) were added. The reaction mixture was stirred overnight at 
65 °C. The suspension was filtered through celite and washed with isopropyl alcohol. The filtrate was 
extracted with DCM three times and the combined organic layers were dried over MgSO4. The solvent 
was evaporated in vacuo. The residue was purified via column chromatography and yielded the desired 
product.  
 
TP10: Typical procedure for the amination of tetrazoles using TMPZnOPiv and amine benzoate 
1-(4-Methoxybenzyl)-1H-tetrazole (110b; 0.5 mmol, 95 mg)  was dissolved in THF (1.5 mL) and 
cooled down to 0 °C.  TMPZnOPiv solution (1 mmol, 2.0 equiv) was slowly added to the stirred 
solution. A dry, argon flushed Schlenk-flask equipped with magnetic stirring bar and septum was 
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charged with amine benzoate (0.5 mmol), copper (II) triflate (36 mg, 0.1 mmol, 20% mol) and THF 
(2.0 mL). The metalated species was slowly added to vigorously stirred solution. After 2 h the mixture 
was quenched with sat. aq. NH4Cl solution (15 mL), extracted with DCM (3×15 mL) and dried over 
anhydrous MgSO4. The crude product was purified by flash column chromatography. 
4.4 Metalation of Tetrazoles using TMPZnOPiv and subsequent Negishi cross-coupling 
reactiongs with aryl halides 
1-(4-Methoxybenzyl)-5-(4-methoxyphenyl)-1H-tetrazole (112a)  
 
1-(4-Methoxybenzyl)-5-(4-methoxyphenyl)-1H-tetrazole (112a) was prepared according to TP8 4-
iodo-anisol (75h; 93.5 mg, 0.5 mmol) as electrophile. The product was purified by flash column 
chromatography (isohexane : EtOAc 9:1 + 5% triethylamine) to obtain the desired product (0.133 g, 
0.45 mmol, 90%) as an white solid.  
M.p. (°C): 120–122. 
1H NMR (400 MHz, CDCl3) δ / ppm = 7.50–7.44 (m, 2H), 7.07–6.99 (m, 2H), 6.98–6.89 (m, 2H), 
6.83–6.75 (m, 2H), 5.47 (s, 2H), 3.80 (s, 3H), 3.72 (s, 3H). 
13C NMR (100 MHz, CDCl3) δ / ppm = 161.9, 154.6, 134.1, 130.4, 129.2, 129.0, 128.7, 127.9, 127.4, 
127.1, 115.7, 114.7, 55.5, 51.3, 27.1, 26.7. 
IR (Diamond-ATR, neat): 3072, 0 29647, 2929, 2842, 1601, 1519, 1475, 1465, 1449, 1294, 1246, 
1163 cm-1. 
MS (EI, 70 eV): m/z (%) 296 (4), 121 (100), 97 (12), 85 (13), 71 (17), 57 (24), 43 (21). 
HRMS (EI): m/z calc. for [C16H16N4O2]: 296.1273; found: 296.1268 (M+). 
The 1H data are in accordance with those reported in the literature.116 
 
 
116 L. E. Kaim, L. Grimaud, P. Patil, Org. Lett 2011, 13, 1261. 
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N-(tert-butyl)-4-(1-(4-methoxybenzyl)-1H-tetrazol-5-yl)benzamide (112b)  
 
N-(tert-butyl)-4-(1-(4-methoxybenzyl)-1H-tetrazol-5-yl)benzamide (112b) was prepared according to 
TP8 using  4-bromo-N-(tert-butyl) benzamide (75m; 128 mg, 0.500 mmol, 1.0 equiv) as electrophile. 
The product was purified by flash column chromatography (isohexane : EtOAc 2:1 + 5% triethylamine) 
to obtain the desired product (0.122 g, 0.335 mmol, 67%) as an white solid.  
M.p. (°C): 120–125. 
1H NMR (400 MHz, CDCl3) δ 7.81 (d, J = 8.4 Hz, 2H), 7.57 (d, J = 8.4 Hz, 2H), 7.04 (d, J = 8.7 Hz, 
2H), 6.81 (d, J = 8.7 Hz, 2H), 6.27 (s, 1H), 5.50 (s, 2H), 3.74 (s, 3H), 1.45 (s, 9H). 
13C NMR (101 MHz, CDCl3) δ 165.7, 160.1, 153.9, 138.6, 129.2, 128.9, 127.7, 126.4, 125.7, 114.7, 
55.5, 52.2, 51.3, 28.9. 
IR (Diamond-ATR, neat): 3418 (w), 2965 (m), 2932 (m), 2864 (w), 2361 (w), 1590 (s), 1478 (vs), 
1460 (s), 1420 (s), 1278 (s), 1023 (s), 720 (s). 
MS (EI, 70 eV): m/z (%) 365 (16), 293 (10), 122 (7), 121 (100). 
HRMS (EI): m/z calc. for [C20H23N5O2]: 365.1852; found: 365.1846. 
4-(1-(4-Methoxybenzyl)-1H-tetrazol-5-yl)benzaldehyde (112c)  
 
4-(1-(4-Methoxybenzyl)-1H-tetrazol-5-yl)benzaldehyde (112c) was prepared according to TP8 using  
4-bromobenzaldehyde (75n; 93 mg, 0.5 mmol. 1.0 eq) as electrophile. The product was purified by 
flash column chromatography (isohexane : EtOAc 2:1 + 5% triethylamine) to obtain the desired product 
(0.120 g, 0.41 mmol, 82%) as an white oil.  
1H NMR (400 MHz, CDCl3) δ 10.04 (s, 1H), 8.06–7.84 (m, 2H), 7.84–7.60 (m, 2H), 7.06–6.95 (m, 
2H), 6.89–6.68 (m, 2H), 5.52 (s, 2H), 3.73 (s, 3H). 
13C NMR (101 MHz, CDCl3) δ 165.5, 159.9, 153.8, 133.0, 130.2, 127.9, 125.5, 114.6, 61.6, 55.3, 51.3, 14.3. 
IR (Diamond-ATR, neat): 2961 (w), 2922 (w), 2838 (w), 1714 (m), 1700 (m), 1610 (m), 1513 (s), 
1459 (m), 1451 (m), 1294 (m), 1253 (vs), 1246 (s), 1208 (s), 1178 (s), 1115 (m), 1028 (s), 742 (s), 687 
(s). 
MS (70 eV, EI) m/z (%): 294 (5), 238 (14), 207 (3), 122 (9), 121 (110), 91 (6), 77 (5). 
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HRMS (EI): m/z calc. for [C16H14N4O2]: 294.1117; found: 294.1111 (M+). 
 
Ethyl 4-(1-(4-methoxybenzyl)-1H-tetrazol-5-yl)benzoate (112d)  
 
Ethyl 4-(1-(4-methoxybenzyl)-1H-tetrazol-5-yl)benzoate (112d) was prepared according to TP8 using  
ethyl 4-bromobenzoate (75c; 106 mg, 0.5 mmol. 1.0 eq) as electrophile. The product was purified by 
flash column chromatography (isohexane : EtOAc 2:1 + 5% triethylamine) to obtain the desired product 
(0.098 g, 0.29 mmol, 58%) as an white solid.  
M.p. (°C): 110–114. 
1H NMR (400 MHz, CDCl3) δ 8.37 – 8.12 (m, 2H), 7.72 – 7.63 (m, 2H), 7.13 – 7.05 (m, 2H), 6.89 – 
6.81 (m, 2H), 5.57 (s, 2H), 4.43 (q, J = 7.2 Hz, 2H), 3.79 (s, 3H), 1.43 (t, J = 7.2 Hz, 3H). 
13C NMR (101 MHz, CDCl3) δ 165.5, 160.0, 153.8, 133.0, 130.2, 128.8, 127.9, 125.5, 114.6, 61.6, 
55.4, 51.3, 14.3. 
IR (Diamond-ATR, neat): 3087 (w), 2954 (w), 2928 (w), 1538 (m), 1481 (s), 1446 (m), 1247 (m), 
1137 (m), 769 (m), 730 (vs), 699 (m), 690 (m), 679 (m), 655 (s). 
MS (70 eV, EI) m/z (%): 338 (13), 277 (72), 183 (17), 121 (100), 91 (44), 71 (39), 57 (52). 
HRMS (EI): m/z calc. for [C18H18N4O3]: 338.1373; found: 338.1367 (M+). 
 
 
5-(4-Isocyanophenyl)-1-(4-methoxybenzyl)-1H-tetrazole (112e)  
 
5-(4-Isocyanophenyl)-1-(4-methoxybenzyl)-1H-tetrazole (112e) was prepared according to TP8 using  
4-bromobenzonitrile (75d; 92 mg, 0.5 mmol, 1.0 equiv) as electrophile. The product was purified by 
flash column chromatography (isohexane : EtOAc 2:1 + 5% triethylamine) to obtain the desired product 
(0.93 g, 0.32 mmol, 64%) as an white solid.  
M.p. (°C): 106–108. 
1H NMR (400 MHz, CDCl3) δ 7.74 (d, J = 8.4 Hz, 2H), 7.70–7.60 (m, 2H), 7.04–6.96 (m, 2H), 6.82 – 
6.78 (m, 2H), 5.51 (s, 3H), 3.73 (s, 3H). 
13C NMR (101 MHz, CDCl3) δ 160.1, 153.0, 132.8, 129.6, 128.6, 128.3, 125.2, 117.5, 115.2, 114.7, 
55.3, 51.4. 
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IR (Diamond-ATR, neat): 2934 (w), 2845 (w), 2214 (w), 1611 (s), 1586 (m), 1512 (vs), 1250 (vs), 
1178 (s), 1106 (s), 1031 (s), 848 (s), 771 (s), 679 (m), 655 (s). 
MS (70 eV, EI) m/z (%): 291 (6), 235 (10), 121 (100), 78 (14), 77 (13), 71 (11), 57 (19), 55 (11), 43 
(16). 
HRMS (EI): m/z calc. for [C16H13N5O]: 291.1120; found: 291.1136.   
 
4-(1-(4-Methoxybenzyl)-1H-tetrazol-5-yl)-N,N-dimethylaniline (112f)  
 
4-(1-(4-Methoxybenzyl)-1H-tetrazol-5-yl)-N,N-dimethylaniline (112f) was prepared according to TP8 
using  4-bromo-N,N-dimethylaniline (75o;100 mg, 0.5 mmol, 1.0 equiv)as electrophile. The product 
was purified by flash column chromatography (isohexane : EtOAc 2:1 + 5% triethylamine) to obtain 
the desired product (0.114 g, 0.37 mmol, 74%) as an white solid.  
M.p. (°C): 120–122. 
1H NMR (400 MHz, CDCl3) δ / ppm = 7.51 (d, J = 9.0 Hz, 2H), 7.14 (d, J = 8.7 Hz, 2H), 6.87 (d, J = 
8.7 Hz, 2H), 6.73 (d, J = 8.9 Hz, 2H), 5.55 (s, 2H), 3.79 (s, 3H), 3.04 (s, 6H). 
13C NMR (100 MHz, CDCl3) δ / ppm = 159.7, 154.9, 152.0, 129.9, 128.6, 126.5, 114.5, 111.8, 110.1, 
55.4, 50.8, 40.1. 
IR (Diamond-ATR, neat): 2938 (w), 2839 (w), 2231 (w), 2220 (vw), 1612 (m), 1514 (vs), 1469 (m), 
1454 (m), 1251 (vs), 1178 (s), 1052 (w), 847 (m), 1028 (s), 840 (s), 833 (s), 821 (s), 776 (vs), 742 (s), 
687 (s). 
MS (EI, 70 eV): m/z (%) 309 (20), 281 (10), 253 (17), 252 (16), 145 (12), 132 (25), 121 (100), 78 (14), 
77 (13). 
HRMS (EI): m/z calc. for [C17H19N5O]: 309.3730; found: 309.1579. 
 
 
4-(1-(4-Methoxybenzyl)-1H-tetrazol-5-yl)aniline (112g)  
 
4-(1-(4-Methoxybenzyl)-1H-tetrazol-5-yl)aniline (112g) was prepared according to TP8 using  4-
bromoaniline (75p; 86 mg, 0.50 mmol, 1.0 equiv) as electrophile. The product was purified by flash 
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column chromatography (isohexane : EtOAc 1:2 + 5% triethylamine) to obtain the desired product 
(95 mg, 0.34 mmol, 68 %) as an white solid.  
M.p. (°C): 118–120. 
1H NMR (400 MHz, CDCl3) δ / ppm 7.40 (d, J = 8.6 Hz, 2H), 7.11 (d, J = 8.7 Hz, 2H), 6.86 (d, J = 
8.7 Hz, 2H), 6.72 (d, J = 8.6 Hz, 2H), 5.52 (s, 2H), 4.06 (s, 2H), 3.78 (s, 3H). 
13C NMR (101 MHz, CDCl3) δ / ppm 159.8, 154.8, 149.4, 130.3, 128.8, 126.3, 115.0, 114.9, 112.8, 
55.5, 50.9. 
IR (Diamond-ATR, neat): 2924 (m), 2867 (w), 2853 (w), 1612 (vs), 1514 (s), 1492 (s), 1252 (m), 
1234 (w), 821 (m), 847 (m), 776 (vs), 742 (s), 687 (s). 
MS (EI, 70 eV): m/z (%) 281 (8), 225 (9), 210 (18), 122 (11), 121 (100), 78 (16), 77 (19). 
HRMS (EI): m/z calc. for [C15H15N5O]: 281.1277; found: 281.1268. 
 
5-(1-(4-Methoxybenzyl)-1H-tetrazol-5-yl)-1H-indole (112h)  
 
5-(1-(4-Methoxybenzyl)-1H-tetrazol-5-yl)-1H-indole (112h) was prepared according to TP8 using  5-
bromo-1H-indole (75q; 98 mg, 0.5 mmol, 1.0 equiv) as electrophile. The product was purified by flash 
column chromatography (isohexane : EtOAc 1:2 + 5% triethylamine) to obtain the desired product 
(94 mg, 0.32 mmol, 62 %) as an white solid.  
M.p. (°C): 115–118. 
1H NMR (400 MHz, CDCl3) δ / ppm 9.36 (s, 1H), 7.86–7.84 (m, 1H), 7.51–7.47 (m, 1H), 7.36 (dd, J 
= 8.5, 1.7 Hz, 1H), 7.33–7.30 (m, 1H), 7.13 (d, J = 8.7 Hz, 2H), 6.84 (d, J = 8.7 Hz, 2H), 6.60–6.55 (m, 
1H), 5.56 (s, 2H), 3.77 (s, 3H). 
13C NMR (101 MHz, CDCl3) δ / ppm 159.7, 156.0, 137.2, 129.0, 128.0, 126.4, 126.3, 122.2, 122.0, 
114.5, 114.4, 112.2, 103.1, 55.3, 50.9.  
IR (Diamond-ATR, neat): 2925 (m), 2853 (m), 1613 (m), 1515 (vs), 1458 (s), 1252 (vs), 1178 (m), 
1076 (w), 1007 (w), 821 (m), 770 (m), 847 (m), 679 (m), 655 (s). 
MS (EI, 70 eV): m/z (%) 305 (18), 249 (8), 234 (7), 122 (8), 121 (100), 78 (6), 77 (7). 
HRMS (EI): m/z calc. for [C17H15N5O]: 305.1277; found: 305.1268.  
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4.5 Preparation of unprotected aryl tetrazoles using ammonium formate and palladium on 
charcoal 
5-(4-Methoxyphenyl)-1H-tetrazole (113a) 
 
According to TP9 1-(4-methoxybenzyl)-5-(4-methoxyphenyl)-1H-tetrazole (112a; 75 mg, 0.25 mmol, 
1.0 equiv) was suspended in water (2 mL) and isopropyl alcohol (2 mL). Subsequently, palladium on 
carbon (53 mg, 0.50 mmol, 5%) and ammonium formate (209 mg, 3.75 mmol, 15 equiv) were added 
and the mixture was stirred overnight at 65 °C. The crude product was purified twice by column 
chromatography (silica gel, DCM/MeOH = 4:1). Compound (113a; 41 mg, 0.24 mmol, 95%) was 
obtained as colorless solid.    
M.p. (°C): 218–220. 
1H NMR (400 MHz, CDCl3) δ / ppm 7.98 (d, J = 8.8 Hz, 2H), 7.09 (d, J = 8.7 Hz, 2H), 6.37 (s, 1H), 
3.81 (s, 3H). 
13C NMR (101 MHz, CDCl3) δ / ppm 161.0, 155.6, 128.4, 117.6, 114.7, 55.4. 
IR (Diamond-ATR, neat): 2842 (w), 1611 (s), 1499 (s), 1259 (s), 1164 (m), 1026 (m), 1020 (s), 832 
(vs), 750 (vs), 821 (m), 770 (m), 847 (m), 679 (m), 655 (s) 
MS (EI, 70 eV): m/z (%) 176 (20), 148 (33), 134 (16), 133 (100), 105 (19), 103 (17), 90 (21), 57 (13), 
44 (79), 43 (48). 
HRMS (EI): m/z calc. for [C8H8N4O]: 176.0698; found: 176.0687. 
 
5-(4-(Trifluoromethyl)phenyl)-1H-tetrazole (113b) 
 
According to TP9 1-(4-methoxybenzyl)-5-(4-(trifluoromethyl)phenyl)-1H-tetrazole (112i; 64 mg, 
0.21 mmol, 1.0 equiv) was suspended in water (2 mL) and isopropyl alcohol (2 mL). Subsequently, 
palladium on carbon (50 mg, 0.05 mmol, 5%) and ammonium formate (198 mg, 3.15 mmol, 15 equiv) 
were added and the mixture was stirred overnight at 65 °C. The crude product was purified twice by 
column chromatography (silica gel, DCM/MeOH = 10:1). Compound (113b; 42mg, 0.19 mmol, 93%) 
was obtained as colorless solid. 
M.p. (°C): 202–205.    
1H NMR (400 MHz, DMSO-d6) δ / ppm 8.18 (d, J = 8.0 Hz, 1H), 7.76 (d, J = 8.1 Hz, 1H). 
13C NMR (101 MHz DMSO-d6) δ / ppm 136.1, 128.1, 127.7, 126.7, 126.3, 125.88 (q, J = 3.9 Hz). 
IR (Diamond-ATR, neat): 2927 (w), 1455 (s), 1323 (vs), 1167 (s), 1123 (s), 1067 (vs), 1013 (s), 986 
(w), 849 (s), 729 (s), 847 (m), 679 (m), 655 (s). 
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MS (EI, 70 eV): m/z (%) 214 (11), 186 (82), 171 (100), 152 (38), 121 (51), 102 (13), 50 (10). 
HRMS (EI): m/z calc. for [C8H5F3N4]: 214.0466; found: 214.0443. 
 
Ethyl 4-(1H-tetrazol-5-yl)benzoate (113c) 
 
According to TP9 ethyl 4-(1-(4-methoxybenzyl)-1H-tetrazol-5-yl)benzoate (112c; 114 mg, 0.33 mmol, 
1.0 equiv) was suspended in water (2 mL) and isopropyl alcohol (2 mL). Subsequently, palladium on 
carbon (16 mg, 0.26 mmol, 5%) and ammonium formate (316 mg, 1.04 mmol, 15 equiv) were added 
and the mixture was stirred overnight at 65 °C. The crude product was purified twice by column 
chromatography (silica gel, DCM/MeOH = 10:1). Compound (113c) (64mg, 0.294 mmol, 88%) was 
obtained as colorless solid. 
M.p. (°C): 220–224.    
1H NMR (400 MHz, DMSO-d6) δ / ppm 8.18–8.03 (m, 2H), 8.03–7.84 (m, 2H), 4.32 (q, J = 7.1 Hz, 
2H), 1.34 (t, J = 7.1 Hz, 3H). 
13C NMR (101 MHz DMSO-d6) δ / ppm 165.7, 130.4, 127.3, 61.4, 55.4, 45.8, 14.6, 8.9. 
IR (Diamond-ATR, neat): 2968 (m), 2936 (m), 2361 (vw), 1660 (w), 1502 (m), 1401 (s), 1275 (s), 
994 (s), 729 (s), 847 (m), 679 (m), 655 (s), 1115 (m), 1028 (s), 840 (s), 833 (s), 821 (s), 776 (vs), 742 
(s). 
MS (EI, 70 eV): m/z (%) 218 (64), 202 (100), 175 (44), 147 (54), 129 (18), 102 (19), 87 (11). 
HRMS (EI): m/z calc. for [C10H10N4O2]: 218.0804; found: 218.1051. 
 
N,N-dimethyl-4-(1H-tetrazol-5-yl)aniline (113d) 
 
According to TP9 4-(1-(4-methoxybenzyl)-1H-tetrazol-5-yl)-N,N-dimethylaniline (112f; 103 mg, 
0.330 mmol, 1.0 equiv) was suspended in water (2 mL) and isopropyl alcohol (2 mL). Subsequently, 
palladium on carbon (70 mg, 0.66 mmol, 5%) and ammonium formate (340 mg, 5.00 mmol, 15 equiv) 
were added and the mixture was stirred overnight at 65 °C. The crude product was purified twice by 
column chromatography (silica gel, DCM/MeOH = 10:1). Compound (113d; 57 mg, 0.31 mmol, 92%) 
was obtained as colorless solid.    
M.p. (°C): 218–220. 
1H NMR (400 MHz, DMSO-d6) δ / ppm 7.85 (d, J = 8.9 Hz, 2H), 6.86 (d, J = 8.9 Hz, 2H), 3.00 (s, 
6H). 
 13C NMR (101 MHz DMSO-d6) δ / ppm 155.4, 152.4, 128.6, 128.4, 112.4, 110.8. 
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MS (EI, 70 eV): m/z (%) 189 (66), 161 (65), 160 (100), 147 (11), 146 (40), 145 (50), 132 (11), 118 
(12), 80 (10). 
IR (Diamond-ATR, neat): 2926 (w), 2853 (w), 2531 (w), 2133 (w), 1658 (w), 1505 (m), 1407 (m), 
1206 (m), 944 (m), 749 (s), 729 (s), 847 (m), 679 (m), 655 (s). 
HRMS (EI): m/z calc. for [C9H11N5]: 189.1014; found: 189.1011. 
4.6 Amination of 1H-tetrazoles using TMPZnOPiv and amine benzoate 
Ethyl 1-(1-(4-methoxybenzyl)-1H-tetrazol-5-yl)piperidine-3-carboxylate (115d) 
 
Ethyl 1-(1-(4-methoxybenzyl)-1H-tetrazol-5-yl)piperidine-3-carboxylate (155d) was prepared 
according to TP10 using 1-(benzoyloxy)piperidine-3-carboxylate (114a; 138 mg, 0.5 mmol) as 
electrophile. The desired product (163 mg, 0.475 mmol, 95 %) was obtained via column 
chromatography (silica gel, isohexane/ethylacetate 1:1) as a colourless solid. 
M.p. (°C): 172–175. 
1H NMR (400 MHz, DMSO-d6) δ / ppm 7.18–7.08 (m, 2H), 6.94–6.80 (m, 2H), 5.41 (s, 2H), 4.10–
3.92 (m, 2H), 3.70 (s, 3H), 3.44 (dd, J = 12.6, 3.8 Hz, 1H), 3.29 (s, 1H), 3.17 (dd, J = 12.6, 8.6 Hz, 1H), 
3.01 (ddd, J = 12.5, 9.3, 3.2 Hz, 1H), 2.61 (dq, J = 8.5, 4.2 Hz, 1H), 1.88–1.77 (m, 1H), 1.72–1.57 (m, 
2H), 1.51 (qt, J = 9.7, 5.1 Hz, 1H), 1.11 (t, J = 7.1 Hz, 3H). 
 13C NMR (101 MHz DMSO-d6) δ / ppm 172.9, 159.5, 158.7, 130.3, 129.2, 127.0, 114.6, 60.6, 55.6, 
51.5, 50.1, 49.8, 26.1, 23.4, 14.4. 
IR (Diamond-ATR, neat): 2250 (vw), 2116 (vw), 1977 (vw), 1944 (vw), 1725 (vw), 1663 (vw), 1515 
(vw), 1252 (vw), 1109 (vw), 887 (vw), 821 (m), 797 (vw), 758 (m). 
MS (EI, 70 eV): m/z (%) 345(1), 317 (11), 156 (14), 122 (10), 121 (100), 92, (2),78 (4), 76 (4). 
HRMS (EI): m/z calc. for [C17H23N5O3]: 345.1801; found: 345.1803. 
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2-(4-(1-(4-Methoxybenzyl)-1H-tetrazol-5-yl)piperazin-1-yl)pyrimidine (115b) 
 
2-(4-(1-(4-Methoxybenzyl)-1H-tetrazol-5-yl)piperazin-1-yl)pyrimidine (114b) was prepared according 
to TP10 using 4-(pyrimidin-2-yl)piperazin-1-yl benzoate (142 mg, 0.5 mmol, 1.0 eq) as electrophile. 
The desired product (115 mg, 0.34 mmol, 68 %) was obtained via column chromatography (silica gel, 
isohexane/ethylacetate 2:1) as a colourless solid. 
M.p. (°C): 175–177. 
1H NMR (400 MHz, DMSO-d6) δ / ppm 8.35 (d, J = 4.7 Hz, 2H), 7.27–7.13 (m, 2H), 6.98–6.78 (m, 
2H), 6.63 (t, J = 4.7 Hz, 1H), 5.47 (s, 2H), 3.88–3.74 (m, 4H), 3.70 (s, 3H), 3.38–3.21 (m, 4H). 
 13C NMR (101 MHz DMSO-d6) δ / ppm 161.5, 159.5, 158.5, 158.4, 129.5, 126.9, 114.7, 111.0, 55.6, 
50.1, 49.3, 43.1. 
IR (Diamond-ATR, neat): 2868 (w), 2167 (w), 1586 (s), 1539 (s), 1484 (s), 1421 (m), 1315 (w), 1250 
(vs), 1176 (s), 1022 (s), 957 (s), 816 (vs), 762 (m), 756 (m). 
MS (EI, 70 eV): m/z (%) 352 (13), 148 (11), 136 (10), 134 (39), 122 (26), 121 (100), 80 (25), 77 (12), 
44 (28). 
HRMS (EI): m/z calc. for [C17H20N8O]: 352.1760; found: 352.1755. 
 
N-((1R,4R)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydronaphthalen-1-yl)-1-(4-methoxybenzyl)-N-
methyl-1H-tetrazol-5-amine (115c) 
 
N-((1R,4R)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydronaphthalen-1-yl)-1-(4-methoxybenzyl)-N-
methyl-1H-tetrazol-5-amine (115c) was prepared according to TP10 using O-benzoyl-N-((1R,4S)-4-
(3,4-dichlorophenyl)-1,2,3,4-tetrahydronaphthalen-1-yl)-N-methylhydroxylamine (114c; 213 mg, 0.5 
mmol)) as electrophile. The desired product (180 mg, 0.365 mmol, 73 %) was obtained via column 
chromatography (silica gel, isohexane/ethylacetate 1:1) as a colourless solid. 
M.p. (°C): 155–160. 
1H NMR (400 MHz, DMSO-d6) δ / ppm 7.34 (d, J = 8.2 Hz, 1H), 7.23–7.14 (m, 2H), 7.13–7.07 (m, 
2H), 7.07–6.99 (m, 2H), 6.96 (dd, J = 7.0, 2.1 Hz, 1H), 6.94–6.88 (m, 2H), 6.81 (dd, J = 8.3, 2.1 Hz, 
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1H), 5.62 (d, J = 16.1 Hz, 1H), 5.38 (d, J = 16.1 Hz, 1H), 5.05 (dd, J = 9.9, 6.7 Hz, 1H), 4.15 (dd, J = 
5.8, 2.8 Hz,1H), 3.84 (s, 3H), 2.78 (s, 3H), 2.18–2.03 (m, 1H), 2.02–1.89 (m, 1H), 1.86–1.69 (m, 2H). 
 13C NMR (101 MHz DMSO-d6) δ / ppm 159.8, 158.8, 146.8, 138.3, 135.4, 132.3, 130.9, 130.6, 130.1, 
128.1, 128.0, 127.8, 127.5, 127.3, 126.4, 114.6, 60.4, 60.2, 55.4, 50.8, 42.9, 33.1, 29.8, 27.0, 23.8. 
IR (Diamond-ATR, neat): 2938 (w), 1584 (m), 1572 (m), 1514 (s), 1466 (m), 1249 (s), 1178 (m), 
1055 (s), 1027 (vs), 1006 (s), 820 (s), 791 (m), 766 (m), 746 (m), 738 (s), 679 (m). 
MS (EI, 70 eV): m/z (%) 493 (4), 273 (8), 271 (12), 201 (12), 159 (20), 129 (13), 121 (100), 43 (10). 
HRMS (EI): m/z calc. for [C26H25Cl2N5O]: 493.1436; found: 493.1431. 
 
(2,6-Difluorophenyl)(4-(3-((1-(4-methoxybenzyl)-1H-tetrazol-5-yl)(phenethyl)amino)propyl)-
phenyl)methanone (115d) 
 
(2,6-Difluorophenyl)(4-(3-((1-(4-methoxybenzyl)-1H-tetrazol-5-yl)(phenethyl)amino)propyl)-
phenyl)methanone (115d) was prepared according to TP10 using (4-(3-
((benzoyloxy)(phenethyl)amino)propyl)phenyl)(2,6-difluorophenyl)methanone (114d; 250 mg, 0.5 
mmol) as electrophile. The desired product (240 mg, 0.425 mmol, 85 %) was obtained via column 
chromatography (silica gel, isohexane/ethylacetate 1:1) as a colourless solid. 
M.p. (°C): 184–185. 
1H NMR (400 MHz, DMSO-d6) δ / ppm 7.85–7.74 (m, 2H), 7.48 (tt, J = 8.5, 6.3 Hz, 1H), 7.28–7.19 
(m, 3H), 7.19–7.13 (m, 2H), 7.09–6.98 (m, 4H), 7.00–6.91 (m, 2H), 6.88–6.81 (m, 2H), 5.17 (s, 2H), 
3.77 (s, 3H), 3.50–3.36 (m, 2H), 3.31–3.20 (m, 2H), 2.73 (dd, J = 8.5, 6.5 Hz, 2H), 2.50 (t, J = 7.7 Hz, 
2H), 1.90–1.71 (m, 2H). 
 13C NMR (101 MHz DMSO-d6) δ / ppm 188.4, 161.0, 161.0, 159.7, 158.5, 158.5, 157.6, 148.3, 138.2, 
135.0, 132.0, 131.9, 131.8, 130.0, 128.7, 128.7, 128.6, 128.2, 126.6, 125.9, 114.4, 112.1, 112.0, 111.9, 
111.8, 111.8, 55.3, 53.6, 51.4, 50.0, 33.8, 32.9, 28.5. 
IR (Diamond-ATR, neat): 938 (w), 2919 (w), 2168 (w), 1672 (s), 1623 (s), 1514 (s), 1501 (w), 1464 
(vs), 1279 (s), 1252 (s), 1006 (s), 931 (s), 792 (s). 
MS (EI, 70 eV): m/z (%) 567 (2), 476 (17), 313 (5), 232 (26), 141 (17), 122 (10), 121 (100), 105 (10). 
HRMS (EI): m/z calc. for [C33H31F2N5O2]: 567.2446; found: 567.2468. 
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